CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: indole-3-methanol
Accession: CHEBI:24814
browse the term
Definition: An indolyl alcohol carrying a hydroxymethyl group at position 3. It is a constituent of the cruciferous vegetables and had anticancer activity.
Synonyms: exact_synonym: 1H-indol-3-ylmethanol
related_synonym: 3-hydroxymethylindole; 3-indolylcarbinol; Formula=C9H9NO; InChI=1S/C9H9NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-5,10-11H,6H2; InChIKey=IVYPNXXAYMYVSP-UHFFFAOYSA-N; SMILES=OCc1c[nH]c2ccccc12; indole-3-carbinol
xref: CAS:700-06-1; Gmelin:1603301; HMDB:HMDB0005785; LINCS:LSM-2011
xref_mesh: MESH:C016517
xref: PMID:11755234; PMID:16634522; PMID:19064917; PMID:23800833; PMID:24200994; PMID:24357105; PMID:24488207; Reaxys:121323; Wikipedia:Indole-3-carbinol
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
4930474N05Rikl1
RIKEN cDNA 4930474N05 gene like 1
affects expression
EXP
indole-3-carbinol affects the expression of 4930474N05RIKL1 mRNA
CTD
PMID:21396975
NCBI chr18:40,617,254...40,619,561
G
A1bg
alpha-1-B glycoprotein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of A1BG mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA]
CTD
PMID:22129741
NCBI chr 7:92,493,934...92,498,460
Ensembl chr 7:92,494,372...92,498,097
G
A2m
alpha-2-macroglobulin
affects expression
EXP
indole-3-carbinol affects the expression of A2M mRNA
CTD
PMID:21396975
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786
G
Aamdc
adipogenesis associated, Mth938 domain containing
affects expression
EXP
indole-3-carbinol affects the expression of AAMDC mRNA
CTD
PMID:21396975
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression multiple interactions
ISO EXP
indole-3-carbinol results in decreased expression of ABCB1 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1A mRNA
CTD
PMID:16082211 PMID:22129741
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCB1B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1B mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression affects expression
EXP
indole-3-carbinol results in increased expression of ABCC1 mRNA indole-3-carbinol affects the expression of ABCC1 mRNA
CTD
PMID:11752103 PMID:21396975
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
indole-3-carbinol results in increased expression of ABCC2 mRNA
CTD
PMID:11752103
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCC3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCC4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
G
Abcd2
ATP binding cassette subfamily D member 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCD2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCD2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
G
Abcd3
ATP binding cassette subfamily D member 3
affects expression
EXP
indole-3-carbinol affects the expression of ABCD3 mRNA
CTD
PMID:21396975
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
indole-3-carbinol results in increased expression of ABCG2 mRNA
CTD
PMID:17077187
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
G
Abcg3l1
ATP-binding cassette, subfamily G (WHITE), member 3-like 1
affects expression
EXP
indole-3-carbinol affects the expression of ABCG3L1 mRNA
CTD
PMID:21396975
NCBI chr14:5,124,541...5,177,265
Ensembl chr14:5,124,353...5,177,184
G
Abcg3l3
ATP-binding cassette, subfamily G (WHITE), member 3-like 3
affects expression
EXP
indole-3-carbinol affects the expression of ABCG3L3 mRNA
CTD
PMID:21396975
NCBI chr14:4,844,161...4,892,194
Ensembl chr14:4,844,218...4,892,194
G
Abcg3l4
ATP-binding cassette, subfamily G (WHITE), member 3-like 4
affects expression
EXP
indole-3-carbinol affects the expression of ABCG3L4 mRNA
CTD
PMID:21396975
NCBI chr14:4,545,206...4,590,223
Ensembl chr14:4,545,223...4,585,347
G
Abcg4
ATP binding cassette subfamily G member 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]
CTD
PMID:22129741
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
G
Abcg5
ATP binding cassette subfamily G member 5
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCG5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG5 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ABCG8 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG8 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
affects expression
EXP
indole-3-carbinol affects the expression of ABHD2 mRNA
CTD
PMID:21396975
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
G
Abhd8
abhydrolase domain containing 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA
CTD
PMID:22129741
NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667
G
Abi2
abl-interactor 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABI2 mRNA
CTD
PMID:22129741
NCBI chr 9:61,827,186...61,905,703
Ensembl chr 9:61,827,139...61,905,699
G
Acad8
acyl-CoA dehydrogenase family, member 8
affects expression
EXP
indole-3-carbinol affects the expression of ACAD8 mRNA
CTD
PMID:21396975
NCBI chr 8:25,382,271...25,406,404
Ensembl chr 8:25,382,273...25,406,414
G
Acer2
alkaline ceramidase 2
affects expression
EXP
indole-3-carbinol affects the expression of ACER2 mRNA
CTD
PMID:21396975
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
G
Acer3
alkaline ceramidase 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACER3 mRNA
CTD
PMID:22129741
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
G
Acot1
acyl-CoA thioesterase 1
affects expression
EXP
indole-3-carbinol affects the expression of ACOT1 mRNA
CTD
PMID:21396975
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot2
acyl-CoA thioesterase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT2 mRNA
CTD
PMID:22129741
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acot3
acyl-CoA thioesterase 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT3 mRNA
CTD
PMID:22129741
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot4
acyl-CoA thioesterase 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT4 mRNA
CTD
PMID:22129741
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Acot8
acyl-CoA thioesterase 8
affects expression
EXP
indole-3-carbinol affects the expression of ACOT8 mRNA
CTD
PMID:21396975
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
G
Acot9
acyl-CoA thioesterase 9
affects expression
EXP
indole-3-carbinol affects the expression of ACOT9 mRNA
CTD
PMID:21396975
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acp3
acid phosphatase 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ACP3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACP3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:104,905,586...104,954,236
G
Acsl3
acyl-CoA synthetase long-chain family member 3
affects expression
EXP
indole-3-carbinol affects the expression of ACSL3 mRNA
CTD
PMID:21396975
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM2 mRNA
CTD
PMID:22129741
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
affects expression
EXP
indole-3-carbinol affects the expression of ACSM3 mRNA
CTD
PMID:21396975
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:174,133,288...174,160,184
G
Acsm5
acyl-CoA synthetase medium-chain family member 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSM5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA]
CTD
PMID:22129741
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
G
Acss1
acyl-CoA synthetase short-chain family member 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA
CTD
PMID:22129741
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:139,450,383...139,500,325
G
Acta2
actin alpha 2, smooth muscle
affects expression
EXP
indole-3-carbinol affects the expression of ACTA2 mRNA
CTD
PMID:21396975
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Acyp1
acylphosphatase 1
affects expression
EXP
indole-3-carbinol affects the expression of ACYP1 mRNA
CTD
PMID:21396975
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
G
Adamts2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADAMTS2 mRNA
CTD
PMID:22129741
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
G
Adamtsl4
ADAMTS-like 4
affects expression
EXP
indole-3-carbinol affects the expression of ADAMTSL4 mRNA
CTD
PMID:21396975
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
G
Adat2
adenosine deaminase, tRNA-specific 2
affects expression
EXP
indole-3-carbinol affects the expression of ADAT2 mRNA
CTD
PMID:21396975
NCBI chr 1:7,954,520...7,975,254
Ensembl chr 1:7,954,631...7,975,251
G
Adcy10
adenylate cyclase 10
affects expression
EXP
indole-3-carbinol affects the expression of ADCY10 mRNA
CTD
PMID:21396975
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
G
Adgrb1
adhesion G protein-coupled receptor B1
affects expression
EXP
indole-3-carbinol affects the expression of ADGRB1 mRNA
CTD
PMID:21396975
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
G
Adgrb2
adhesion G protein-coupled receptor B2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB2 mRNA
CTD
PMID:22129741
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
G
Adgrb3
adhesion G protein-coupled receptor B3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB3 mRNA
CTD
PMID:22129741
NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855
G
Adgrg2
adhesion G protein-coupled receptor G2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG2 mRNA
CTD
PMID:22129741
NCBI chr X:38,106,067...38,231,286
Ensembl chr X:34,297,402...34,422,609
G
Adgrg6
adhesion G protein-coupled receptor G6
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG6 mRNA
CTD
PMID:22129741
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
G
Adgrv1
adhesion G protein-coupled receptor V1
affects expression
EXP
indole-3-carbinol affects the expression of ADGRV1 mRNA
CTD
PMID:21396975
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adissp
adipose secreted signaling protein
affects expression
EXP
indole-3-carbinol affects the expression of ADISSP mRNA
CTD
PMID:21396975
NCBI chr 3:118,364,730...118,378,881
Ensembl chr 3:118,362,363...118,378,838
G
Adora1
adenosine A1 receptor
affects expression
EXP
indole-3-carbinol affects the expression of ADORA1 mRNA
CTD
PMID:21396975
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Aebp1
AE binding protein 1
affects expression
EXP
indole-3-carbinol affects the expression of AEBP1 mRNA
CTD
PMID:21396975
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
G
Afg2a
AFG2 AAA ATPase homolog A
affects expression
EXP
indole-3-carbinol affects the expression of AFG2A mRNA
CTD
PMID:21396975
NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705
G
Agtr1a
angiotensin II receptor, type 1a
affects expression
EXP
indole-3-carbinol affects the expression of AGTR1A mRNA
CTD
PMID:21396975
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Ahi1
Abelson helper integration site 1
affects expression
EXP
indole-3-carbinol affects the expression of AHI1 mRNA
CTD
PMID:21396975
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
G
Ahnak
AHNAK nucleoprotein
affects expression
EXP
indole-3-carbinol affects the expression of AHNAK mRNA
CTD
PMID:21396975
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Ahr
aryl hydrocarbon receptor
multiple interactions increases expression affects expression decreases expression
ISO EXP
[indole-3-carbinol co-treated with DDT] results in increased expression of AHR mRNA; ARNT protein affects the reaction [indole-3-carbinol results in decreased expression of AHR protein]; indole-3-carbinol binds to and results in increased activity of AHR protein; indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [indole-3-carbinol results in increased expression of CYP1A1 mRNA]; indole-3-carbinol binds to and results in increased activity of AHR protein; indole-3-carbinol inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] indole-3-carbinol results in increased expression of AHR mRNA AHR protein affects the reaction [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL22 mRNA]; AHR protein affects the susceptibility to [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein]; AHR protein affects the susceptibility to [indole-3-carbinol results in decreased expression of ITGAX protein]; AHR protein affects the susceptibility to [indole-3-carbinol results in increased expression of CD86 protein] indole-3-carbinol affects the expression of AHR mRNA
CTD
PMID:8384853 PMID:9407059 PMID:11752103 PMID:17311112 PMID:18259752 PMID:21396975 PMID:21948866 PMID:22129741 PMID:35295139 PMID:37217010 More...
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akap5
A-kinase anchoring protein 5
affects expression
EXP
indole-3-carbinol affects the expression of AKAP5 mRNA
CTD
PMID:21396975
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
G
Akip1
A-kinase interacting protein 1
affects expression
EXP
indole-3-carbinol affects the expression of AKIP1 mRNA
CTD
PMID:21396975
NCBI chr 1:163,734,730...163,743,648
Ensembl chr 1:163,734,798...163,743,648
G
Akirin1
akirin 1
affects expression
EXP
indole-3-carbinol affects the expression of AKIRIN1 mRNA
CTD
PMID:21396975
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
G
Akr7a2
aldo-keto reductase family 7, member A2
increases expression
EXP
indole-3-carbinol results in increased expression of AKR7A5
CTD
PMID:9806166
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:151,552,343...151,560,909
G
Akr7a3
aldo-keto reductase family 7 member A3
affects expression multiple interactions increases activity
EXP
indole-3-carbinol affects the expression of AKR7A3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA indole-3-carbinol results in increased activity of AKR7A3 protein
CTD
PMID:9328168 PMID:21396975 PMID:22129741
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO
indole-3-carbinol results in decreased expression of and results in decreased phosphorylation of AKT1 protein indole-3-carbinol results in decreased phosphorylation of AKT1 protein
CTD
PMID:29992829 PMID:33118390
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alas2
5'-aminolevulinate synthase 2
affects expression
EXP
indole-3-carbinol affects the expression of ALAS2 mRNA
CTD
PMID:21396975
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression affects expression multiple interactions
ISO EXP
indole-3-carbinol results in increased expression of ALDH1A1 mRNA indole-3-carbinol affects the expression of ALDH1A1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA
CTD
PMID:21396975 PMID:21948866 PMID:22129741
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of ALDH1A2 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in decreased expression of ALDH1A2 mRNA]
CTD
PMID:21948866
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:71,877,850...71,957,107
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ALDH3A1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH3A1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Alox15
arachidonate 15-lipoxygenase
affects expression
EXP
indole-3-carbinol affects the expression of ALOX15 mRNA
CTD
PMID:21396975
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Alpk1
alpha-kinase 1
affects expression
EXP
indole-3-carbinol affects the expression of ALPK1 mRNA
CTD
PMID:21396975
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions
EXP
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of ALPL protein]
CTD
PMID:37150287
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Amdhd1
amidohydrolase domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of AMDHD1 mRNA
CTD
PMID:21396975
NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
G
Amdhd2
amidohydrolase domain containing 2
affects expression
EXP
indole-3-carbinol affects the expression of AMDHD2 mRNA
CTD
PMID:21396975
NCBI chr10:13,187,579...13,196,148
Ensembl chr10:13,187,578...13,196,095
G
Amfr
autocrine motility factor receptor
affects expression
EXP
indole-3-carbinol affects the expression of AMFR mRNA
CTD
PMID:21396975
NCBI chr19:10,996,705...11,032,260
Ensembl chr19:10,996,099...11,032,247
G
Anapc10
anaphase promoting complex subunit 10
affects expression
EXP
indole-3-carbinol affects the expression of ANAPC10 mRNA
CTD
PMID:21396975
NCBI chr19:28,152,299...28,205,552
Ensembl chr19:28,152,299...28,205,467
G
Angptl4
angiopoietin-like 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANGPTL4 mRNA
CTD
PMID:22129741
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankrd22
ankyrin repeat domain 22
affects expression
EXP
indole-3-carbinol affects the expression of ANKRD22 mRNA
CTD
PMID:21396975
NCBI chr 1:231,639,035...231,670,537
Ensembl chr 1:231,639,314...231,670,381
G
Ankrd29
ankyrin repeat domain 29
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ANKRD29 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANKRD29 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296
G
Ankrd37
ankyrin repeat domain 37
affects expression
EXP
indole-3-carbinol affects the expression of ANKRD37 mRNA
CTD
PMID:21396975
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:46,268,443...46,271,963
G
Ankrd42
ankyrin repeat domain 42
affects expression
EXP
indole-3-carbinol affects the expression of ANKRD42 mRNA
CTD
PMID:21396975
NCBI chr 1:146,648,080...146,691,086
Ensembl chr 1:146,648,080...146,691,108
G
Ankrd65
ankyrin repeat domain 65
affects expression
EXP
indole-3-carbinol affects the expression of ANKRD65 mRNA
CTD
PMID:21396975
NCBI chr 5:166,398,359...166,400,616
Ensembl chr 5:166,397,748...166,400,953
G
Anp32e
acidic nuclear phosphoprotein 32 family member E
affects expression
EXP
indole-3-carbinol affects the expression of ANP32E mRNA
CTD
PMID:21396975
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
G
Anxa5
annexin A5
affects expression
EXP
indole-3-carbinol affects the expression of ANXA5 mRNA
CTD
PMID:21396975
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Anxa7
annexin A7
affects expression
EXP
indole-3-carbinol affects the expression of ANXA7 mRNA
CTD
PMID:21396975
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
indole-3-carbinol results in increased expression of APAF1 protein
CTD
PMID:29775573
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apbb1
amyloid beta precursor protein binding family B member 1
affects expression
EXP
indole-3-carbinol affects the expression of APBB1 mRNA
CTD
PMID:21396975
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
G
Apeg3
antisense paternally expressed gene 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of APEG3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of APEG3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181 Ensembl chr 1:67,121,900...67,122,181
G
Aph1b
aph-1 homolog B, gamma secretase subunit
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of APH1B mRNA
CTD
PMID:22129741
NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243
G
Apip
APAF1 interacting protein
affects expression
EXP
indole-3-carbinol affects the expression of APIP mRNA
CTD
PMID:21396975
NCBI chr 3:89,431,964...89,458,000
Ensembl chr 3:89,432,037...89,458,340
G
App
amyloid beta precursor protein
affects expression
EXP
indole-3-carbinol affects the expression of APP mRNA
CTD
PMID:21396975
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aqp1
aquaporin 1
affects expression
EXP
indole-3-carbinol affects the expression of AQP1 mRNA
CTD
PMID:21396975
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Ar
androgen receptor
decreases activity multiple interactions
ISO EXP
indole-3-carbinol results in decreased activity of AR protein indole-3-carbinol inhibits the reaction [bisphenol A results in increased expression of AR protein]
CTD
PMID:16082211 PMID:24257414
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arhgap18
Rho GTPase activating protein 18
affects expression
EXP
indole-3-carbinol affects the expression of ARHGAP18 mRNA
CTD
PMID:21396975
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgef9
Cdc42 guanine nucleotide exchange factor 9
affects expression
EXP
indole-3-carbinol affects the expression of ARHGEF9 mRNA
CTD
PMID:21396975
NCBI chr X:59,919,560...60,077,538
Ensembl chr X:59,920,870...60,077,513
G
Arl13a
ARF like GTPase 13A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARL13A mRNA
CTD
PMID:22129741
NCBI chr X:97,380,370...97,406,704
Ensembl chr X:97,380,390...97,406,702
G
Arl4a
ARF like GTPase 4A
affects expression
EXP
indole-3-carbinol affects the expression of ARL4A mRNA
CTD
PMID:21396975
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
G
Arl6
ARF like GTPase 6
affects expression
EXP
indole-3-carbinol affects the expression of ARL6 mRNA
CTD
PMID:21396975
NCBI chr11:40,711,878...40,738,254
Ensembl chr11:40,712,022...40,737,937
G
Armcx1
armadillo repeat containing, X-linked 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ARMCX1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ARMCX1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
G
Armcx3
armadillo repeat containing, X-linked 3
affects expression
EXP
indole-3-carbinol affects the expression of ARMCX3 mRNA
CTD
PMID:21396975
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
ARNT protein affects the reaction [indole-3-carbinol results in decreased expression of AHR protein]
CTD
PMID:37217010
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arpp21
cAMP regulated phosphoprotein 21
affects expression
EXP
indole-3-carbinol affects the expression of ARPP21 mRNA
CTD
PMID:21396975
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
G
Arrdc3
arrestin domain containing 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARRDC3 mRNA
CTD
PMID:22129741
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Arv1
ARV1 homolog, fatty acid homeostasis modulator
affects expression
EXP
indole-3-carbinol affects the expression of ARV1 mRNA
CTD
PMID:21396975
NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
affects expression
EXP
indole-3-carbinol affects the expression of ASAP2 mRNA
CTD
PMID:21396975
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
G
Asb10
ankyrin repeat and SOCS box-containing 10
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB10 mRNA
CTD
PMID:22129741
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
G
Asb5
ankyrin repeat and SOCS box-containing 5
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ASB5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB5 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr16:37,237,869...37,305,207
Ensembl chr16:37,235,405...37,278,109
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ASNS mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASNS mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Aspg
asparaginase
affects expression
EXP
indole-3-carbinol affects the expression of ASPG mRNA
CTD
PMID:21396975
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
G
Astl
astacin like metalloendopeptidase
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ASTL mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASTL mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 3:114,563,135...114,580,295
Ensembl chr 3:114,563,135...114,578,868
G
Atad2
ATPase family, AAA domain containing 2
affects expression
EXP
indole-3-carbinol affects the expression of ATAD2 mRNA
CTD
PMID:21396975
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
affects expression
EXP
indole-3-carbinol affects the expression of ATF3 mRNA
CTD
PMID:21396975
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
affects expression
EXP
indole-3-carbinol affects the expression of ATP2B2 mRNA
CTD
PMID:21396975
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
G
Atp5if1
ATP synthase inhibitory factor subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of ATP5IF1 mRNA
CTD
PMID:21396975
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
G
Atp5mc3
ATP synthase membrane subunit c locus 3
affects expression
EXP
indole-3-carbinol affects the expression of ATP5MC3 mRNA
CTD
PMID:21396975
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
G
Atp6ap1l
ATPase H+ transporting accessory protein 1 like
affects expression
EXP
indole-3-carbinol affects the expression of ATP6AP1L mRNA
CTD
PMID:21396975
NCBI chr 2:22,037,542...22,079,376
Ensembl chr 2:22,037,563...22,065,038
G
Atp6v0d2
ATPase H+ transporting V0 subunit D2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA
CTD
PMID:22129741
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
G
Atp6v1c2
ATPase H+ transporting V1 subunit C2
affects expression
EXP
indole-3-carbinol affects the expression of ATP6V1C2 mRNA
CTD
PMID:21396975
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
G
Atp8b2
ATPase phospholipid transporting 8B2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATP8B2 mRNA
CTD
PMID:22129741
NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883
G
Atpaf1
ATP synthase mitochondrial F1 complex assembly factor 1
affects expression
EXP
indole-3-carbinol affects the expression of ATPAF1 mRNA
CTD
PMID:21396975
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
G
Atrnl1
attractin like 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ATRNL1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATRNL1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
G
Aurkb
aurora kinase B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AURKB mRNA
CTD
PMID:22129741
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Avpr1a
arginine vasopressin receptor 1A
affects expression
EXP
indole-3-carbinol affects the expression of AVPR1A mRNA
CTD
PMID:21396975
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
G
B3galt5
Beta-1,3-galactosyltransferase 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GALT5 mRNA
CTD
PMID:22129741
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
G
B3gnt2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
affects expression
EXP
indole-3-carbinol affects the expression of B3GNT2 mRNA
CTD
PMID:21396975
NCBI chr14:101,009,682...101,034,507
Ensembl chr14:96,806,664...96,835,273
G
B3gnt9
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GNT9 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of B3GNT9 mRNA
CTD
PMID:22129741
NCBI chr19:50,039,649...50,042,206
Ensembl chr19:33,128,142...33,132,344
G
B9d1
B9 domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of B9D1 mRNA
CTD
PMID:21396975
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
G
Bahd1
bromo adjacent homology domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of BAHD1 mRNA
CTD
PMID:21396975
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
G
Barx2
BARX homeobox 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BARX2 mRNA
CTD
PMID:22129741
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
indole-3-carbinol results in increased expression of BAX; indole-3-carbinol results in increased expression of BAX protein
CTD
PMID:16082211 PMID:29775573 PMID:33118390 PMID:34085558
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bbof1
basal body orientation factor 1
affects expression
EXP
indole-3-carbinol affects the expression of BBOF1 mRNA
CTD
PMID:21396975
NCBI chr 6:104,055,246...104,081,036
Ensembl chr 6:104,055,241...104,082,071
G
Bbs5
Bardet-Biedl syndrome 5
affects expression
EXP
indole-3-carbinol affects the expression of BBS5 mRNA
CTD
PMID:21396975
NCBI chr 3:54,410,429...54,431,831
Ensembl chr 3:54,410,775...54,431,829
G
Bbs7
Bardet-Biedl syndrome 7
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of BBS7 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BBS7 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:119,434,760...119,474,665
Ensembl chr 2:119,434,760...119,474,396
G
Bcas1
brain enriched myelin associated protein 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCAS1 mRNA
CTD
PMID:22129741
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of BCL2; indole-3-carbinol results in decreased expression of BCL2 protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of BCL2 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein]
CTD
PMID:15811958 PMID:16082211 PMID:29775573 PMID:33118390 PMID:34085558
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein]
CTD
PMID:15811958
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of BCL2L1; indole-3-carbinol results in decreased expression of BCL2L1 protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of BCL2L1 protein]
CTD
PMID:16082211 PMID:29992829 PMID:33118390 PMID:34085558
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
indole-3-carbinol results in increased expression of BCL2L11 protein
CTD
PMID:33118390 PMID:34085558
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:115,366,646...115,404,068
G
Bcl6
BCL6, transcription repressor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA
CTD
PMID:22129741
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
affects expression
EXP
indole-3-carbinol affects the expression of BDH2 mRNA
CTD
PMID:21396975
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
G
Bex3
brain expressed X-linked 3
affects expression
EXP
indole-3-carbinol affects the expression of BEX3 mRNA
CTD
PMID:21396975
NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800
G
Bhlhe40
basic helix-loop-helix family, member e40
affects expression
EXP
indole-3-carbinol affects the expression of BHLHE40 mRNA
CTD
PMID:21396975
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]
CTD
PMID:15811958
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]
CTD
PMID:15811958
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] indole-3-carbinol results in decreased expression of BIRC5
CTD
PMID:15811958 PMID:16082211
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Blnk
B-cell linker
affects expression
EXP
indole-3-carbinol affects the expression of BLNK mRNA
CTD
PMID:21396975
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bloc1s6
biogenesis of lysosomal organelles complex 1 subunit 6
affects expression
EXP
indole-3-carbinol affects the expression of BLOC1S6 mRNA
CTD
PMID:21396975
NCBI chr 3:109,816,397...109,826,528
Ensembl chr 3:109,816,366...109,828,308
G
Bmal1
basic helix-loop-helix ARNT like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA
CTD
PMID:22129741
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Bmp2k
BMP-2 inducible kinase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BMP2K mRNA
CTD
PMID:22129741
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
G
Bmp4
bone morphogenetic protein 4
affects expression
EXP
indole-3-carbinol affects the expression of BMP4 mRNA
CTD
PMID:21396975
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Bmp5
bone morphogenetic protein 5
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of BMP5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
G
Bms1
BMS1 ribosome biogenesis factor
affects expression
EXP
indole-3-carbinol affects the expression of BMS1 mRNA
CTD
PMID:21396975
NCBI chr 4:151,558,163...151,595,187
Ensembl chr 4:151,558,163...151,595,127
G
Borcs8
BLOC-1 related complex subunit 8
affects expression
EXP
indole-3-carbinol affects the expression of BORCS8 mRNA
CTD
PMID:21396975
NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339
G
Brca1
BRCA1, DNA repair associated
multiple interactions increases expression
ISO
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein; BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]]; indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] indole-3-carbinol results in increased expression of BRCA1 mRNA; indole-3-carbinol results in increased expression of BRCA1 protein
CTD
PMID:11110848 PMID:16434996 PMID:18259752
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
increases expression multiple interactions affects expression
ISO EXP
indole-3-carbinol results in increased expression of BRCA2 mRNA; indole-3-carbinol results in increased expression of BRCA2 protein [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein indole-3-carbinol affects the expression of BRCA2 mRNA
CTD
PMID:16434996 PMID:21396975
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Btf3l4
basic transcription factor 3-like 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTF3L4 mRNA
CTD
PMID:22129741
NCBI chr 5:123,567,902...123,587,527
Ensembl chr 5:123,567,907...123,586,866
G
Btn1a1
butyrophilin, subfamily 1, member A1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTN1A1 mRNA
CTD
PMID:22129741
NCBI chr17:41,653,499...41,664,246
Ensembl chr17:41,654,249...41,664,272
G
Bzw2
basic leucine zipper and W2 domains 2
affects expression
EXP
indole-3-carbinol affects the expression of BZW2 mRNA
CTD
PMID:21396975
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
G
C16h10orf71
similar to human chromosome 10 open reading frame 71
affects expression
EXP
indole-3-carbinol affects the expression of C16H10ORF71 mRNA
CTD
PMID:21396975
NCBI chr16:7,910,597...7,961,900
Ensembl chr16:7,910,433...7,961,958
G
C19h16orf74
similar to human chromosome 16 open reading frame 74
affects expression
EXP
indole-3-carbinol affects the expression of C19H16ORF74 mRNA
CTD
PMID:21396975
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
G
C1h11orf24
similar to human chromosome 11 open reading frame 24
affects expression
EXP
indole-3-carbinol affects the expression of C1H11ORF24 mRNA
CTD
PMID:21396975
NCBI chr 1:200,945,188...200,953,953
Ensembl chr 1:200,945,180...200,962,585
G
C5ar1
complement C5a receptor 1
affects expression
EXP
indole-3-carbinol affects the expression of C5AR1 mRNA
CTD
PMID:21396975
NCBI chr 1:76,948,622...76,959,826
G
C7
complement C7
affects expression
EXP
indole-3-carbinol affects the expression of C7 mRNA
CTD
PMID:21396975
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
G
C8h15orf61
similar to human chromosome 15 open reading frame 61
affects expression
EXP
indole-3-carbinol affects the expression of C8H15ORF61 mRNA
CTD
PMID:21396975
NCBI chr 8:63,868,125...63,872,863
Ensembl chr 8:63,868,125...63,872,751
G
Cabcoco1
ciliary associated calcium binding coiled-coil 1
affects expression
EXP
indole-3-carbinol affects the expression of CABCOCO1 mRNA
CTD
PMID:21396975
NCBI chr20:20,058,492...20,167,973
Ensembl chr20:20,058,454...20,167,725
G
Cables1
Cdk5 and Abl enzyme substrate 1
affects expression
EXP
indole-3-carbinol affects the expression of CABLES1 mRNA
CTD
PMID:21396975
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA
CTD
PMID:22129741
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
G
Calr3
calreticulin 3
affects expression
EXP
indole-3-carbinol affects the expression of CALR3 mRNA
CTD
PMID:21396975
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
affects expression
EXP
indole-3-carbinol affects the expression of CAMK2N1 mRNA
CTD
PMID:21396975
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Car3
carbonic anhydrase 3
affects expression
EXP
indole-3-carbinol affects the expression of CAR3 mRNA
CTD
PMID:21396975
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Car6
carbonic anhydrase 6
affects expression
EXP
indole-3-carbinol affects the expression of CAR6 mRNA
CTD
PMID:21396975
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
G
Casp3
caspase 3
increases activity multiple interactions increases cleavage decreases expression
ISO EXP
indole-3-carbinol results in increased activity of CASP3 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP3 protein; indole-3-carbinol results in increased cleavage of and results in increased activity of CASP3 protein indole-3-carbinol results in increased cleavage of CASP3 protein indole-3-carbinol results in decreased expression of CASP3 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CASP3 protein]
CTD
PMID:16082211 PMID:17297389 PMID:20335513 PMID:29775573 PMID:29992829 PMID:33118390 PMID:34085558 PMID:37150287 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
affects expression
EXP
indole-3-carbinol affects the expression of CASP4 mRNA
CTD
PMID:21396975
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:2,598,876...2,635,092
G
Casp7
caspase 7
decreases expression multiple interactions increases cleavage increases activity
ISO EXP
indole-3-carbinol results in decreased expression of CASP7 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP7 protein indole-3-carbinol results in increased cleavage of CASP7 protein indole-3-carbinol results in increased activity of CASP7 protein
CTD
PMID:17297389 PMID:29992829 PMID:33118390 PMID:34085558
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases activity multiple interactions increases cleavage
ISO EXP
indole-3-carbinol results in increased activity of CASP9 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP9 protein; indole-3-carbinol results in increased cleavage of and results in increased activity of CASP9 protein indole-3-carbinol results in increased cleavage of CASP9 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CASP9 protein]
CTD
PMID:16082211 PMID:17297389 PMID:20335513 PMID:29775573 PMID:33118390 PMID:34085558 PMID:37150287 More...
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases activity
ISO EXP
indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased activity of CAT protein] indole-3-carbinol results in increased activity of CAT protein indole-3-carbinol inhibits the reaction [Thioacetamide results in decreased expression of CAT protein]
CTD
PMID:29775573 PMID:37150287
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Catsper2
cation channel, sperm associated 2
affects expression
EXP
indole-3-carbinol affects the expression of CATSPER2 mRNA
CTD
PMID:21396975
NCBI chr 3:108,368,654...108,389,380
Ensembl chr 3:108,368,668...108,388,050
G
Cavin3
caveolae associated protein 3
affects expression
EXP
indole-3-carbinol affects the expression of CAVIN3 mRNA
CTD
PMID:21396975
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
G
Cby1
chibby 1, beta catenin antagonist
affects expression
EXP
indole-3-carbinol affects the expression of CBY1 mRNA
CTD
PMID:21396975
NCBI chr 7:111,216,835...111,223,305
G
Cc2d2a
coiled-coil and C2 domain containing 2A
affects expression
EXP
indole-3-carbinol affects the expression of CC2D2A mRNA
CTD
PMID:21396975
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
G
Ccdc121
coiled-coil domain containing 121
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC121 mRNA
CTD
PMID:22129741
NCBI chr 6:24,970,845...24,973,451
Ensembl chr 6:24,970,833...24,973,478
G
Ccdc152
coiled-coil domain containing 152
affects expression
EXP
indole-3-carbinol affects the expression of CCDC152 mRNA
CTD
PMID:21396975
NCBI chr 2:52,507,987...52,532,880
Ensembl chr 2:52,507,981...52,532,826
G
Ccdc158
coiled-coil domain containing 158
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC158 mRNA
CTD
PMID:22129741
NCBI chr14:15,411,178...15,468,579
Ensembl chr14:15,411,163...15,468,581
G
Ccdc178
coiled-coil domain containing 178
affects expression
EXP
indole-3-carbinol affects the expression of CCDC178 mRNA
CTD
PMID:21396975
NCBI chr18:13,074,834...13,472,732
Ensembl chr18:13,075,468...13,472,160
G
Ccdc28a
coiled-coil domain containing 28A
affects expression
EXP
indole-3-carbinol affects the expression of CCDC28A mRNA
CTD
PMID:21396975
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
G
Ccdc43
coiled-coil domain containing 43
affects expression
EXP
indole-3-carbinol affects the expression of CCDC43 mRNA
CTD
PMID:21396975
NCBI chr10:87,650,554...87,662,788
Ensembl chr10:87,650,556...87,662,818
G
Ccdc59
coiled-coil domain containing 59
affects expression
EXP
indole-3-carbinol affects the expression of CCDC59 mRNA
CTD
PMID:21396975
NCBI chr 7:41,142,760...41,149,143
Ensembl chr 7:41,142,760...41,149,143
G
Ccdc71l
coiled-coil domain containing 71-like
affects expression
EXP
indole-3-carbinol affects the expression of CCDC71L mRNA
CTD
PMID:21396975
NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841 Ensembl chr 6:48,960,191...48,960,841
G
Ccdc88b
coiled-coil domain containing 88B
affects expression
EXP
indole-3-carbinol affects the expression of CCDC88B mRNA
CTD
PMID:21396975
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
G
Ccl1
C-C motif chemokine ligand 1
multiple interactions
ISO
indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CCL1 mRNA]
CTD
PMID:27783115
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCL11 mRNA
CTD
PMID:22129741
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl21
C-C motif chemokine ligand 21
affects expression
EXP
indole-3-carbinol affects the expression of CCL21 mRNA
CTD
PMID:21396975
NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:56,980,558...56,981,686
G
Ccl4
C-C motif chemokine ligand 4
affects expression
EXP
indole-3-carbinol affects the expression of CCL4 mRNA
CTD
PMID:21396975
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccn1
cellular communication network factor 1
affects expression
EXP
indole-3-carbinol affects the expression of CCN1 mRNA
CTD
PMID:21396975
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
affects expression
EXP
indole-3-carbinol affects the expression of CCN2 mRNA
CTD
PMID:21396975
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNA2 mRNA
CTD
PMID:22129741
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CCNB1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNB1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions decreases expression affects expression
ISO EXP
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CCND1 protein] indole-3-carbinol results in decreased expression of CCND1 indole-3-carbinol affects the expression of CCND1 mRNA
CTD
PMID:15811958 PMID:16082211 PMID:21396975
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
affects expression
EXP
indole-3-carbinol affects the expression of CCND2 mRNA
CTD
PMID:21396975
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccne1
cyclin E1
affects localization multiple interactions decreases expression
ISO
indole-3-carbinol affects the localization of CCNE1 protein indole-3-carbinol affects the localization of [CDK2 protein binds to CCNE1 protein alternative form]; indole-3-carbinol promotes the reaction [CDK2 protein binds to CCNE1 protein alternative form] indole-3-carbinol results in decreased expression of CCNE1
CTD
PMID:15611077 PMID:16082211
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCNE2 mRNA
CTD
PMID:22129741
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnf
cyclin F
affects expression
EXP
indole-3-carbinol affects the expression of CCNF mRNA
CTD
PMID:21396975
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
G
Ccnq
cyclin Q
affects expression
EXP
indole-3-carbinol affects the expression of CCNQ mRNA
CTD
PMID:21396975
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
indole-3-carbinol results in increased expression of CCR5 protein
CTD
PMID:27783115
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Ccr7
C-C motif chemokine receptor 7
multiple interactions
ISO
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CCR7 protein
CTD
PMID:27783115
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,097,381...84,108,309
G
Cd14
CD14 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD14 mRNA
CTD
PMID:21396975
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd207
CD207 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD207 mRNA
CTD
PMID:21396975
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
G
Cd24
CD24 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD24 mRNA
CTD
PMID:21396975
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd300c2l1
CD300C molecule 2 like 1
affects expression
EXP
indole-3-carbinol affects the expression of CD300C2L1 mRNA
CTD
PMID:21396975
NCBI chr10:100,136,144...100,140,607
Ensembl chr10:100,136,867...100,140,427
G
Cd38
CD38 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD38 mRNA
CTD
PMID:21396975
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
G
Cd40
CD40 molecule
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CD40 protein; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 protein] indole-3-carbinol results in decreased expression of CD40 protein
CTD
PMID:21948866
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd46
CD46 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD46 mRNA
CTD
PMID:21396975
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
Cd69
Cd69 molecule
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CD69 protein]
CTD
PMID:24200994
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cd80
Cd80 molecule
increases expression multiple interactions
ISO
indole-3-carbinol results in increased expression of CD80 protein [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of CD80 protein; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CD80 protein]
CTD
PMID:21948866
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
decreases expression
ISO
indole-3-carbinol results in decreased expression of CD83 protein
CTD
PMID:27783115
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:20,887,309...20,907,083
G
Cd84
CD84 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD84 mRNA
CTD
PMID:21396975
NCBI chr13:84,327,580...84,367,153
Ensembl chr13:84,327,553...84,362,076
G
Cd86
CD86 molecule
multiple interactions decreases expression increases expression
ISO
[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of CD86 protein; AHR protein affects the susceptibility to [indole-3-carbinol results in increased expression of CD86 protein]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CD86 protein] indole-3-carbinol results in decreased expression of CD86 protein [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CD86 protein
CTD
PMID:21948866 PMID:27783115
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
Cd9
CD9 molecule
affects expression
EXP
indole-3-carbinol affects the expression of CD9 mRNA
CTD
PMID:21396975
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdc25b
cell division cycle 25B
affects expression
EXP
indole-3-carbinol affects the expression of CDC25B mRNA
CTD
PMID:21396975
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdca8
cell division cycle associated 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDCA8 mRNA
CTD
PMID:22129741
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdh1
cadherin 1
multiple interactions
EXP
[Hemin co-treated with indole-3-carbinol co-treated with 1,2-Dimethylhydrazine] affects the expression of CDH1 mRNA
CTD
PMID:29269057
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh11
cadherin 11
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDH11 mRNA
CTD
PMID:22129741
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdh13
cadherin 13
affects expression
EXP
indole-3-carbinol affects the expression of CDH13 mRNA
CTD
PMID:21396975
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
G
Cdh17
cadherin 17
affects expression
EXP
indole-3-carbinol affects the expression of CDH17 mRNA
CTD
PMID:21396975
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
G
Cdk2
cyclin dependent kinase 2
affects localization multiple interactions decreases activity decreases expression
ISO
indole-3-carbinol affects the localization of CDK2 protein indole-3-carbinol affects the localization of [CDK2 protein binds to CCNE1 protein alternative form]; indole-3-carbinol promotes the reaction [CDK2 protein binds to CCNE1 protein alternative form] indole-3-carbinol analog results in decreased activity of CDK2 protein; indole-3-carbinol results in decreased activity of CDK2 protein indole-3-carbinol results in decreased expression of CDK2
CTD
PMID:15611077 PMID:16082211 PMID:18023427 PMID:20570586
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
increases expression decreases activity decreases expression
ISO
indole-3-carbinol analog results in increased expression of CDK4 protein indole-3-carbinol analog results in decreased activity of CDK4 protein indole-3-carbinol results in decreased expression of CDK4
CTD
PMID:16082211 PMID:20570586
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
multiple interactions decreases activity decreases expression increases expression
EXP ISO
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDK6 mRNA indole-3-carbinol analog inhibits the reaction [SP1 protein binds to CDK6 promoter] indole-3-carbinol analog results in decreased activity of CDK6 promoter; indole-3-carbinol analog results in decreased activity of CDK6 protein indole-3-carbinol analog results in decreased expression of CDK6 mRNA; indole-3-carbinol analog results in decreased expression of CDK6 protein; indole-3-carbinol results in decreased expression of CDK6 indole-3-carbinol analog results in increased expression of CDK6 mRNA
CTD
PMID:16082211 PMID:18023427 PMID:20570586 PMID:22129741
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkl3
cyclin-dependent kinase-like 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDKL3 mRNA
CTD
PMID:22129741
NCBI chr10:36,263,212...36,349,268
Ensembl chr10:36,266,977...36,349,268
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression affects expression multiple interactions
ISO EXP
indole-3-carbinol analog results in increased expression of CDKN1A protein; indole-3-carbinol results in increased expression of CDKN1A; indole-3-carbinol results in increased expression of CDKN1A mRNA indole-3-carbinol affects the expression of CDKN1A mRNA; indole-3-carbinol affects the expression of CDKN1A protein [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDKN1A mRNA
CTD
PMID:16082211 PMID:17311112 PMID:18025290 PMID:20570586 PMID:21396975 PMID:22129741 More...
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
indole-3-carbinol analog results in increased expression of CDKN1B protein; indole-3-carbinol results in increased expression of CDKN1B; indole-3-carbinol results in increased expression of CDKN1B protein
CTD
PMID:16082211 PMID:20570586 PMID:34085558
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
increases expression
ISO
indole-3-carbinol results in increased expression of CDKN2B
CTD
PMID:16082211
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cds1
CDP-diacylglycerol synthase 1
affects expression
EXP
indole-3-carbinol affects the expression of CDS1 mRNA
CTD
PMID:21396975
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Cdx1
caudal type homeo box 1
affects expression
EXP
indole-3-carbinol affects the expression of CDX1 mRNA
CTD
PMID:21396975
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
G
Cdx2
caudal type homeo box 2
multiple interactions
ISO
indole-3-carbinol promotes the reaction [CL 075 results in increased expression of CDX2 mRNA]
CTD
PMID:27783115
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
G
Ceacam20
CEA cell adhesion molecule 20
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CEACAM20 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM20 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782
G
Ceacam4
CEA cell adhesion molecule 4
multiple interactions affects expression
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM10 mRNA indole-3-carbinol affects the expression of CEACAM10 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
G
Cenpf
centromere protein F
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPF mRNA
CTD
PMID:22129741
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpk
centromere protein K
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPK mRNA
CTD
PMID:22129741
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Cenpl
centromere protein L
affects expression
EXP
indole-3-carbinol affects the expression of CENPL mRNA
CTD
PMID:21396975
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
G
Cep76
centrosomal protein 76
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA
CTD
PMID:22129741
NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504
G
Cep83
centrosomal protein 83
affects expression
EXP
indole-3-carbinol affects the expression of CEP83 mRNA
CTD
PMID:21396975
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
G
Cers5
ceramide synthase 5
affects expression
EXP
indole-3-carbinol affects the expression of CERS5 mRNA
CTD
PMID:21396975
NCBI chr 7:130,859,993...130,897,979
Ensembl chr 7:130,859,990...130,897,947
G
Cert1
ceramide transporter 1
affects expression
EXP
indole-3-carbinol affects the expression of CERT1 mRNA
CTD
PMID:21396975
NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
G
Ces2c
carboxylesterase 2C
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CES2C mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CES2C mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790
G
Ces2h
carboxylesterase 2H
affects expression
EXP
indole-3-carbinol affects the expression of CES2H mRNA
CTD
PMID:21396975
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions decreases expression
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] indole-3-carbinol results in decreased expression of CFLAR
CTD
PMID:15811958 PMID:16082211
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Chchd6
coiled-coil-helix-coiled-coil-helix domain containing 6
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CHCHD6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
G
Chek1
checkpoint kinase 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CHEK1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA
CTD
PMID:22129741
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
G
Chid1
chitinase domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of CHID1 mRNA
CTD
PMID:21396975
NCBI chr 1:196,594,357...196,629,700
Ensembl chr 1:196,587,509...196,629,606
G
Chka
choline kinase alpha
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHKA mRNA
CTD
PMID:22129741
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chmp4bl1
chromatin modifying protein 4B-like 1
affects expression
EXP
indole-3-carbinol affects the expression of CHMP4BL1 mRNA
CTD
PMID:21396975
NCBI chr 4:68,049,742...68,050,791
Ensembl chr 4:68,049,705...68,050,676
G
Chmp4c
charged multivesicular body protein 4C
affects expression
EXP
indole-3-carbinol affects the expression of CHMP4C mRNA
CTD
PMID:21396975
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
G
Chpf
chondroitin polymerizing factor
affects expression
EXP
indole-3-carbinol affects the expression of CHPF mRNA
CTD
PMID:21396975
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
G
Chrac1
chromatin accessibility complex subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of CHRAC1 mRNA
CTD
PMID:21396975
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
G
Chrm2
cholinergic receptor, muscarinic 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHRM2 mRNA
CTD
PMID:22129741
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
G
Chrnb1
cholinergic receptor nicotinic beta 1 subunit
affects expression
EXP
indole-3-carbinol affects the expression of CHRNB1 mRNA
CTD
PMID:21396975
NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345
G
Chst14
carbohydrate sulfotransferase 14
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHST14 mRNA
CTD
PMID:22129741
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
G
Chtf8
chromosome transmission fidelity factor 8
affects expression
EXP
indole-3-carbinol affects the expression of CHTF8 mRNA
CTD
PMID:21396975
NCBI chr19:34,782,005...34,792,306
Ensembl chr19:34,781,856...34,792,578
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of CHUK protein]
CTD
PMID:15811958
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Cidea
cell death-inducing DFFA-like effector a
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CIDEA mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:60,894,874...60,920,481
G
Cimap1a
ciliary microtubule associated protein 1A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIMAP1A mRNA
CTD
PMID:22129741
NCBI chr 1:195,926,034...195,929,250
Ensembl chr 1:195,926,041...195,929,248
G
Cimap1b
ciliary microtubule associated protein 1B
affects expression
EXP
indole-3-carbinol affects the expression of CIMAP1B mRNA
CTD
PMID:21396975
NCBI chr 7:120,444,232...120,447,294
Ensembl chr 7:120,444,232...120,446,749
G
Cirbp
cold inducible RNA binding protein
affects expression
EXP
indole-3-carbinol affects the expression of CIRBP mRNA
CTD
PMID:21396975
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Cish
cytokine inducible SH2-containing protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CISH mRNA
CTD
PMID:22129741
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Ckap4
cytoskeleton-associated protein 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CKAP4 mRNA
CTD
PMID:22129741
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Clcc1
chloride channel CLIC-like 1
affects expression
EXP
indole-3-carbinol affects the expression of CLCC1 mRNA
CTD
PMID:21396975
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
G
Cldn1
claudin 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CLDN1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLDN1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn18
claudin 18
multiple interactions
EXP
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of CLDN18 mRNA]
CTD
PMID:27178563
NCBI chr 8:100,246,499...100,265,797
Ensembl chr 8:100,247,633...100,273,351
G
Clec10a
C-type lectin domain containing 10A
affects expression
EXP
indole-3-carbinol affects the expression of CLEC10A mRNA
CTD
PMID:21396975
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
G
Clec4g
C-type lectin domain family 4, member G
affects expression
EXP
indole-3-carbinol affects the expression of CLEC4G mRNA
CTD
PMID:21396975
NCBI chr12:1,780,370...1,785,027
Ensembl chr12:1,780,371...1,784,985
G
Clec9a
C-type lectin domain containing 9A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLEC9A mRNA
CTD
PMID:22129741
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
G
Clybl
citramalyl-CoA lyase
affects expression
EXP
indole-3-carbinol affects the expression of CLYBL mRNA
CTD
PMID:21396975
NCBI chr15:99,283,644...99,505,697
Ensembl chr15:99,283,650...99,505,695
G
Cma1
chymase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CMA1 mRNA
CTD
PMID:22129741
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Col14a1
collagen type XIV alpha 1 chain
affects expression
EXP
indole-3-carbinol affects the expression of COL14A1 mRNA
CTD
PMID:21396975
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col1a1
collagen type I alpha 1 chain
affects expression
EXP
indole-3-carbinol affects the expression of COL1A1 mRNA
CTD
PMID:21396975
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of COLQ mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA]
CTD
PMID:22129741
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Copg2
COPI coat complex subunit gamma 2
affects expression
EXP
indole-3-carbinol affects the expression of COPG2 mRNA
CTD
PMID:21396975
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
G
Coq10b
coenzyme Q10B
affects expression
EXP
indole-3-carbinol affects the expression of COQ10B mRNA
CTD
PMID:21396975
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
G
Coro6
coronin 6
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CORO6 mRNA
CTD
PMID:22129741
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
G
Cox6c-ps1
cytochrome c oxidase subunit VIc, pseudogene
affects expression
EXP
indole-3-carbinol affects the expression of COX6C-PS1 mRNA
CTD
PMID:21396975
NCBI chr19:52,192,612...52,193,470
Ensembl chr19:52,192,612...52,193,470
G
Cox8c
cytochrome c oxidase subunit 8C
affects expression
EXP
indole-3-carbinol affects the expression of COX8C mRNA
CTD
PMID:21396975
NCBI chr 6:122,028,566...122,029,889
Ensembl chr 6:122,028,566...122,029,889
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
affects expression
EXP
indole-3-carbinol affects the expression of CPEB2 mRNA
CTD
PMID:21396975
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
G
Cplx1
complexin 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPLX1 mRNA
CTD
PMID:22129741
NCBI chr14:1,184,677...1,216,392
G
Cplx2
complexin 2
affects expression
EXP
indole-3-carbinol affects the expression of CPLX2 mRNA
CTD
PMID:21396975
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
G
Cpt1b
carnitine palmitoyltransferase 1B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA
CTD
PMID:22129741
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
G
Cpz
carboxypeptidase Z
affects expression
EXP
indole-3-carbinol affects the expression of CPZ mRNA
CTD
PMID:21396975
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
G
Crat
carnitine O-acetyltransferase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA
CTD
PMID:22129741
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Crlf2
cytokine receptor-like factor 2
affects expression
EXP
indole-3-carbinol affects the expression of CRLF2 mRNA
CTD
PMID:21396975
NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642
G
Cryab
crystallin, alpha B
affects expression
EXP
indole-3-carbinol affects the expression of CRYAB mRNA
CTD
PMID:21396975
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Cryga
crystallin, gamma A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRYGA mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA]
CTD
PMID:22129741
NCBI chr 9:66,482,176...66,484,638
Ensembl chr 9:66,482,176...66,509,896
G
Cryl1
crystallin, lambda 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA
CTD
PMID:22129741
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Csmd1
CUB and Sushi multiple domains 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CSMD1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
G
Csrp1
cysteine and glycine-rich protein 1
affects expression
EXP
indole-3-carbinol affects the expression of CSRP1 mRNA
CTD
PMID:21396975
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Cstf3
cleavage stimulation factor subunit 3
affects expression
EXP
indole-3-carbinol affects the expression of CSTF3 mRNA
CTD
PMID:21396975
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
G
Ctps1
CTP synthase 1
affects expression
EXP
indole-3-carbinol affects the expression of CTPS1 mRNA
CTD
PMID:21396975
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctrc
chymotrypsin C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CTRC mRNA
CTD
PMID:22129741
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
G
Ctsd
cathepsin D
decreases expression
ISO
indole-3-carbinol results in decreased expression of CTSD protein
CTD
PMID:11110848
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
G
Ctse
cathepsin E
affects expression
EXP
indole-3-carbinol affects the expression of CTSE mRNA
CTD
PMID:21396975
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Cux2
cut-like homeobox 2
multiple interactions affects expression
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] indole-3-carbinol affects the expression of CUX2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cxcl17
C-X-C motif chemokine ligand 17
affects expression
EXP
indole-3-carbinol affects the expression of CXCL17 mRNA
CTD
PMID:21396975
NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:80,984,964...80,996,726
G
Cxcl9
C-X-C motif chemokine ligand 9
affects expression
EXP
indole-3-carbinol affects the expression of CXCL9 mRNA
CTD
PMID:21396975
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
ISO EXP
indole-3-carbinol affects the localization of CYCS protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CYCS protein]
CTD
PMID:16082211 PMID:37150287
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyfip2
cytoplasmic FMR1 interacting protein 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA
CTD
PMID:22129741
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression increases activity affects expression
ISO EXP
[indole-3-carbinol co-treated with DDT] results in increased expression of CYP1A1 mRNA indole-3-carbinol results in increased expression of CYP1A1 mRNA; indole-3-carbinol results in increased expression of CYP1A1 protein [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP1A1 mRNA; AHR protein promotes the reaction [indole-3-carbinol results in increased expression of CYP1A1 mRNA]; indole-3-carbinol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] indole-3-carbinol results in increased expression of CYP1A1; indole-3-carbinol results in increased expression of CYP1A1 mRNA indole-3-carbinol results in increased activity of CYP1A1 protein indole-3-carbinol affects the expression of CYP1A1 mRNA indole-3-carbinol results in increased expression of CYP1A1; indole-3-carbinol results in increased expression of CYP1A1 mRNA; indole-3-carbinol results in increased expression of CYP1A1 protein
CTD
PMID:8384853 PMID:9395520 PMID:9806166 PMID:11339718 PMID:11446830 PMID:11752103 PMID:12147290 PMID:15890477 PMID:17297389 PMID:17311112 PMID:21203749 PMID:21396975 PMID:21948866 PMID:22129741 PMID:22328411 PMID:24418717 More...
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity affects expression increases expression multiple interactions
EXP ISO
indole-3-carbinol results in increased activity of CYP1A2; indole-3-carbinol results in increased activity of CYP1A2 protein indole-3-carbinol affects the expression of CYP1A2 mRNA indole-3-carbinol results in increased expression of CYP1A2 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] indole-3-carbinol results in increased expression of CYP1A2; indole-3-carbinol results in increased expression of CYP1A2 protein indole-3-carbinol results in increased expression of CYP1A2 mRNA
CTD
PMID:8384853 PMID:9806166 PMID:12147290 PMID:17297389 PMID:21396975 PMID:22129741 PMID:22328411 PMID:28357125 More...
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression affects expression
ISO EXP
[indole-3-carbinol co-treated with DDT] results in increased expression of CYP1B1 mRNA indole-3-carbinol results in increased expression of CYP1B1 mRNA indole-3-carbinol affects the expression of CYP1B1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA]
CTD
PMID:12147290 PMID:15890477 PMID:17311112 PMID:21396975 PMID:22129741
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp26c1
cytochrome P450, family 26, subfamily C, polypeptide 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP26C1 mRNA
CTD
PMID:22129741
NCBI chr 1:235,458,961...235,468,433
Ensembl chr 1:235,459,356...235,466,842
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression increases activity
EXP
indole-3-carbinol results in increased expression of CYP2B1; indole-3-carbinol results in increased expression of CYP2B1 protein indole-3-carbinol results in increased activity of CYP2B1 protein
CTD
PMID:8384853 PMID:9806166 PMID:17297389
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b12
cytochrome P450, family 2, subfamily b, polypeptide 12
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CYP2B12 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B12 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression affects expression multiple interactions increases activity
EXP
indole-3-carbinol results in increased expression of CYP2B2; indole-3-carbinol results in increased expression of CYP2B2 protein indole-3-carbinol affects the expression of CYP2B2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA indole-3-carbinol results in increased activity of CYP2B2 protein
CTD
PMID:8384853 PMID:9806166 PMID:17297389 PMID:21396975 PMID:22129741
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
affects expression
EXP
indole-3-carbinol affects the expression of CYP2C55 mRNA
CTD
PMID:21396975
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CYP2C6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2C6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity multiple interactions
ISO EXP
indole-3-carbinol results in decreased activity of CYP2E1 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased activity of CYP2E1 protein]
CTD
PMID:17582584 PMID:37150287
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2j10
cytochrome P450, family 2, subfamily j, polypeptide 10
affects expression
EXP
indole-3-carbinol affects the expression of CYP2J10 mRNA
CTD
PMID:21396975
NCBI chr 5:110,960,319...110,995,220
Ensembl chr 5:110,960,317...110,995,115
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
multiple interactions increases expression
EXP
[indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA indole-3-carbinol results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:24418717
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of CYP3A62 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP3A62 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects expression
EXP
indole-3-carbinol affects the expression of CYP3A9 mRNA
CTD
PMID:21396975
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA
CTD
PMID:22129741
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Cyp4a8
cytochrome P450, family 4, subfamily a, polypeptide 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP4A8 mRNA
CTD
PMID:22129741
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
affects expression
EXP
indole-3-carbinol affects the expression of CYP7B1 mRNA
CTD
PMID:21396975
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Dab1
DAB adaptor protein 1
affects expression
EXP
indole-3-carbinol affects the expression of DAB1 mRNA
CTD
PMID:21396975
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
G
Dact2
dishevelled-binding antagonist of beta-catenin 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DACT2 mRNA
CTD
PMID:22129741
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
G
Dapp1
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
affects expression
EXP
indole-3-carbinol affects the expression of DAPP1 mRNA
CTD
PMID:21396975
NCBI chr 2:229,099,319...229,148,868
Ensembl chr 2:226,425,898...226,475,423
G
Dbn1
drebrin 1
affects expression
EXP
indole-3-carbinol affects the expression of DBN1 mRNA
CTD
PMID:21396975
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Dcun1d1
defective in cullin neddylation 1 domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of DCUN1D1 mRNA
CTD
PMID:21396975
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
G
Ddah2
DDAH family member 2, ADMA-independent
affects expression
EXP
indole-3-carbinol affects the expression of DDAH2 mRNA
CTD
PMID:21396975
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
G
Ddc
dopa decarboxylase
affects expression
EXP
indole-3-carbinol affects the expression of DDC mRNA
CTD
PMID:21396975
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddhd1
DDHD domain containing 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DDHD1 mRNA
CTD
PMID:22129741
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
G
Ddx21-ps11
DExD-box helicase 21, pseudogene 11
affects expression
EXP
indole-3-carbinol affects the expression of DDX21-PS11 mRNA
CTD
PMID:21396975
NCBI chr 7:16,170,788...16,192,428
G
Ddx21-ps9
DExD-box helicase 21, pseudogene 9
affects expression
EXP
indole-3-carbinol affects the expression of DDX21-PS9 mRNA
CTD
PMID:21396975
NCBI chr 7:15,150,261...15,152,679
G
Defb105a
defensin beta 105A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB12 mRNA
CTD
PMID:22129741
NCBI chr16:70,136,218...70,138,645
Ensembl chr16:70,725,701...70,728,143 Ensembl chr16:70,725,701...70,728,143
G
Defb18
defensin beta 18
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB18 mRNA
CTD
PMID:22129741
NCBI chr 9:20,852,230...20,853,247
Ensembl chr 9:20,852,300...20,853,211
G
Defb49
defensin beta 49
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB49 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA]
CTD
PMID:22129741
NCBI chr 9:20,832,686...20,837,352
Ensembl chr 9:20,832,686...20,837,352
G
Degs1l2
delta(4)-desaturase, sphingolipid 1 like 2
affects expression
EXP
indole-3-carbinol affects the expression of DEGS1L2 mRNA
CTD
PMID:21396975
NCBI chr13:92,831,549...92,839,257
Ensembl chr13:92,831,537...92,839,246
G
Derl3
derlin 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of DERL3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DERL3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
G
Dhh
desert hedgehog signaling molecule
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DHH mRNA
CTD
PMID:22129741
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
G
Dhrs7
dehydrogenase/reductase 7
affects expression
EXP
indole-3-carbinol affects the expression of DHRS7 mRNA
CTD
PMID:21396975
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Dhrsx
dehydrogenase/reductase X-linked
affects expression
EXP
indole-3-carbinol affects the expression of DHRSX mRNA
CTD
PMID:21396975
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
G
Dhx9
DExH-box helicase 9
affects expression
EXP
indole-3-carbinol affects the expression of DHX9 mRNA
CTD
PMID:21396975
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Diablo
diablo, IAP-binding mitochondrial protein
affects expression
EXP
indole-3-carbinol affects the expression of DIABLO mRNA
CTD
PMID:21396975
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
G
Diaph3
diaphanous-related formin 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DIAPH3 mRNA
CTD
PMID:22129741
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
G
Dimt1
DIM1 rRNA methyltransferase and ribosome maturation factor
affects expression
EXP
indole-3-carbinol affects the expression of DIMT1 mRNA
CTD
PMID:21396975
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
G
Dlg5l17
discs large MAGUK scaffold protein 5 like 17
affects expression
EXP
indole-3-carbinol affects the expression of DLG5L17 mRNA
CTD
PMID:21396975
NCBI chr 8:38,165,288...38,171,353
Ensembl chr 8:38,167,231...38,192,620
G
Dmac2l
distal membrane arm assembly component 2 like
affects expression
EXP
indole-3-carbinol affects the expression of DMAC2L mRNA
CTD
PMID:21396975
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
G
Dmbt1
deleted in malignant brain tumors 1
affects expression
EXP
indole-3-carbinol affects the expression of DMBT1 mRNA
CTD
PMID:21396975
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dmrt1
doublesex and mab-3 related transcription factor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DMRT1 mRNA
CTD
PMID:22129741
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
G
Dmxl2
Dmx-like 2
affects expression
EXP
indole-3-carbinol affects the expression of DMXL2 mRNA
CTD
PMID:21396975
NCBI chr 8:54,741,164...54,884,948
Ensembl chr 8:54,741,160...54,885,161
G
Dnaaf2
dynein, axonemal, assembly factor 2
affects expression
EXP
indole-3-carbinol affects the expression of DNAAF2 mRNA
CTD
PMID:21396975
NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:87,660,821...87,670,199
G
Dnah3
dynein, axonemal, heavy chain 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]
CTD
PMID:22129741
NCBI chr 1:174,305,929...174,479,490
Ensembl chr 1:174,306,644...174,479,474
G
Dnai1
dynein, axonemal, intermediate chain 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DNAI1 mRNA
CTD
PMID:22129741
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
G
Dnajc18
DnaJ heat shock protein family (Hsp40) member C18
affects expression
EXP
indole-3-carbinol affects the expression of DNAJC18 mRNA
CTD
PMID:21396975
NCBI chr18:27,269,350...27,303,453
Ensembl chr18:27,269,355...27,298,344
G
Dnlz
DNL-type zinc finger
affects expression
EXP
indole-3-carbinol affects the expression of DNLZ mRNA
CTD
PMID:21396975
NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551
G
Dnmt3b
DNA methyltransferase 3 beta
affects expression
EXP
indole-3-carbinol affects the expression of DNMT3B mRNA
CTD
PMID:21396975
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Dock3
dedicator of cyto-kinesis 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DOCK3 mRNA
CTD
PMID:22129741
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
G
Dpep1
dipeptidase 1
affects expression
EXP
indole-3-carbinol affects the expression of DPEP1 mRNA
CTD
PMID:21396975
NCBI chr19:68,118,270...68,143,781
Ensembl chr19:51,219,660...51,235,257
G
Dppa3-ps1
developmental pluripotency-associated 3, pseudogene 1
affects expression
EXP
indole-3-carbinol affects the expression of DPPA3-PS1 mRNA
CTD
PMID:21396975
NCBI chr 3:106,480,217...106,482,060
G
Dppa3l4
developmental pluripotency associated 3 like 4
affects expression
EXP
indole-3-carbinol affects the expression of DPPA3L4 mRNA
CTD
PMID:21396975
NCBI chr 7:90,402,832...90,404,317
G
Dqx1
DEAQ box RNA-dependent ATPase 1
affects expression
EXP
indole-3-carbinol affects the expression of DQX1 mRNA
CTD
PMID:21396975
NCBI chr 4:115,563,497...115,572,598
Ensembl chr 4:115,563,752...115,572,590
G
Drg1
developmentally regulated GTP binding protein 1
affects expression
EXP
indole-3-carbinol affects the expression of DRG1 mRNA
CTD
PMID:21396975
NCBI chr14:78,103,876...78,119,976
Ensembl chr14:78,103,876...78,119,953
G
Dtx3
deltex E3 ubiquitin ligase 3
affects expression
EXP
indole-3-carbinol affects the expression of DTX3 mRNA
CTD
PMID:21396975
NCBI chr 7:63,013,769...63,018,431
Ensembl chr 7:63,013,371...63,018,522
G
Dusp13b
dual specificity phosphatase 13B
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of DUSP13B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DUSP13B mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr15:2,567,432...2,575,105
Ensembl chr15:2,533,547...2,575,539
G
Dusp19
dual specificity phosphatase 19
affects expression
EXP
indole-3-carbinol affects the expression of DUSP19 mRNA
CTD
PMID:21396975
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
G
Dusp4
dual specificity phosphatase 4
affects expression
EXP
indole-3-carbinol affects the expression of DUSP4 mRNA
CTD
PMID:21396975
NCBI chr16:64,079,893...64,101,396
Ensembl chr16:57,377,229...57,398,138
G
Dusp8
dual specificity phosphatase 8
affects expression
EXP
indole-3-carbinol affects the expression of DUSP8 mRNA
CTD
PMID:21396975
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Dut
deoxyuridine triphosphatase
affects expression
EXP
indole-3-carbinol affects the expression of DUT mRNA
CTD
PMID:21396975
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Dync2i1
dynein 2 intermediate chain 1
affects expression
EXP
indole-3-carbinol affects the expression of DYNC2I1 mRNA
CTD
PMID:21396975
NCBI chr 6:137,133,418...137,189,937
Ensembl chr 6:137,133,418...137,188,719
G
Dync2li1
dynein cytoplasmic 2 light intermediate chain 1
affects expression
EXP
indole-3-carbinol affects the expression of DYNC2LI1 mRNA
CTD
PMID:21396975
NCBI chr 6:9,992,537...10,025,355
Ensembl chr 6:9,992,541...10,025,336
G
Eef1akmt2
EEF1A lysine methyltransferase 2
affects expression
EXP
indole-3-carbinol affects the expression of EEF1AKMT2 mRNA
CTD
PMID:21396975
NCBI chr 1:187,616,156...187,640,934
Ensembl chr 1:187,500,744...187,640,937
G
Eeig2
EEIG family member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EEIG2 mRNA
CTD
PMID:22129741
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
G
Efcab3
EF-hand calcium binding domain 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA
CTD
PMID:22129741
NCBI chr10:89,583,526...90,077,260
Ensembl chr10:89,644,522...90,077,259
G
Efna1
ephrin A1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA
CTD
PMID:22129741
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
G
Efna5
ephrin A5
affects expression
EXP
indole-3-carbinol affects the expression of EFNA5 mRNA
CTD
PMID:21396975
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:102,320,295...102,597,413
G
Egflam
EGF-like, fibronectin type III and laminin G domains
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EGFLAM mRNA
CTD
PMID:22129741
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
indole-3-carbinol results in decreased expression of EGFR protein
CTD
PMID:18025290
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egln3
egl-9 family hypoxia-inducible factor 3
affects expression
EXP
indole-3-carbinol affects the expression of EGLN3 mRNA
CTD
PMID:21396975
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:71,650,297...71,675,766
G
Egr1
early growth response 1
affects expression
EXP
indole-3-carbinol affects the expression of EGR1 mRNA
CTD
PMID:21396975
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif2b2
eukaryotic translation initiation factor 2B subunit beta
affects expression
EXP
indole-3-carbinol affects the expression of EIF2B2 mRNA
CTD
PMID:21396975
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
G
Eif5a2
eukaryotic translation initiation factor 5A2
affects expression
EXP
indole-3-carbinol affects the expression of EIF5A2 mRNA
CTD
PMID:21396975
NCBI chr 2:111,728,587...111,746,087
Ensembl chr 2:111,729,323...111,746,087
G
Elapor1
endosome-lysosome associated apoptosis and autophagy regulator 1
affects expression
EXP
indole-3-carbinol affects the expression of ELAPOR1 mRNA
CTD
PMID:21396975
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
G
Elavl4
ELAV like RNA binding protein 4
affects expression
EXP
indole-3-carbinol affects the expression of ELAVL4 mRNA
CTD
PMID:21396975
NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446
G
Elovl1
ELOVL fatty acid elongase 1
multiple interactions
EXP
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of ELOVL1 mRNA]
CTD
PMID:27178563
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
G
Elp6
elongator acetyltransferase complex subunit 6
affects expression
EXP
indole-3-carbinol affects the expression of ELP6 mRNA
CTD
PMID:21396975
NCBI chr 8:110,280,059...110,295,070
Ensembl chr 8:110,279,979...110,295,067
G
Emb
embigin
affects expression
EXP
indole-3-carbinol affects the expression of EMB mRNA
CTD
PMID:21396975
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Emilin2
elastin microfibril interfacer 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA
CTD
PMID:22129741
NCBI chr 9:111,160,708...111,220,463
Ensembl chr 9:111,160,712...111,220,352
G
Eml5
EMAP like 5
affects expression
EXP
indole-3-carbinol affects the expression of EML5 mRNA
CTD
PMID:21396975
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
G
Emp3
epithelial membrane protein 3
affects expression
EXP
indole-3-carbinol affects the expression of EMP3 mRNA
CTD
PMID:21396975
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Enc1
ectodermal-neural cortex 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ENC1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ENC1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Eno3
enolase 3
affects expression
EXP
indole-3-carbinol affects the expression of ENO3 mRNA
CTD
PMID:21396975
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Enpep
glutamyl aminopeptidase
affects expression
EXP
indole-3-carbinol affects the expression of ENPEP mRNA
CTD
PMID:21396975
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Enpp5
ectonucleotide pyrophosphatase/phosphodiesterase family member 5
affects expression
EXP
indole-3-carbinol affects the expression of ENPP5 mRNA
CTD
PMID:21396975
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
G
Enpp7
ectonucleotide pyrophosphatase/phosphodiesterase 7
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENPP7 mRNA
CTD
PMID:22129741
NCBI chr10:104,242,169...104,247,185
Ensembl chr10:104,242,223...104,246,589
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
affects expression
EXP
indole-3-carbinol affects the expression of ENTPD5 mRNA
CTD
PMID:21396975
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
G
Entrep1
endosomal transmembrane epsin interactor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENTREP1 mRNA
CTD
PMID:22129741
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
G
Entrep3
endosomal transmembrane epsin interactor 3
affects expression
EXP
indole-3-carbinol affects the expression of ENTREP3 mRNA
CTD
PMID:21396975
NCBI chr 2:174,588,984...174,595,281
Ensembl chr 2:174,589,337...174,595,281
G
Epcam
epithelial cell adhesion molecule
affects expression
EXP
indole-3-carbinol affects the expression of EPCAM mRNA
CTD
PMID:21396975
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Epha1
Eph receptor A1
affects expression
EXP
indole-3-carbinol affects the expression of EPHA1 mRNA
CTD
PMID:21396975
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
G
Epha2
Eph receptor A2
affects expression
EXP
indole-3-carbinol affects the expression of EPHA2 mRNA
CTD
PMID:21396975
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephb1
Eph receptor B1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPHB1 mRNA
CTD
PMID:22129741
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
G
Ephb6
Eph receptor B6
affects expression
EXP
indole-3-carbinol affects the expression of EPHB6 mRNA
CTD
PMID:21396975
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
G
Ephx1
epoxide hydrolase 1
affects expression
EXP
indole-3-carbinol affects the expression of EPHX1 mRNA
CTD
PMID:21396975
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Eps8
EGFR pathway substrate 8, signaling adaptor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPS8 mRNA
CTD
PMID:22129741
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
G
Eral1
Era-like 12S mitochondrial rRNA chaperone 1
affects expression
EXP
indole-3-carbinol affects the expression of ERAL1 mRNA
CTD
PMID:21396975
NCBI chr10:62,961,725...62,968,747
Ensembl chr10:62,961,730...62,968,994
G
Ercc4l1
excision repair cross-complementing rodent repair deficiency, complementation group 4-like 1
affects expression
EXP
indole-3-carbinol affects the expression of ERCC4L1 mRNA
CTD
PMID:21396975
NCBI chr10:954,927...983,651
Ensembl chr10:954,977...983,174
G
Ermard
ER membrane-associated RNA degradation
affects expression
EXP
indole-3-carbinol affects the expression of ERMARD mRNA
CTD
PMID:21396975
NCBI chr 1:55,983,312...56,004,569
Ensembl chr 1:55,983,403...56,002,687
G
Esr1
estrogen receptor 1
decreases expression multiple interactions
ISO EXP
indole-3-carbinol analog results in decreased expression of ESR1 protein BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]]; indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein] indole-3-carbinol inhibits the reaction [bisphenol A results in increased expression of ESR1 protein]
CTD
PMID:11110848 PMID:16434996 PMID:20570586 PMID:24257414
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esrra
estrogen related receptor, alpha
affects expression
EXP
indole-3-carbinol affects the expression of ESRRA mRNA
CTD
PMID:21396975
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
Exog
exo/endonuclease G
affects expression
EXP
indole-3-carbinol affects the expression of EXOG mRNA
CTD
PMID:21396975
NCBI chr 8:119,184,974...119,204,819
Ensembl chr 8:119,185,136...119,204,672
G
Exosc2
exosome component 2
affects expression
EXP
indole-3-carbinol affects the expression of EXOSC2 mRNA
CTD
PMID:21396975
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
G
Eya1
EYA transcriptional coactivator and phosphatase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EYA1 mRNA
CTD
PMID:22129741
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
G
F13a1
coagulation factor XIII A1 chain
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA
CTD
PMID:22129741
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
F13b
coagulation factor XIII B chain
affects expression
EXP
indole-3-carbinol affects the expression of F13B mRNA
CTD
PMID:21396975
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
G
Faap24
FA core complex associated protein 24
affects expression
EXP
indole-3-carbinol affects the expression of FAAP24 mRNA
CTD
PMID:21396975
NCBI chr 1:88,051,523...88,057,997
Ensembl chr 1:88,051,911...88,057,989
G
Fabp12
fatty acid binding protein 12
affects expression
EXP
indole-3-carbinol affects the expression of FABP12 mRNA
CTD
PMID:21396975
NCBI chr 2:91,539,568...91,554,999
Ensembl chr 2:91,500,539...91,554,996
G
Fabp4
fatty acid binding protein 4
affects expression
EXP
indole-3-carbinol affects the expression of FABP4 mRNA
CTD
PMID:21396975
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fads2
fatty acid desaturase 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of FADS2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fam114a1
family with sequence similarity 114, member A1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A1 mRNA
CTD
PMID:22129741
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
G
Fam114a2
family with sequence similarity 114, member A2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA
CTD
PMID:22129741
NCBI chr10:41,661,787...41,696,790
Ensembl chr10:41,661,787...41,696,741
G
Fam13a
family with sequence similarity 13, member A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM13A mRNA
CTD
PMID:22129741
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
G
Fam186a
family with sequence similarity 186 member A
multiple interactions affects expression
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM186A mRNA indole-3-carbinol affects the expression of FAM186A mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:131,043,586...131,102,312
G
Fam3d
FAM3 metabolism regulating signaling molecule D
affects expression
EXP
indole-3-carbinol affects the expression of FAM3D mRNA
CTD
PMID:21396975
NCBI chr15:16,538,881...16,574,468
Ensembl chr15:16,539,489...16,573,034
G
Fam89a
family with sequence similarity 89, member A
affects expression
EXP
indole-3-carbinol affects the expression of FAM89A mRNA
CTD
PMID:21396975
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
G
Far1
fatty acyl CoA reductase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAR1 mRNA
CTD
PMID:22129741
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
G
Far2
fatty acyl CoA reductase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FAR2 mRNA
CTD
PMID:22129741
NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:181,007,622...181,087,255
G
Fbxo27
F-box protein 27
affects expression
EXP
indole-3-carbinol affects the expression of FBXO27 mRNA
CTD
PMID:21396975
NCBI chr 1:83,965,426...83,987,781
Ensembl chr 1:83,965,986...83,987,778
G
Fbxo30
F-box protein 30
affects expression
EXP
indole-3-carbinol affects the expression of FBXO30 mRNA
CTD
PMID:21396975
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fbxo44
F-box protein 44
affects expression
EXP
indole-3-carbinol affects the expression of FBXO44 mRNA
CTD
PMID:21396975
NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363
G
Fcnb
ficolin B
affects expression
EXP
indole-3-carbinol affects the expression of FCNB mRNA
CTD
PMID:21396975
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
G
Fdps-ps4
farnesyl diphosphate synthase, pseudogene 4
affects expression
EXP
indole-3-carbinol affects the expression of FDPS-PS4 mRNA
CTD
PMID:21396975
NCBI chr 8:18,816,786...18,818,020
G
Fdxacb1
ferredoxin-fold anticodon binding domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of FDXACB1 mRNA
CTD
PMID:21396975
NCBI chr 8:51,111,831...51,118,253
Ensembl chr 8:51,113,397...51,118,308
G
Fer1l5
fer-1-like family member 5
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of FER1L5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FER1L5 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
G
Fgd1
FYVE, RhoGEF and PH domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of FGD1 mRNA
CTD
PMID:21396975
NCBI chr X:20,023,746...20,066,734
Ensembl chr X:20,023,746...20,066,566
G
Fgf1
fibroblast growth factor 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of FGF1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf12
fibroblast growth factor 12
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF12 mRNA
CTD
PMID:22129741
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
G
Fgf2
fibroblast growth factor 2
affects expression
EXP
indole-3-carbinol affects the expression of FGF2 mRNA
CTD
PMID:21396975
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgf21
fibroblast growth factor 21
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF21 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA]
CTD
PMID:22129741
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Fgfr2
fibroblast growth factor receptor 2
affects expression
EXP
indole-3-carbinol affects the expression of FGFR2 mRNA
CTD
PMID:21396975
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fhit
fragile histidine triad diadenosine triphosphatase
affects expression
EXP
indole-3-carbinol affects the expression of FHIT mRNA
CTD
PMID:21396975
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
G
Fkbp11
FKBP prolyl isomerase 11
affects expression
EXP
indole-3-carbinol affects the expression of FKBP11 mRNA
CTD
PMID:21396975
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Fkbp3
FKBP prolyl isomerase 3
affects expression
EXP
indole-3-carbinol affects the expression of FKBP3 mRNA
CTD
PMID:21396975
NCBI chr 6:83,113,885...83,125,500
Ensembl chr 6:83,113,786...83,127,011
G
Flg
filaggrin
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FLG mRNA
CTD
PMID:22129741
NCBI chr 2:178,884,793...178,912,986
G
Fmn1
formin 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FMN1 mRNA
CTD
PMID:22129741
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
G
Fn3k
fructosamine 3 kinase
affects expression
EXP
indole-3-carbinol affects the expression of FN3K mRNA
CTD
PMID:21396975
NCBI chr10:106,700,670...106,715,903
Ensembl chr10:106,700,670...106,715,895
G
Fndc5
fibronectin type III domain containing 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FNDC5 mRNA
CTD
PMID:22129741
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA]
CTD
PMID:22129741
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Foxd2
forkhead box D2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA
CTD
PMID:22129741
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
G
Foxd4
forkhead box D4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of FOXD4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:222,557,494...222,559,189
Ensembl chr 1:222,557,360...222,559,159
G
Foxo3
forkhead box O3
increases expression
ISO
indole-3-carbinol results in increased expression of FOXO3 protein
CTD
PMID:33118390
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
G
Frg2
FSHD region gene 2
affects expression
EXP
indole-3-carbinol affects the expression of FRG2B mRNA
CTD
PMID:21396975
NCBI chr14:80,427,260...80,429,560
Ensembl chr14:80,427,673...80,429,181
G
Fxc1-ps1
fractured callus expressed transcript 1, pseudogene 1
affects expression
EXP
indole-3-carbinol affects the expression of FXC1-PS1 mRNA
CTD
PMID:21396975
NCBI chr20:47,048,327...47,049,191
G
Fxyd2
FXYD domain-containing ion transport regulator 2
affects expression
EXP
indole-3-carbinol affects the expression of FXYD2 mRNA
CTD
PMID:21396975
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
G
Fxyd3
FXYD domain-containing ion transport regulator 3
affects expression
EXP
indole-3-carbinol affects the expression of FXYD3 mRNA
CTD
PMID:21396975
NCBI chr 1:86,305,531...86,312,455
G
Fxyd6
FXYD domain-containing ion transport regulator 6
affects expression
EXP
indole-3-carbinol affects the expression of FXYD6 mRNA
CTD
PMID:21396975
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC1 mRNA
CTD
PMID:22129741
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45A mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GADD45A mRNA
CTD
PMID:22129741
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of GADD45B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GADD45B mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA
CTD
PMID:22129741
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
affects expression
EXP
indole-3-carbinol affects the expression of GALNT16 mRNA
CTD
PMID:21396975
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
G
Galntl5
polypeptide N-acetylgalactosaminyltransferase-like 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GALNTL5 mRNA
CTD
PMID:22129741
NCBI chr 4:9,873,426...9,923,297
Ensembl chr 4:9,873,428...9,923,136
G
Gapdhl10
glyceraldehyde-3-phosphate dehydrogenase like 10
affects expression
EXP
indole-3-carbinol affects the expression of GAPDHL10 mRNA
CTD
PMID:21396975
NCBI chr16:15,370,290...15,371,300
Ensembl chr16:15,370,293...15,371,300
G
Gapdhl9
glyceraldehyde-3-phosphate dehydrogenase like 9
affects expression
EXP
indole-3-carbinol affects the expression of GAPDHL9 mRNA
CTD
PMID:21396975
NCBI chr 2:210,784,633...210,785,652
G
Gar1
GAR1 ribonucleoprotein
affects expression
EXP
indole-3-carbinol affects the expression of GAR1 mRNA
CTD
PMID:21396975
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
G
Garin3
golgi associated RAB2 interactor family member 3
affects expression
EXP
indole-3-carbinol affects the expression of GARIN3 mRNA
CTD
PMID:21396975
NCBI chr10:30,829,877...30,833,115
Ensembl chr10:30,829,877...30,833,111
G
Gcat
glycine C-acetyltransferase
affects expression
EXP
indole-3-carbinol affects the expression of GCAT mRNA
CTD
PMID:21396975
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
affects expression
EXP
indole-3-carbinol affects the expression of GCNT3 mRNA
CTD
PMID:21396975
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
increases expression multiple interactions
ISO
indole-3-carbinol results in increased expression of GDF15 [indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15
CTD
PMID:15670751
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdnf
glial cell derived neurotrophic factor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GDNF mRNA
CTD
PMID:22129741
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gfra3
GDNF family receptor alpha 3
affects expression
EXP
indole-3-carbinol affects the expression of GFRA3 mRNA
CTD
PMID:21396975
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Ggt1
gamma-glutamyltransferase 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of GGT1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GGT1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GGT1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gimd1
GIMAP family P-loop NTPase domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of GIMD1 mRNA
CTD
PMID:21396975
NCBI chr 2:221,103,878...221,138,559
Ensembl chr 2:221,103,878...221,138,553
G
Gins4
GINS complex subunit 4
affects expression
EXP
indole-3-carbinol affects the expression of GINS4 mRNA
CTD
PMID:21396975
NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273
G
Gipc2
GIPC PDZ domain containing family, member 2
affects expression
EXP
indole-3-carbinol affects the expression of GIPC2 mRNA
CTD
PMID:21396975
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
G
Gkn2
gastrokine 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GKN2 mRNA
CTD
PMID:22129741
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
G
Glcci1
glucocorticoid induced 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GLCCI1 mRNA
CTD
PMID:22129741
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
G
Gldc
glycine decarboxylase
affects expression
EXP
indole-3-carbinol affects the expression of GLDC mRNA
CTD
PMID:21396975
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Glmn
glomulin, FKBP associated protein
affects expression
EXP
indole-3-carbinol affects the expression of GLMN mRNA
CTD
PMID:21396975
NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420
G
Glrx
glutaredoxin
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of GLRX mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glt1d1
glycosyltransferase 1 domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of GLT1D1 mRNA
CTD
PMID:21396975
NCBI chr12:28,975,984...29,049,707
Ensembl chr12:28,975,988...29,049,695
G
Gltp
glycolipid transfer protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLTP mRNA
CTD
PMID:22129741
NCBI chr12:41,907,168...41,927,321
Ensembl chr12:41,907,144...41,927,319
G
Gnai1
G protein subunit alpha i1
affects expression
EXP
indole-3-carbinol affects the expression of GNAI1 mRNA
CTD
PMID:21396975
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnptab
N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
affects expression
EXP
indole-3-carbinol affects the expression of GNPTAB mRNA
CTD
PMID:21396975
NCBI chr 7:22,800,502...22,866,336
Ensembl chr 7:22,800,485...22,866,933
G
Gnrh1
gonadotropin releasing hormone 1
affects expression
EXP
indole-3-carbinol affects the expression of GNRH1 mRNA
CTD
PMID:21396975
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions
EXP
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of GOT1 protein]
CTD
PMID:37150287
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gp2
glycoprotein 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GP2 mRNA
CTD
PMID:22129741
NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
G
Gp5
glycoprotein V (platelet)
affects expression
EXP
indole-3-carbinol affects the expression of GP5 mRNA
CTD
PMID:21396975
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
G
Gpa33
glycoprotein A33
affects expression
EXP
indole-3-carbinol affects the expression of GPA33 mRNA
CTD
PMID:21396975
NCBI chr13:78,381,141...78,414,765
Ensembl chr13:78,381,141...78,414,765
G
Gpatch4
G patch domain containing 4
affects expression
EXP
indole-3-carbinol affects the expression of GPATCH4 mRNA
CTD
PMID:21396975
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
G
Gpbar1
G protein-coupled bile acid receptor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPBAR1 mRNA
CTD
PMID:22129741
NCBI chr 9:75,860,758...75,863,260
Ensembl chr 9:75,860,677...75,863,168
G
Gpc3
glypican 3
affects expression
EXP
indole-3-carbinol affects the expression of GPC3 mRNA
CTD
PMID:21396975
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gpc5
glypican 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPC5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA]
CTD
PMID:22129741
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
G
Gpr153
G protein-coupled receptor 153
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR153 mRNA
CTD
PMID:22129741
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
G
Gpr20
G protein-coupled receptor 20
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR20 mRNA
CTD
PMID:22129741
NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430
G
Gpr55
G protein-coupled receptor 55
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR55 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA]
CTD
PMID:22129741
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
G
Gprin1
G protein-regulated inducer of neurite outgrowth 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPRIN1 mRNA
CTD
PMID:22129741
NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of GPT protein]
CTD
PMID:37150287
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx2
glutathione peroxidase 2
affects expression multiple interactions increases expression
EXP
indole-3-carbinol affects the expression of GPX2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GPX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] indole-3-carbinol results in increased expression of GPX2 mRNA
CTD
PMID:21203749 PMID:21396975 PMID:22129741 PMID:24418717
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Grifin
galectin-related inter-fiber protein
affects expression
EXP
indole-3-carbinol affects the expression of GRIFIN mRNA
CTD
PMID:21396975
NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
affects expression increases expression
EXP
indole-3-carbinol affects the expression of GRIN2C mRNA indole-3-carbinol results in increased expression of GRIN2C mRNA
CTD
PMID:21396975 PMID:23824016
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grk5
G protein-coupled receptor kinase 5
affects expression
EXP
indole-3-carbinol affects the expression of GRK5 mRNA
CTD
PMID:21396975
NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:260,028,242...260,218,701
G
Gsn
gelsolin
affects expression
EXP
indole-3-carbinol affects the expression of GSN mRNA
CTD
PMID:21396975
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Gsta2
glutathione S-transferase alpha 2
increases expression multiple interactions
EXP ISO
indole-3-carbinol results in increased expression of GSTA2 mRNA [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA2 mRNA indole-3-carbinol results in increased expression of GSTA2 protein
CTD
PMID:11309284 PMID:11446830
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
increases expression multiple interactions
EXP
indole-3-carbinol results in increased expression of GSTA3 mRNA; indole-3-carbinol results in increased expression of GSTA3 protein [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA3 mRNA; [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA3 protein
CTD
PMID:9794803 PMID:11446830
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:23,658,574...23,684,240
G
Gsta4
glutathione S-transferase alpha 4
affects expression increases expression
EXP
indole-3-carbinol affects the expression of GSTA4 mRNA indole-3-carbinol results in increased expression of GSTA4 protein
CTD
PMID:9794803 PMID:21396975
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions increases activity increases expression affects expression
EXP ISO
[indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 mRNA; [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 protein; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTA5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA] indole-3-carbinol results in increased activity of GSTA5 protein indole-3-carbinol results in increased expression of GSTA5; indole-3-carbinol results in increased expression of GSTA5 mRNA; indole-3-carbinol results in increased expression of GSTA5 protein indole-3-carbinol affects the expression of GSTA5 mRNA indole-3-carbinol results in increased expression of GSTA1 protein
CTD
PMID:9328168 PMID:9794803 PMID:9806166 PMID:11309284 PMID:11446830 PMID:21396975 PMID:22129741 More...
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression multiple interactions
ISO EXP
indole-3-carbinol results in increased expression of GSTM1 protein [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA
CTD
PMID:11309284 PMID:22129741
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
affects expression multiple interactions increases expression
EXP ISO
indole-3-carbinol affects the expression of GSTM2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM2 mRNA indole-3-carbinol results in increased expression of GSTM5 protein
CTD
PMID:11309284 PMID:21396975 PMID:22129741
NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of GSTM4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Gstm5
glutathione S-transferase, mu 5
affects expression multiple interactions increases expression
EXP
indole-3-carbinol affects the expression of GSTM3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA indole-3-carbinol results in increased expression of GSTM3 mRNA; indole-3-carbinol results in increased expression of GSTM3 protein
CTD
PMID:9794803 PMID:21396975 PMID:22129741 PMID:24418717
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gsto2
glutathione S-transferase omega 2
affects expression
EXP
indole-3-carbinol affects the expression of GSTO2 mRNA
CTD
PMID:21396975
NCBI chr 1:246,731,314...246,757,592
Ensembl chr 1:246,732,089...246,753,866
G
Gstp1
glutathione S-transferase pi 1
affects expression multiple interactions increases expression
EXP ISO
indole-3-carbinol affects the expression of GSTP1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA] indole-3-carbinol results in increased expression of GSTP1 protein indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of GSTP1 protein] [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of GSTP1 mRNA; [indole-3-carbinol co-treated with xanthohumol] results in increased expression of GSTP1 mRNA
CTD
PMID:9794803 PMID:21396975 PMID:22129741 PMID:29775573 PMID:32070777
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
increases expression affects expression
EXP
indole-3-carbinol results in increased expression of GSTT1 mRNA; indole-3-carbinol results in increased expression of GSTT1 protein indole-3-carbinol affects the expression of GSTT1 mRNA
CTD
PMID:9794803 PMID:10413528 PMID:21396975
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Gtdc1
glycosyltransferase-like domain containing 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GTDC1 mRNA
CTD
PMID:22129741
NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271
G
Gtf2h5
general transcription factor IIH subunit 5
affects expression
EXP
indole-3-carbinol affects the expression of GTF2H5 mRNA
CTD
PMID:21396975
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
G
Gtpbp10
GTP binding protein 10
affects expression
EXP
indole-3-carbinol affects the expression of GTPBP10 mRNA
CTD
PMID:21396975
NCBI chr 4:28,476,857...28,494,375
Ensembl chr 4:28,476,857...28,494,375
G
Gtpbp8
GTP binding protein 8
affects expression
EXP
indole-3-carbinol affects the expression of GTPBP8 mRNA
CTD
PMID:21396975
NCBI chr11:55,945,778...55,955,743
Ensembl chr11:55,945,795...55,955,635
G
Gxylt1
glucoside xylosyltransferase 1
affects expression
EXP
indole-3-carbinol affects the expression of GXYLT1 mRNA
CTD
PMID:21396975
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
G
H3f3al3
H3.3 histone A like 3
affects expression
EXP
indole-3-carbinol affects the expression of H3F3AL3 mRNA
CTD
PMID:21396975
NCBI chr 9:42,494,007...42,495,112
Ensembl chr 9:42,494,353...42,494,763
G
Hacd1
3-hydroxyacyl-CoA dehydratase 1
affects expression
EXP
indole-3-carbinol affects the expression of HACD1 mRNA
CTD
PMID:21396975
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
G
Hal
histidine ammonia lyase
affects expression
EXP
indole-3-carbinol affects the expression of HAL mRNA
CTD
PMID:21396975
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hamp
hepcidin antimicrobial peptide
affects expression
EXP
indole-3-carbinol affects the expression of HAMP mRNA
CTD
PMID:21396975
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hao2
hydroxyacid oxidase 2
affects expression
EXP
indole-3-carbinol affects the expression of HAO2 mRNA
CTD
PMID:21396975
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Haus1
HAUS augmin-like complex, subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of HAUS1 mRNA
CTD
PMID:21396975
NCBI chr18:71,275,417...71,286,626
Ensembl chr18:71,273,537...71,286,660
G
Hbb
hemoglobin subunit beta
affects expression
EXP
indole-3-carbinol affects the expression of HBB mRNA; indole-3-carbinol affects the expression of HBB-B1 mRNA
CTD
PMID:21396975
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hdac1
histone deacetylase 1
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC1 mRNA]
CTD
PMID:24200994
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Hdac2
histone deacetylase 2
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA]
CTD
PMID:24200994
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hdac4
histone deacetylase 4
multiple interactions
ISO
indole-3-carbinol promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC4 mRNA]
CTD
PMID:24200994
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdac6
histone deacetylase 6
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC6 mRNA]
CTD
PMID:24200994
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
G
Hdac8
histone deacetylase 8
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC8 mRNA]
CTD
PMID:24200994
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
G
Hdc
histidine decarboxylase
affects expression
EXP
indole-3-carbinol affects the expression of HDC mRNA
CTD
PMID:21396975
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hddc2
HD domain containing 2
affects expression
EXP
indole-3-carbinol affects the expression of HDDC2 mRNA
CTD
PMID:21396975
NCBI chr 1:26,294,030...26,313,914
Ensembl chr 1:26,294,030...26,313,935
G
Hebp2
heme binding protein 2
affects expression
EXP
indole-3-carbinol affects the expression of HEBP2 mRNA
CTD
PMID:21396975
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
G
Hells
helicase, lymphoid specific
affects expression
EXP
indole-3-carbinol affects the expression of HELLS mRNA
CTD
PMID:21396975
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Helz2
helicase with zinc finger 2
affects expression
EXP
indole-3-carbinol affects the expression of HELZ2 mRNA
CTD
PMID:21396975
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
G
Hhip
Hedgehog-interacting protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HHIP mRNA
CTD
PMID:22129741
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
G
Hid1
HID1 domain containing
affects expression
EXP
indole-3-carbinol affects the expression of HID1 mRNA
CTD
PMID:21396975
NCBI chr10:100,589,555...100,610,050
Ensembl chr10:100,589,555...100,610,041
G
Hira
histone cell cycle regulator
affects expression
EXP
indole-3-carbinol affects the expression of HIRA mRNA
CTD
PMID:21396975
NCBI chr11:82,024,469...82,133,212
Ensembl chr11:82,024,469...82,133,529
G
Hist1h2ah
histone cluster 1 H2A family member H
affects expression
EXP
indole-3-carbinol affects the expression of HIST1H2AH mRNA
CTD
PMID:21396975
NCBI chr17:41,384,521...41,385,018
G
Hist1h2ail2
histone cluster 1, H2ai like 2
affects expression
EXP
indole-3-carbinol affects the expression of HIST1H2AIL2 mRNA
CTD
PMID:21396975
NCBI chr17:42,753,160...42,753,620
Ensembl chr17:41,534,691...41,539,869 Ensembl chr17:41,534,691...41,539,869
G
Hlcs
holocarboxylase synthetase
affects expression
EXP
indole-3-carbinol affects the expression of HLCS mRNA
CTD
PMID:21396975
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
G
Hltf
helicase-like transcription factor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HLTF mRNA
CTD
PMID:22129741
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmg20a
high mobility group 20A
affects expression
EXP
indole-3-carbinol affects the expression of HMG20A mRNA
CTD
PMID:21396975
NCBI chr 8:56,819,673...56,895,658
Ensembl chr 8:56,819,659...56,895,656
G
Hmgb1-ps31
high-mobility group box 1, pseudogene 31
affects expression
EXP
indole-3-carbinol affects the expression of HMGB1-PS31 mRNA
CTD
PMID:21396975
NCBI chr18:37,968,898...37,969,438
G
Hmgb2
high mobility group box 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of HMGB2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
G
Hmgb4-ps5
high-mobility group box 4, pseudogene 5
affects expression
EXP
indole-3-carbinol affects the expression of HMGB4-PS5 mRNA
CTD
PMID:21396975
NCBI chr X:126,731,922...126,732,399
Ensembl chr X:136,290,233...136,290,934
G
Hmgb4l7
high-mobility group box 4 like 7
affects expression
EXP
indole-3-carbinol affects the expression of HMGB4L7 mRNA
CTD
PMID:21396975
NCBI chr X:135,622,322...135,623,034
Ensembl chr X:135,622,361...135,623,009 Ensembl chr X:135,622,361...135,623,009
G
Hmgb4l8
high-mobility group box 4 like 8
affects expression
EXP
indole-3-carbinol affects the expression of HMGB4L8 mRNA
CTD
PMID:21396975
NCBI chr X:129,470,473...129,471,169
Ensembl chr X:129,470,475...129,471,174 Ensembl chr X:129,470,475...129,471,174
G
Hmgb4l9
high-mobility group box 4 like 9
affects expression
EXP
indole-3-carbinol affects the expression of HMGB4L9 mRNA
CTD
PMID:21396975
NCBI chr X:134,184,390...134,185,772
Ensembl chr X:134,184,560...134,185,264
G
Hmgn3
high mobility group nucleosomal binding domain 3
affects expression
EXP
indole-3-carbinol affects the expression of HMGN3 mRNA
CTD
PMID:21396975
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hmox1
heme oxygenase 1
multiple interactions
EXP ISO
indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]] indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 protein]
CTD
PMID:28619389 PMID:29775573
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnf4g
hepatocyte nuclear factor 4, gamma
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HNF4G mRNA
CTD
PMID:22129741
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
G
Hoxc13
homeobox C13
affects expression
EXP
indole-3-carbinol affects the expression of HOXC13 mRNA
CTD
PMID:21396975
NCBI chr 7:134,058,640...134,065,479
Ensembl chr 7:134,058,640...134,064,800
G
Hpgds
hematopoietic prostaglandin D synthase
affects expression
EXP
indole-3-carbinol affects the expression of HPGDS mRNA
CTD
PMID:21396975
NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:94,373,342...94,397,883
G
Hps3
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of HPS3 mRNA
CTD
PMID:21396975
NCBI chr 2:102,484,574...102,527,580
Ensembl chr 2:102,484,574...102,526,047
G
Hpse
heparanase
affects expression
EXP
indole-3-carbinol affects the expression of HPSE mRNA
CTD
PMID:21396975
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
G
Hsdl2
hydroxysteroid dehydrogenase like 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HSDL2 mRNA
CTD
PMID:22129741
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
indole-3-carbinol results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Htatip2
HIV-1 Tat interactive protein 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of HTATIP2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HTATIP2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Ica1
islet cell autoantigen 1
affects expression
EXP
indole-3-carbinol affects the expression of ICA1 mRNA
CTD
PMID:21396975
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
G
Icam1
intercellular adhesion molecule 1
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of ICAM1 protein; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] indole-3-carbinol results in decreased expression of ICAM1 protein
CTD
PMID:21948866
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Id3
inhibitor of DNA binding 3
multiple interactions
EXP
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of ID3 mRNA]
CTD
PMID:27178563
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
G
Idi2
isopentenyl-diphosphate delta isomerase 2
affects expression
EXP
indole-3-carbinol affects the expression of IDI2 mRNA
CTD
PMID:21396975
NCBI chr17:61,331,385...61,334,987
Ensembl chr17:61,331,669...61,334,285
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression multiple interactions
ISO
indole-3-carbinol results in increased expression of IDO1 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of IDO1 mRNA]
CTD
PMID:21948866
NCBI chr16:74,133,259...74,145,328
Ensembl chr16:67,430,578...67,442,730
G
Ido2
indoleamine 2,3-dioxygenase 2
increases expression multiple interactions
ISO
indole-3-carbinol results in increased expression of IDO2 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of IDO2 mRNA]
CTD
PMID:21948866
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
G
Ifna12l
interferon alpha 12 like
affects expression
EXP
indole-3-carbinol affects the expression of IFNA12L mRNA
CTD
PMID:21396975
NCBI chr 5:103,476,362...103,477,427
Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211
G
Ifng
interferon gamma
decreases secretion multiple interactions
ISO
indole-3-carbinol results in decreased secretion of IFNG protein indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IFNG protein]
CTD
PMID:21948866 PMID:24200994
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ift43
intraflagellar transport 43
affects expression
EXP
indole-3-carbinol affects the expression of IFT43 mRNA
CTD
PMID:21396975
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
G
Ift74
intraflagellar transport 74
affects expression
EXP
indole-3-carbinol affects the expression of IFT74 mRNA
CTD
PMID:21396975
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
G
Iftap
intraflagellar transport associated protein
affects expression
EXP
indole-3-carbinol affects the expression of IFTAP mRNA
CTD
PMID:21396975
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
affects expression
EXP
indole-3-carbinol affects the expression of IGFALS mRNA
CTD
PMID:21396975
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA]
CTD
PMID:22129741
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of IKBKB protein]
CTD
PMID:15811958
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
affects expression
EXP
indole-3-carbinol affects the expression of IKBKE mRNA
CTD
PMID:21396975
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Ikzf1
IKAROS family zinc finger 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IKZF1 mRNA
CTD
PMID:22129741
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
multiple interactions decreases secretion
ISO EXP
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of IL10 mRNA; [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein; AHR protein affects the susceptibility to [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] indole-3-carbinol results in decreased secretion of IL10 protein indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]; indole-3-carbinol inhibits the reaction [Thioacetamide results in decreased expression of IL10 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of IL10 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]]
CTD
PMID:21948866 PMID:28619389 PMID:37150287
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA]; indole-3-carbinol inhibits the reaction [Poly I-C results in increased expression of IL12A mRNA]
CTD
PMID:27783115
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
G
Il12rb1
interleukin 12 receptor subunit beta 1
affects expression
EXP
indole-3-carbinol affects the expression of IL12RB1 mRNA
CTD
PMID:21396975
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
G
Il17d
interleukin 17D
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IL17D mRNA
CTD
PMID:22129741
NCBI chr15:31,671,337...31,688,833
G
Il1b
interleukin 1 beta
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of RELA protein]; indole-3-carbinol promotes the reaction [CL 075 results in increased expression of IL1B mRNA]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of IL1B protein; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:15811958 PMID:21948866 PMID:27783115
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL2 protein]
CTD
PMID:24200994
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il27
interleukin 27
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of IL27 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in decreased expression of IL27 mRNA]
CTD
PMID:21948866
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:181,173,372...181,178,582
G
Il33
interleukin 33
affects expression
EXP
indole-3-carbinol affects the expression of IL33 mRNA
CTD
PMID:21396975
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il36b
interleukin 36, beta
affects expression
EXP
indole-3-carbinol affects the expression of IL36B mRNA
CTD
PMID:21396975
NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619
G
Il6
interleukin 6
increases expression multiple interactions
ISO EXP
indole-3-carbinol results in increased expression of IL6 mRNA [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of IL6 protein; [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL6 mRNA; indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL6 protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of IL6 protein]
CTD
PMID:18025290 PMID:21948866 PMID:24200994 PMID:29775573 PMID:37150287
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Inhbc
inhibin subunit beta C
affects expression
EXP
indole-3-carbinol affects the expression of INHBC mRNA
CTD
PMID:21396975
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
G
Ins1
insulin 1
multiple interactions
EXP
indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of INS1 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]]
CTD
PMID:28619389
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Insig1
insulin induced gene 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA
CTD
PMID:22129741
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insyn1
inhibitory synaptic factor 1
affects expression
EXP
indole-3-carbinol affects the expression of INSYN1 mRNA
CTD
PMID:21396975
NCBI chr 8:58,904,153...58,914,850
Ensembl chr 8:58,904,153...58,914,843
G
Ipo7
importin 7
affects expression
EXP
indole-3-carbinol affects the expression of IPO7 mRNA
CTD
PMID:21396975
NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938
G
Irf1
interferon regulatory factor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA
CTD
PMID:22129741
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irgm
immunity-related GTPase M
affects expression
EXP
indole-3-carbinol affects the expression of IRGM mRNA
CTD
PMID:21396975
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Irs2
insulin receptor substrate 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA
CTD
PMID:22129741
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
G
Itgax
integrin subunit alpha X
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of ITGAX protein; AHR protein affects the susceptibility to [indole-3-carbinol results in decreased expression of ITGAX protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAX protein]
CTD
PMID:21948866
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb1bp2
integrin subunit beta 1 binding protein 2
affects expression
EXP
indole-3-carbinol affects the expression of ITGB1BP2 mRNA
CTD
PMID:21396975
NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174
G
Itgb3bp
integrin subunit beta 3 binding protein
affects expression
EXP
indole-3-carbinol affects the expression of ITGB3BP mRNA
CTD
PMID:21396975
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
G
Itgb6
integrin subunit beta 6
affects expression
EXP
indole-3-carbinol affects the expression of ITGB6 mRNA
CTD
PMID:21396975
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP ISO
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of JUN mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of JUN mRNA indole-3-carbinol results in increased expression of JUN mRNA indole-3-carbinol results in increased expression of JUN protein
CTD
PMID:22129741 PMID:24418717 PMID:29992829
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Ka11
type I keratin KA11
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of KA11 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KA11 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:85,161,424...85,164,737
Ensembl chr10:85,066,802...85,171,799
G
Katnal2
katanin catalytic subunit A1 like 2
affects expression
EXP
indole-3-carbinol affects the expression of KATNAL2 mRNA
CTD
PMID:21396975
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
G
Kcnh5
potassium voltage-gated channel subfamily H member 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNH5 mRNA
CTD
PMID:22129741
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
affects expression
EXP
indole-3-carbinol affects the expression of KCNN2 mRNA
CTD
PMID:21396975
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Kcnq2
potassium voltage-gated channel subfamily Q member 2
affects expression
EXP
indole-3-carbinol affects the expression of KCNQ2 mRNA
CTD
PMID:21396975
NCBI chr 3:168,194,776...168,253,831
Ensembl chr 3:168,195,357...168,275,071
G
Kcnq5
potassium voltage-gated channel subfamily Q member 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNQ5 mRNA
CTD
PMID:22129741
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
G
Kctd12
potassium channel tetramerization domain containing 12
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD12 mRNA
CTD
PMID:22129741
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
G
Kctd4
potassium channel tetramerization domain containing 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCTD4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD4 mRNA
CTD
PMID:22129741
NCBI chr15:51,263,664...51,278,030
Ensembl chr15:51,274,295...51,277,499
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of KEAP1 protein]
CTD
PMID:29775573
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kiaa1671
KIAA1671 homolog
affects expression
EXP
indole-3-carbinol affects the expression of KIAA1671 mRNA
CTD
PMID:21396975
NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157
G
Kif14
kinesin family member 14
affects expression
EXP
indole-3-carbinol affects the expression of KIF14 mRNA
CTD
PMID:21396975
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
G
Kif1c
kinesin family member 1C
affects expression
EXP
indole-3-carbinol affects the expression of KIF1C mRNA
CTD
PMID:21396975
NCBI chr10:55,414,412...55,444,587
Ensembl chr10:55,415,900...55,443,545
G
Kif20a
kinesin family member 20A
affects expression
EXP
indole-3-carbinol affects the expression of KIF20A mRNA
CTD
PMID:21396975
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif26b
kinesin family member 26B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIF26B mRNA
CTD
PMID:22129741
NCBI chr13:90,282,821...90,689,058
Ensembl chr13:90,283,404...90,682,811
G
Kif2a
kinesin family member 2A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIF2A mRNA
CTD
PMID:22129741
NCBI chr 2:38,367,998...38,431,237
Ensembl chr 2:38,367,998...38,431,508
G
Kif3a
kinesin family member 3a
affects expression
EXP
indole-3-carbinol affects the expression of KIF3A mRNA
CTD
PMID:21396975
NCBI chr10:37,725,930...37,761,183
Ensembl chr10:37,725,970...37,759,191
G
Kifc3
kinesin family member C3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of KIFC3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIFC3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
G
Kirrel1
kirre like nephrin family adhesion molecule 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIRREL1 mRNA
CTD
PMID:22129741
NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299
G
Klf6
KLF transcription factor 6
affects expression
EXP
indole-3-carbinol affects the expression of KLF6 mRNA
CTD
PMID:21396975
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klhl4
kelch-like family member 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KLHL4 mRNA
CTD
PMID:22129741
NCBI chr X:79,429,193...79,719,482
Ensembl chr X:79,622,113...79,719,480
G
Klk7
kallikrein-related peptidase 7
affects expression
EXP
indole-3-carbinol affects the expression of KLK7 mRNA
CTD
PMID:21396975
NCBI chr 1:94,267,170...94,271,361
Ensembl chr 1:94,266,605...94,271,332
G
Knop1
lysine-rich nucleolar protein 1
affects expression
EXP
indole-3-carbinol affects the expression of KNOP1 mRNA
CTD
PMID:21396975
NCBI chr 1:173,180,400...173,199,253
Ensembl chr 1:173,180,405...173,202,245
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KNSTRN mRNA
CTD
PMID:22129741
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kpna6
karyopherin subunit alpha 6
affects expression
EXP
indole-3-carbinol affects the expression of KPNA6 mRNA
CTD
PMID:21396975
NCBI chr 5:141,988,111...142,021,483
Ensembl chr 5:141,991,568...142,021,120
G
Kremen2
kringle containing transmembrane protein 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KREMEN2 mRNA
CTD
PMID:22129741
NCBI chr10:12,763,345...12,767,622
Ensembl chr10:12,763,397...12,767,854
G
Krt14
keratin 14
affects expression
EXP
indole-3-carbinol affects the expression of KRT14 mRNA
CTD
PMID:21396975
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
G
Krt19
keratin 19
affects expression
EXP
indole-3-carbinol affects the expression of KRT19 mRNA
CTD
PMID:21396975
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt20
keratin 20
affects expression
EXP
indole-3-carbinol affects the expression of KRT20 mRNA
CTD
PMID:21396975
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
G
Krt35
keratin 35
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT35 mRNA
CTD
PMID:22129741
NCBI chr10:85,026,171...85,029,568
Ensembl chr10:85,026,171...85,029,568
G
Krt4
keratin 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT4 mRNA
CTD
PMID:22129741
NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019
G
Krt78
keratin 78
affects expression
EXP
indole-3-carbinol affects the expression of KRT78 mRNA
CTD
PMID:21396975
NCBI chr 7:133,074,193...133,081,536
Ensembl chr 7:133,074,215...133,082,021
G
Krtap10-10l1
keratin associated protein 10-10 like 1
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP10-10L1 mRNA
CTD
PMID:21396975
NCBI chr20:10,824,177...10,825,590
G
Krtap14
keratin associated protein 14
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP14 mRNA
CTD
PMID:21396975
NCBI chr11:28,126,660...28,127,502
Ensembl chr11:28,126,660...28,127,502
G
Krtap16-5
keratin associated protein 16-5
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP19-3 mRNA
CTD
PMID:21396975
NCBI chr11:28,249,212...28,249,796
Ensembl chr11:28,249,212...28,249,796
G
Krtap2-4l2
keratin associated protein 2-4 like 2
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP2-4 mRNA; indole-3-carbinol affects the expression of KRTAP2-4L2 mRNA
CTD
PMID:21396975
NCBI chr10:84,584,364...84,585,548
Ensembl chr10:84,584,363...84,584,808
G
Krtap3-2
keratin associated protein 3-2
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP3-2 mRNA
CTD
PMID:21396975
NCBI chr10:84,518,634...84,518,964
Ensembl chr10:84,517,977...84,518,988 Ensembl chr10:84,517,977...84,518,988
G
Krtap5-8
keratin associated protein 5-8
affects expression
EXP
indole-3-carbinol affects the expression of KRTAP5-2 mRNA; indole-3-carbinol affects the expression of KRTAP5-5 mRNA
CTD
PMID:21396975
NCBI chr 1:197,446,125...197,446,817
Ensembl chr 1:197,446,125...197,446,817
G
Lama3
laminin subunit alpha 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMA3 mRNA
CTD
PMID:22129741
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
G
Lamc2
laminin subunit gamma 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMC2 mRNA
CTD
PMID:22129741
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Las1l
LAS1-like, ribosome biogenesis factor
affects expression
EXP
indole-3-carbinol affects the expression of LAS1L mRNA
CTD
PMID:21396975
NCBI chr X:60,851,969...60,873,717
Ensembl chr X:60,851,962...60,873,687
G
Layn
layilin
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAYN mRNA
CTD
PMID:22129741
NCBI chr 8:51,363,928...51,384,748
Ensembl chr 8:51,367,091...51,384,330
G
Lce1f
late cornified envelope 1F
affects expression
EXP
indole-3-carbinol affects the expression of LCE1F mRNA
CTD
PMID:21396975
NCBI chr 2:178,305,786...178,307,372
Ensembl chr 2:178,305,786...178,307,372
G
Leap2
liver enriched antimicrobial peptide 2
affects expression
EXP
indole-3-carbinol affects the expression of LEAP2 mRNA
CTD
PMID:21396975
NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244
G
Lgals1
galectin 1
affects expression
EXP
indole-3-carbinol affects the expression of LGALS1 mRNA
CTD
PMID:21396975
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lgals2
galectin 2
affects expression
EXP
indole-3-carbinol affects the expression of LGALS2 mRNA
CTD
PMID:21396975
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
G
Lgalsl
galectin-like
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA
CTD
PMID:22129741
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
indole-3-carbinol inhibits the reaction [letrozole results in increased expression of LHB protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in increased expression of LHB protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in increased expression of LHB protein]]
CTD
PMID:28619389
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhx8
LIM homeobox 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LHX8 mRNA
CTD
PMID:22129741
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
G
Liph
lipase H
affects expression
EXP
indole-3-carbinol affects the expression of LIPH mRNA
CTD
PMID:21396975
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
G
Lipi
lipase I
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LIPI mRNA
CTD
PMID:22129741
NCBI chr11:14,189,323...14,228,992
Ensembl chr11:14,189,323...14,228,985
G
Lonrf1
LON peptidase N-terminal domain and ring finger 1
affects expression
EXP
indole-3-carbinol affects the expression of LONRF1 mRNA
CTD
PMID:21396975
NCBI chr16:55,984,572...56,015,156
Ensembl chr16:55,984,463...56,015,156
G
Loxl1
lysyl oxidase-like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LOXL1 mRNA
CTD
PMID:22129741
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lpin1
lipin 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LPIN1 mRNA
CTD
PMID:22129741
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpin2
lipin 2
affects expression
EXP
indole-3-carbinol affects the expression of LPIN2 mRNA
CTD
PMID:21396975
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Lpl
lipoprotein lipase
affects expression
EXP
indole-3-carbinol affects the expression of LPL mRNA
CTD
PMID:21396975
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lpo
lactoperoxidase
affects expression
EXP
indole-3-carbinol affects the expression of LPO mRNA
CTD
PMID:21396975
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Lrrc51
leucine rich repeat containing 51
affects expression
EXP
indole-3-carbinol affects the expression of LRRC51 mRNA
CTD
PMID:21396975
NCBI chr 1:156,278,617...156,297,838
Ensembl chr 1:156,278,618...156,297,773
G
Lrrcc1
leucine rich repeat and coiled-coil centrosomal protein 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRCC1 mRNA
CTD
PMID:22129741
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
G
Lrrn4
leucine rich repeat neuronal 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA
CTD
PMID:22129741
NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831
G
Lsm3
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
affects expression
EXP
indole-3-carbinol affects the expression of LSM3 mRNA
CTD
PMID:21396975
NCBI chr 4:124,021,023...124,027,269
Ensembl chr 4:124,021,023...124,027,269
G
Lsm5
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LSM5 mRNA
CTD
PMID:22129741
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
G
Lxn
latexin
affects expression
EXP
indole-3-carbinol affects the expression of LXN mRNA
CTD
PMID:21396975
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
G
Ly49si1
immunoreceptor Ly49si1
affects expression
EXP
indole-3-carbinol affects the expression of LY49SI1 mRNA
CTD
PMID:21396975
NCBI chr 4:163,586,930...163,600,528
Ensembl chr 4:163,514,541...163,751,214 Ensembl chr 4:163,514,541...163,751,214
G
Ly9
lymphocyte antigen 9
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of LY9 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LY9 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr13:84,079,345...84,100,783
Ensembl chr13:84,079,458...84,100,823
G
Ly96
lymphocyte antigen 96
affects expression
EXP
indole-3-carbinol affects the expression of LY96 mRNA
CTD
PMID:21396975
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:2,582,254...2,612,386
G
Lyg2
lysozyme G2
affects expression
EXP
indole-3-carbinol affects the expression of LYG2 mRNA
CTD
PMID:21396975
NCBI chr 9:40,141,144...40,150,821
Ensembl chr 9:40,141,381...40,150,821
G
Lynx1
Ly6/neurotoxin 1
affects expression
EXP
indole-3-carbinol affects the expression of LYNX1 mRNA
CTD
PMID:21396975
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
G
Lypd1
Ly6/Plaur domain containing 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LYPD1 mRNA
CTD
PMID:22129741
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
G
Lyplal1
lysophospholipase-like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYPLAL1 mRNA
CTD
PMID:22129741
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
G
Lyset
lysosomal enzyme trafficking factor
affects expression
EXP
indole-3-carbinol affects the expression of LYSET mRNA
CTD
PMID:21396975
NCBI chr 6:121,884,577...121,886,319
Ensembl chr 6:121,884,643...121,886,275
G
Lyzl4
lysozyme-like 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYZL4 mRNA
CTD
PMID:22129741
NCBI chr 8:121,248,129...121,255,366
Ensembl chr 8:121,248,168...121,255,353
G
Macrod2
mono-ADP ribosylhydrolase 2
affects expression
EXP
indole-3-carbinol affects the expression of MACROD2 mRNA
CTD
PMID:21396975
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
G
Maged2
MAGE family member D2
affects expression
EXP
indole-3-carbinol affects the expression of MAGED2 mRNA
CTD
PMID:21396975
NCBI chr X:19,733,593...19,741,769
Ensembl chr X:19,733,597...19,740,477
G
Magee1
MAGE family member E1
affects expression
EXP
indole-3-carbinol affects the expression of MAGEE1 mRNA
CTD
PMID:21396975
NCBI chr X:70,189,242...70,192,789
Ensembl chr X:70,189,187...70,192,810
G
Magoh
mago homolog, exon junction complex subunit
affects expression
EXP
indole-3-carbinol affects the expression of MAGOH mRNA
CTD
PMID:21396975
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
G
Mall
mal, T-cell differentiation protein-like
affects expression
EXP
indole-3-carbinol affects the expression of MALL mRNA
CTD
PMID:21396975
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
affects expression multiple interactions
EXP ISO
indole-3-carbinol affects the expression of MAP3K5 mRNA Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]; indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein
CTD
PMID:21396975 PMID:33118390
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
affects expression
EXP
indole-3-carbinol affects the expression of MAP4K4 mRNA
CTD
PMID:21396975
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
indole-3-carbinol results in increased phosphorylation of MAPK1 protein
CTD
PMID:33118390
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
indole-3-carbinol results in increased phosphorylation of MAPK3 protein
CTD
PMID:33118390
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapkapk3
MAPK activated protein kinase 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of MAPKAPK3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:107,929,762...107,963,568
G
Mapt
microtubule-associated protein tau
affects expression
EXP
indole-3-carbinol affects the expression of MAPT mRNA
CTD
PMID:21396975
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Marchf3
membrane associated ring-CH-type finger 3
affects expression
EXP
indole-3-carbinol affects the expression of MARCHF3 mRNA
CTD
PMID:21396975
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
G
Max
MYC associated factor X
affects expression
EXP
indole-3-carbinol affects the expression of MAX mRNA
CTD
PMID:21396975
NCBI chr 6:95,636,859...95,662,204
Ensembl chr 6:95,636,858...95,662,137
G
Mcam
melanoma cell adhesion molecule
affects expression
EXP
indole-3-carbinol affects the expression of MCAM mRNA
CTD
PMID:21396975
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcpt1l3
mast cell protease 1-like 3
affects expression
EXP
indole-3-carbinol affects the expression of MCPT1L3 mRNA
CTD
PMID:21396975
NCBI chr15:29,836,398...29,841,731
Ensembl chr15:29,532,079...29,873,922
G
Mcpt8l2
mast cell protease 8-like 2
affects expression
EXP
indole-3-carbinol affects the expression of MCPT1L2 mRNA
CTD
PMID:21396975
G
Mdp1
magnesium-dependent phosphatase 1
affects expression
EXP
indole-3-carbinol affects the expression of MDP1 mRNA
CTD
PMID:21396975
NCBI chr15:29,148,994...29,151,868
Ensembl chr15:29,148,994...29,151,905
G
Me1
malic enzyme 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ME1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ME1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Me2
malic enzyme 2
affects expression
EXP
indole-3-carbinol affects the expression of ME2 mRNA
CTD
PMID:21396975
NCBI chr18:67,350,833...67,400,987
Ensembl chr18:67,355,795...67,400,987
G
Med19
mediator complex subunit 19
affects expression
EXP
indole-3-carbinol affects the expression of MED19 mRNA
CTD
PMID:21396975
NCBI chr 3:69,762,138...69,772,661
Ensembl chr 3:69,762,166...69,772,036
G
Med21
mediator complex subunit 21
affects expression
EXP
indole-3-carbinol affects the expression of MED21 mRNA
CTD
PMID:21396975
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
G
Metap1d
methionyl aminopeptidase type 1D (mitochondrial)
affects expression
EXP
indole-3-carbinol affects the expression of METAP1D mRNA
CTD
PMID:21396975
NCBI chr 3:56,279,471...56,354,518
Ensembl chr 3:56,279,493...56,351,981
G
Metrnl
meteorin-like, glial cell differentiation regulator
affects expression
EXP
indole-3-carbinol affects the expression of METRNL mRNA
CTD
PMID:21396975
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
G
Mfap4
microfibril associated protein 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of MFAP4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MFAP4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mgme1
mitochondrial genome maintenance exonuclease 1
affects expression
EXP
indole-3-carbinol affects the expression of MGME1 mRNA
CTD
PMID:21396975
NCBI chr 3:131,640,770...131,649,933
Ensembl chr 3:131,640,944...131,649,932
G
Mgst2
microsomal glutathione S-transferase 2
affects expression
EXP
indole-3-carbinol affects the expression of MGST2 mRNA
CTD
PMID:21396975
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mier1
MIER1 transcriptional regulator
affects expression
EXP
indole-3-carbinol affects the expression of MIER1 mRNA
CTD
PMID:21396975
NCBI chr 5:117,876,012...117,927,592
Ensembl chr 5:117,870,382...117,927,589
G
Mindy2
MINDY lysine 48 deubiquitinase 2
affects expression
EXP
indole-3-carbinol affects the expression of MINDY2 mRNA
CTD
PMID:21396975
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
G
Mindy4
MINDY lysine 48 deubiquitinase 4
affects expression
EXP
indole-3-carbinol affects the expression of MINDY4 mRNA
CTD
PMID:21396975
NCBI chr 4:84,358,660...84,469,189
Ensembl chr 4:84,358,902...84,463,395
G
Misp3
MISP family member 3
affects expression
EXP
indole-3-carbinol affects the expression of MISP3 mRNA
CTD
PMID:21396975
NCBI chr19:24,139,998...24,142,006
Ensembl chr19:24,140,033...24,142,631
G
Mlc1
modulator of VRAC current 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MLC1 mRNA
CTD
PMID:22129741
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
G
Mllt6
MLLT6, PHD finger containing
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MLLT6 mRNA
CTD
PMID:22129741
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
G
Mmd2
monocyte to macrophage differentiation-associated 2
affects expression
EXP
indole-3-carbinol affects the expression of MMD2 mRNA
CTD
PMID:21396975
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
G
Mmgt1
membrane magnesium transporter 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MMGT1 mRNA
CTD
PMID:22129741
NCBI chr X:134,408,463...134,420,798
Ensembl chr X:134,408,466...134,420,729
G
Mmp12
matrix metallopeptidase 12
affects expression
EXP
indole-3-carbinol affects the expression of MMP12 mRNA
CTD
PMID:21396975
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611
G
Mmp14
matrix metallopeptidase 14
affects expression
EXP
indole-3-carbinol affects the expression of MMP14 mRNA
CTD
PMID:21396975
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp27
matrix metallopeptidase 27
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of MMP27 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MMP27 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:4,745,887...4,755,806
Ensembl chr 8:4,745,883...4,755,806
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] indole-3-carbinol results in decreased expression of MMP9 protein
CTD
PMID:15811958 PMID:29775573
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mnd1
meiotic nuclear divisions 1
affects expression
EXP
indole-3-carbinol affects the expression of MND1 mRNA
CTD
PMID:21396975
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mnda
myeloid cell nuclear differentiation antigen
affects expression
EXP
indole-3-carbinol affects the expression of IFI204 mRNA
CTD
PMID:21396975
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mob2
MOB kinase activator 2
affects expression
EXP
indole-3-carbinol affects the expression of MOB2 mRNA
CTD
PMID:21396975
NCBI chr 1:197,092,991...197,149,978
Ensembl chr 1:197,092,994...197,149,933
G
Mob4
MOB family member 4, phocein
affects expression
EXP
indole-3-carbinol affects the expression of MOB4 mRNA
CTD
PMID:21396975
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Morn2
MORN repeat containing 2
affects expression
EXP
indole-3-carbinol affects the expression of MORN2 mRNA
CTD
PMID:21396975
NCBI chr 6:14,718,799...14,725,281
G
Mospd1
motile sperm domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of MOSPD1 mRNA
CTD
PMID:21396975
NCBI chr X:133,100,200...133,127,960
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908 Ensembl chr14:133,100,422...133,127,908
G
Mov10l1
Mov10 like RNA helicase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MOV10L1 mRNA
CTD
PMID:22129741
NCBI chr 7:120,070,171...120,135,406
Ensembl chr 7:120,070,135...120,134,765
G
Mpped1
metallophosphoesterase domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of MPPED1 mRNA
CTD
PMID:21396975
NCBI chr 7:114,932,221...115,011,797
Ensembl chr 7:114,944,764...115,011,787
G
Mrap
melanocortin 2 receptor accessory protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MRAP mRNA
CTD
PMID:22129741
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
G
Mras
muscle RAS oncogene homolog
affects expression
EXP
indole-3-carbinol affects the expression of MRAS mRNA
CTD
PMID:21396975
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
G
Mrm3
mitochondrial rRNA methyltransferase 3
affects expression
EXP
indole-3-carbinol affects the expression of MRM3 mRNA
CTD
PMID:21396975
NCBI chr10:61,095,920...61,125,421
Ensembl chr10:61,095,952...61,102,630
G
Mrps27
mitochondrial ribosomal protein S27
affects expression
EXP
indole-3-carbinol affects the expression of MRPS27 mRNA
CTD
PMID:21396975
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
G
Ms4a8
membrane spanning 4-domains A8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MS4A8A mRNA
CTD
PMID:22129741
NCBI chr 1:207,730,665...207,744,260
Ensembl chr 1:207,730,665...207,744,324
G
Msgn1
mesogenin 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MSGN1 mRNA
CTD
PMID:22129741
NCBI chr 6:33,912,787...33,913,427
Ensembl chr 6:33,912,787...33,913,427
G
Msln
mesothelin
affects expression
EXP
indole-3-carbinol affects the expression of MSLN mRNA
CTD
PMID:21396975
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Mta3
metastasis associated 1 family, member 3
affects expression
EXP
indole-3-carbinol affects the expression of MTA3 mRNA
CTD
PMID:21396975
NCBI chr 6:10,867,028...10,987,221
Ensembl chr 6:10,867,011...10,986,883
G
Mterf3
mitochondrial transcription termination factor 3
affects expression
EXP
indole-3-carbinol affects the expression of MTERF3 mRNA
CTD
PMID:21396975
NCBI chr 7:63,826,418...63,844,747
Ensembl chr 7:63,826,427...63,844,658
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
affects expression
EXP
indole-3-carbinol affects the expression of MTHFD2 mRNA
CTD
PMID:21396975
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mthfr
methylenetetrahydrofolate reductase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MTHFR mRNA
CTD
PMID:22129741
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mtmr7
myotubularin related protein 7
affects expression
EXP
indole-3-carbinol affects the expression of MTMR7 mRNA
CTD
PMID:21396975
NCBI chr16:51,641,267...51,732,212
Ensembl chr16:51,641,190...51,732,182
G
Mto1
mitochondrial tRNA translation optimization 1
affects expression
EXP
indole-3-carbinol affects the expression of MTO1 mRNA
CTD
PMID:21396975
NCBI chr 8:79,309,681...79,335,231
Ensembl chr 8:79,309,982...79,335,231
G
Muc1
mucin 1, cell surface associated
decreases expression affects expression
ISO EXP
indole-3-carbinol results in decreased expression of MUC1 mRNA; indole-3-carbinol results in decreased expression of MUC1 protein indole-3-carbinol affects the expression of MUC1 mRNA
CTD
PMID:15027113 PMID:21396975
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Muc19
mucin 19, oligomeric
affects expression
EXP
indole-3-carbinol affects the expression of MUC19 mRNA
CTD
PMID:21396975
NCBI chr 7:124,897,424...125,018,582
Ensembl chr 7:123,017,896...123,139,053
G
Muc6
mucin 6, oligomeric mucus/gel-forming
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of MUC6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MUC6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Mucl3
mucin like 3
affects expression
EXP
indole-3-carbinol affects the expression of MUCL3 mRNA
CTD
PMID:21396975
NCBI chr20:3,100,652...3,108,569
Ensembl chr20:3,100,679...3,108,569
G
Mup4
major urinary protein 4
affects expression
EXP
indole-3-carbinol affects the expression of MUP4 mRNA
CTD
PMID:21396975
NCBI chr 5:74,961,143...74,964,686
Ensembl chr 5:74,842,319...75,061,474
G
Mybph
myosin binding protein H
affects expression
EXP
indole-3-carbinol affects the expression of MYBPH mRNA
CTD
PMID:21396975
NCBI chr13:45,653,156...45,660,893
Ensembl chr13:45,653,234...45,660,893
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYC mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYC mRNA]
CTD
PMID:22129741
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycbpap
Mycbp associated protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYCBPAP mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYCBPAP mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYCBPAP mRNA]
CTD
PMID:22129741
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
G
Myef2
myelin expression factor 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYEF2 mRNA
CTD
PMID:22129741
NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181
G
Myh10
myosin heavy chain 10
affects expression
EXP
indole-3-carbinol affects the expression of MYH10 mRNA
CTD
PMID:21396975
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Myh14
myosin heavy chain 14
affects expression
EXP
indole-3-carbinol affects the expression of MYH14 mRNA
CTD
PMID:21396975
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
G
Myh2
myosin heavy chain 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYH2 mRNA
CTD
PMID:22129741
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
G
Myl6
myosin light chain 6
affects expression
EXP
indole-3-carbinol affects the expression of MYL6 mRNA
CTD
PMID:21396975
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
G
Myo7b
myosin VIIb
affects expression
EXP
indole-3-carbinol affects the expression of MYO7B mRNA
CTD
PMID:21396975
NCBI chr18:23,588,307...23,669,841
Ensembl chr18:23,588,307...23,669,809
G
Myog
myogenin
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MYOG mRNA
CTD
PMID:22129741
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
N4bp2l1
NEDD4 binding protein 2-like 1
affects expression
EXP
indole-3-carbinol affects the expression of N4BP2L1 mRNA
CTD
PMID:21396975
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
Naa38
N(alpha)-acetyltransferase 38, NatC auxiliary subunit
affects expression
EXP
indole-3-carbinol affects the expression of NAA38 mRNA
CTD
PMID:21396975
NCBI chr10:54,117,754...54,118,913
Ensembl chr10:54,117,163...54,119,494
G
Nae1
NEDD8 activating enzyme E1 subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of NAE1 mRNA
CTD
PMID:21396975
NCBI chr19:446,015...472,145
Ensembl chr19:446,000...472,371
G
Nap1l6
nucleosome assembly protein 1 like 6
affects expression
EXP
indole-3-carbinol affects the expression of NAP1L6 mRNA
CTD
PMID:21396975
NCBI chr 7:118,084,674...118,085,850
Ensembl chr 7:118,084,696...118,085,850
G
Nat8
N-acetyltransferase 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NAT8 mRNA
CTD
PMID:22129741
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
G
Ncam2
neural cell adhesion molecule 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of NCAM2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NCAM2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
G
Ndufaf1
NADH:ubiquinone oxidoreductase complex assembly factor 1
affects expression
EXP
indole-3-carbinol affects the expression of NDUFAF1 mRNA
CTD
PMID:21396975
NCBI chr 3:106,639,025...106,650,549
Ensembl chr 3:106,639,851...106,650,212
G
Nek4
NIMA-related kinase 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of NEK4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr16:6,144,900...6,185,376
Ensembl chr16:6,144,959...6,188,932
G
Nenf
neudesin neurotrophic factor
affects expression
EXP
indole-3-carbinol affects the expression of NENF mRNA
CTD
PMID:21396975
NCBI chr13:102,888,004...102,894,804
Ensembl chr13:102,888,004...102,894,804
G
Neto2
neuropilin and tolloid like 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NETO2 mRNA
CTD
PMID:22129741
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
G
Neu3
neuraminidase 3
affects expression
EXP
indole-3-carbinol affects the expression of NEU3 mRNA
CTD
PMID:21396975
NCBI chr 1:154,137,732...154,148,879
Ensembl chr 1:154,050,855...154,148,813
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of NEURL3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NEURL3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity affects activity affects expression multiple interactions
ISO EXP
indole-3-carbinol results in decreased activity of NFE2L2 protein indole-3-carbinol affects the activity of NFE2L2 protein indole-3-carbinol affects the expression of NFE2L2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA]; indole-3-carbinol inhibits the reaction [Letrozole results in decreased expression of NFE2L2 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in decreased expression of NFE2L2 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in decreased expression of NFE2L2 protein]] indole-3-carbinol inhibits the reaction [Doxorubicin affects the expression of and affects the localization of NFE2L2 protein] [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of NFE2L2 mRNA
CTD
PMID:11309284 PMID:16082211 PMID:21396975 PMID:22129741 PMID:28619389 PMID:29775573 PMID:32070777 More...
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfil3
nuclear factor, interleukin 3 regulated
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NFIL3 mRNA
CTD
PMID:22129741
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions decreases activity
ISO
[indole-3-carbinol co-treated with phenethyl isothiocyanate] results in decreased expression of NFKB1 mRNA; indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] indole-3-carbinol results in decreased activity of NFKB1 protein
CTD
PMID:15811958 PMID:16082211 PMID:32070777
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased ubiquitination of NFKBIA protein]
CTD
PMID:15811958
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbil1
NFKB inhibitor like 1
affects expression
EXP
indole-3-carbinol affects the expression of NFKBIL1 mRNA
CTD
PMID:21396975
NCBI chr20:3,595,319...3,610,295
Ensembl chr20:3,590,642...3,605,616
G
Niban1
niban apoptosis regulator 1
affects expression
EXP
indole-3-carbinol affects the expression of NIBAN1 mRNA
CTD
PMID:21396975
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nifk
nucleolar protein interacting with the FHA domain of MKI67
affects expression
EXP
indole-3-carbinol affects the expression of NIFK mRNA
CTD
PMID:21396975
NCBI chr13:29,393,303...29,403,387
Ensembl chr13:29,393,286...29,405,896
G
Nipal2
NIPA-like domain containing 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of NIPAL2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NIPAL2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:65,774,477...65,884,807
Ensembl chr 7:65,774,477...65,884,807
G
Nkx2-4
NK2 homeobox 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NKX2-4 mRNA
CTD
PMID:22129741
NCBI chr 3:134,514,368...134,517,243
Ensembl chr 3:134,515,039...134,516,505
G
Nlrc4
NLR family, CARD domain containing 4
affects expression
EXP
indole-3-carbinol affects the expression of NLRC4 mRNA
CTD
PMID:21396975
NCBI chr 6:20,991,785...21,018,254
Ensembl chr 6:20,995,266...21,018,248
G
Nmral1
NmrA like redox sensor 1
affects expression
EXP
indole-3-carbinol affects the expression of NMRAL1 mRNA
CTD
PMID:21396975
NCBI chr10:10,841,693...10,850,199
Ensembl chr10:10,841,799...10,850,192
G
Nmt2
N-myristoyltransferase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NMT2 mRNA
CTD
PMID:22129741
NCBI chr17:74,917,833...74,964,788
Ensembl chr17:74,917,833...74,961,080
G
Nol3
nucleolar protein 3
affects expression
EXP
indole-3-carbinol affects the expression of NOL3 mRNA
CTD
PMID:21396975
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:33,154,062...33,158,250
G
Nop58
NOP58 ribonucleoprotein
affects expression
EXP
indole-3-carbinol affects the expression of NOP58 mRNA
CTD
PMID:21396975
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
G
Nopchap1
NOP protein chaperone 1
affects expression
EXP
indole-3-carbinol affects the expression of NOPCHAP1 mRNA
CTD
PMID:21396975
NCBI chr 7:20,353,626...20,359,685
Ensembl chr 7:20,353,634...20,359,690
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein]
CTD
PMID:29775573
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notum
NOTUM, palmitoleoyl-protein carboxylesterase
affects expression
EXP
indole-3-carbinol affects the expression of NOTUM mRNA
CTD
PMID:21396975
NCBI chr10:105,933,245...105,940,327
Ensembl chr10:105,933,249...105,940,315
G
Npas2
neuronal PAS domain protein 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPAS2 mRNA
CTD
PMID:22129741
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Npff
neuropeptide FF-amide peptide precursor
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NPFF mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NPFF mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NPFF mRNA]
CTD
PMID:22129741
NCBI chr 7:133,654,530...133,655,319
G
Npm3
nucleophosmin/nucleoplasmin, 3
affects expression
EXP
indole-3-carbinol affects the expression of NPM3 mRNA
CTD
PMID:21396975
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases activity increases expression affects expression multiple interactions
EXP ISO
indole-3-carbinol results in increased activity of NQO1 protein indole-3-carbinol results in increased expression of NQO1 protein indole-3-carbinol results in increased expression of NQO1; indole-3-carbinol results in increased expression of NQO1 mRNA indole-3-carbinol affects the expression of NQO1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NQO1 mRNA] indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of NQO1 protein] [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of NQO1 mRNA; [indole-3-carbinol co-treated with Resveratrol] results in increased expression of NQO1 mRNA; [indole-3-carbinol co-treated with xanthohumol] results in increased expression of NQO1 mRNA
CTD
PMID:9806166 PMID:11309284 PMID:11446830 PMID:21203749 PMID:21396975 PMID:22129741 PMID:24418717 PMID:29775573 PMID:32070777 More...
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
affects expression
EXP
indole-3-carbinol affects the expression of NR1D1 mRNA
CTD
PMID:21396975
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
indole-3-carbinol results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
affects expression
EXP
indole-3-carbinol affects the expression of NR4A1 mRNA
CTD
PMID:21396975
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrep
neuronal regeneration related protein
affects expression
EXP
indole-3-carbinol affects the expression of NREP mRNA
CTD
PMID:21396975
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrg1
neuregulin 1
affects expression
EXP
indole-3-carbinol affects the expression of NRG1 mRNA
CTD
PMID:21396975
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Nt5m
5',3'-nucleotidase, mitochondrial
affects expression
EXP
indole-3-carbinol affects the expression of NT5M mRNA
CTD
PMID:21396975
NCBI chr10:44,652,845...44,680,549
Ensembl chr10:44,652,975...44,679,150
G
Ntf3
neurotrophin 3
affects expression
EXP
indole-3-carbinol affects the expression of NTF3 mRNA
CTD
PMID:21396975
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
G
Ntsr1
neurotensin receptor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NTSR1 mRNA
CTD
PMID:22129741
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
Nuak2
NUAK family kinase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA
CTD
PMID:22129741
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
G
Nudt11
nudix hydrolase 11
affects expression
EXP
indole-3-carbinol affects the expression of NUDT10 mRNA; indole-3-carbinol affects the expression of NUDT11 mRNA
CTD
PMID:21396975
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Nudt15
nudix hydrolase 15
affects expression
EXP
indole-3-carbinol affects the expression of NUDT15 mRNA
CTD
PMID:21396975
NCBI chr15:48,707,776...48,713,847
Ensembl chr15:48,709,700...48,747,363
G
Nupr1
nuclear protein 1, transcriptional regulator
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of NUPR1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUPR1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nxn
nucleoredoxin
affects expression
EXP
indole-3-carbinol affects the expression of NXN mRNA
CTD
PMID:21396975
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
G
Oat
ornithine aminotransferase
affects expression
EXP
indole-3-carbinol affects the expression of OAT mRNA
CTD
PMID:21396975
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Obp1f
odorant binding protein I f
affects expression
EXP
indole-3-carbinol affects the expression of OBP1F mRNA
CTD
PMID:21396975
NCBI chr X:41,955,618...41,960,681
Ensembl chr X:41,955,618...41,960,681
G
Obp3
alpha-2u globulin PGCL4
affects expression
EXP
indole-3-carbinol affects the expression of OBP3 mRNA
CTD
PMID:21396975
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Odf2
outer dense fiber of sperm tails 2
affects expression
EXP
indole-3-carbinol affects the expression of ODF2 mRNA
CTD
PMID:21396975
NCBI chr 3:13,160,981...13,207,223
Ensembl chr 3:13,161,494...13,206,985
G
Ogdhl
oxoglutarate dehydrogenase L
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OGDHL mRNA
CTD
PMID:22129741
NCBI chr16:7,578,343...7,604,385
Ensembl chr16:7,578,367...7,604,386
G
Ogn
osteoglycin
affects expression
EXP
indole-3-carbinol affects the expression of OGN mRNA
CTD
PMID:21396975
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
G
Olfml2a
olfactomedin-like 2A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OLFML2A mRNA
CTD
PMID:22129741
NCBI chr 3:22,688,590...22,717,917
Ensembl chr 3:22,688,598...22,717,909
G
Olr1090
olfactory receptor 1090
affects expression
EXP
indole-3-carbinol affects the expression of OLR1090 mRNA
CTD
PMID:21396975
NCBI chr 7:12,358,509...12,359,465
Ensembl chr 7:12,355,981...12,388,686
G
Olr1093
olfactory receptor 1093
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OLR1093 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1093 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:12,575,398...12,576,354
Ensembl chr 7:12,574,956...12,587,973
G
Olr1428
olfactory receptor 1428
affects expression
EXP
indole-3-carbinol affects the expression of OLR1428 mRNA
CTD
PMID:21396975
NCBI chr10:42,947,353...42,948,300
Ensembl chr10:42,944,142...42,948,881
G
Olr1451
olfactory receptor 1451
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OLR1451 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1451 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:43,429,140...43,430,069
Ensembl chr10:43,424,036...43,432,210
G
Olr1481
olfactory receptor 1481
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OLR1481 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR1481 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:58,237,886...58,238,830
Ensembl chr10:58,235,688...58,239,281
G
Olr1633
olfactory receptor 1633
affects expression
EXP
indole-3-carbinol affects the expression of OLR1633 mRNA
CTD
PMID:21396975
NCBI chr15:23,893,574...23,894,506
Ensembl chr15:23,893,337...23,900,171 Ensembl chr15:23,893,337...23,900,171
G
Olr59
olfactory receptor 59
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OLR59 mRNA
CTD
PMID:22129741
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
G
Omd
osteomodulin
affects expression
EXP
indole-3-carbinol affects the expression of OMD mRNA
CTD
PMID:21396975
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
G
Omg
oligodendrocyte-myelin glycoprotein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OMG mRNA
CTD
PMID:22129741
NCBI chr10:64,461,350...64,464,084
Ensembl chr10:64,461,350...64,464,084
G
Or10ak7b
olfactory receptor family 5 subfamily AK member 7B
affects expression
EXP
indole-3-carbinol affects the expression of OR10AK7B mRNA
CTD
PMID:21396975
NCBI chr 5:132,373,994...132,374,941
Ensembl chr 5:132,373,994...132,374,941
G
Or10al4c
olfactory receptor family 10 subfamily AL member 4C
affects expression
EXP
indole-3-carbinol affects the expression of OR10AL4C mRNA
CTD
PMID:21396975
NCBI chr20:752,444...753,409
Ensembl chr20:752,367...756,331
G
Or10al5b
olfactory receptor family 10 subfamily AL member 5B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR10AL5B mRNA
CTD
PMID:22129741
NCBI chr20:798,038...810,925
Ensembl chr20:734,965...811,125
G
Or10h1d
olfactory receptor family 10 subfamily H member 1D
affects expression
EXP
indole-3-carbinol affects the expression of OR10H1D mRNA
CTD
PMID:21396975
NCBI chr 7:12,839,664...12,840,620
Ensembl chr 7:12,839,050...12,849,389
G
Or13p9
olfactory receptor family 13 subfamily P member 9
affects expression
EXP
indole-3-carbinol affects the expression of OR13P9 mRNA
CTD
PMID:21396975
NCBI chr 5:132,203,917...132,204,855
Ensembl chr 5:132,201,895...132,209,008
G
Or1f28
olfactory receptor family 1 subfamily F member 28
affects expression
EXP
indole-3-carbinol affects the expression of OR1F28 mRNA
CTD
PMID:21396975
NCBI chr10:12,523,624...12,524,565
Ensembl chr10:12,521,027...12,526,540
G
Or1f30
olfactory receptor family 1 subfamily F member 30
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OR1F30 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR1F30 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:12,483,032...12,483,973
Ensembl chr10:12,481,906...12,484,513
G
Or2ak5e
olfactory receptor family 2 subfamily AK member 5E
affects expression
EXP
indole-3-carbinol affects the expression of OR2AK5E mRNA
CTD
PMID:21396975
NCBI chr10:43,089,865...43,090,782
Ensembl chr10:43,087,519...43,093,395 Ensembl chr10:43,087,519...43,093,395
G
Or2ak5f
olfactory receptor family 2 subfamily AK member 5F
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OR2AK6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR2AK6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:43,269,046...43,269,960
Ensembl chr10:43,289,142...43,290,062
G
Or2n1h
olfactory receptor family 2 subfamily N member 1H
affects expression
EXP
indole-3-carbinol affects the expression of OR2N1H mRNA
CTD
PMID:21396975
NCBI chr20:240,423...241,361
Ensembl chr20:236,379...241,666 Ensembl chr20:236,379...241,666
G
Or2r3b
olfactory receptor family 2 subfamily R member 3B
affects expression
EXP
indole-3-carbinol affects the expression of OR2R3B mRNA
CTD
PMID:21396975
NCBI chr 4:71,389,526...71,390,464
Ensembl chr 4:71,389,526...71,390,464
G
Or2t29
olfactory receptor family 2 subfamily T member 29
affects expression
EXP
indole-3-carbinol affects the expression of OR2T29 mRNA
CTD
PMID:21396975
NCBI chr10:42,907,259...42,908,197
Ensembl chr10:42,907,259...42,908,197
G
Or2t48d
olfactory receptor family 2 subfamily T member 48D
affects expression
EXP
indole-3-carbinol affects the expression of OR2T48D mRNA
CTD
PMID:21396975
NCBI chr10:42,855,972...42,856,916
Ensembl chr10:42,855,530...42,860,622
G
Or2t48e
olfactory receptor family 2 subfamily T member 48E
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of OR2T48E mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR2T48E mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:42,690,368...42,691,297
Ensembl chr10:42,689,609...42,701,405
G
Or2v2
olfactory receptor family 2 subfamily V member 2
affects expression
EXP
indole-3-carbinol affects the expression of OR2V2 mRNA
CTD
PMID:21396975
NCBI chr10:33,379,863...33,380,810
Ensembl chr10:33,376,687...33,381,900
G
Or2y13
olfactory receptor family 2 subfamily Y member 13
affects expression
EXP
indole-3-carbinol affects the expression of OR2Y13 mRNA
CTD
PMID:21396975
NCBI chr10:33,788,832...33,789,767
Ensembl chr10:33,784,923...33,791,043
G
Or4a77d
olfactory receptor family 4 subfamily A member 77D
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4A77D mRNA
CTD
PMID:22129741
NCBI chr 3:75,796,815...75,797,765
Ensembl chr 3:75,796,364...75,801,803
G
Or4c105b
olfactory receptor family 4 subfamily C member 105B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4C105B mRNA
CTD
PMID:22129741
NCBI chr 3:74,458,280...74,459,209
Ensembl chr 3:74,455,596...74,467,433
G
Or4f14f
olfactory receptor family 4 subfamily F member 14F
affects expression
EXP
indole-3-carbinol affects the expression of OR4F14F mRNA
CTD
PMID:21396975
NCBI chr 3:98,533,476...98,534,414
Ensembl chr 3:98,532,858...98,537,641
G
Or4f4b
olfactory receptor family 4 subfamily F member 4B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4F4B mRNA
CTD
PMID:22129741
NCBI chr 3:98,058,061...98,061,955
Ensembl chr 3:98,049,537...98,062,343
G
Or4p20b
olfactory receptor family 4 subfamily P member 20B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4P20B mRNA
CTD
PMID:22129741
NCBI chr 3:74,022,169...74,023,089
Ensembl chr 3:74,022,169...74,023,089
G
Or4q3
olfactory receptor family 4 subfamily Q member 3
affects expression
EXP
indole-3-carbinol affects the expression of OR4Q3 mRNA
CTD
PMID:21396975
NCBI chr15:23,531,029...23,535,992
G
Or4s2
olfactory receptor family 4 subfamily S member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR4S2 mRNA
CTD
PMID:22129741
NCBI chr 3:74,377,492...74,378,427
Ensembl chr 3:74,375,165...74,381,097
G
Or51i2
olfactory receptor family 51 subfamily I member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR51I2 mRNA
CTD
PMID:22129741
NCBI chr 1:158,513,673...158,514,611
Ensembl chr 1:158,513,673...158,514,611
G
Or51q1d
olfactory receptor family 51 subfamily Q member 1D
affects expression
EXP
indole-3-carbinol affects the expression of OR51Q1 mRNA
CTD
PMID:21396975
NCBI chr 1:158,426,462...158,427,427
Ensembl chr 1:158,426,462...158,427,427
G
Or51q1e
olfactory receptor family 51 subfamily Q member 1E
affects expression
EXP
indole-3-carbinol affects the expression of OR51Q1E mRNA
CTD
PMID:21396975
NCBI chr 1:158,482,153...158,483,100
Ensembl chr 1:158,482,135...158,483,100
G
Or52e15b
olfactory receptor family 52 subfamily E member 15B
affects expression
EXP
indole-3-carbinol affects the expression of OR52E15B mRNA
CTD
PMID:21396975
NCBI chr 1:159,391,482...159,392,420
Ensembl chr 1:159,391,193...159,394,866
G
Or5ac23b
olfactory receptor family 5 subfamily AC member 23B
affects expression
EXP
indole-3-carbinol affects the expression of OR5AC23B mRNA
CTD
PMID:21396975
NCBI chr11:41,033,670...41,034,587
Ensembl chr11:41,031,258...41,034,640
G
Or5as1
olfactory receptor family 5 subfamily AS member 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR5AS1 mRNA
CTD
PMID:22129741
NCBI chr 3:72,324,043...72,324,981
Ensembl chr 3:72,323,706...72,326,585
G
Or6c203c
olfactory receptor family 6 subfamily C member 203C
affects expression
EXP
indole-3-carbinol affects the expression of OR6C203C mRNA
CTD
PMID:21396975
NCBI chr 7:1,799,358...1,800,293
Ensembl chr 7:1,799,238...1,816,490
G
Or6d13c
olfactory receptor family 6 subfamily D member 13C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR6D13C mRNA
CTD
PMID:22129741
NCBI chr 4:149,752,294...149,753,277
Ensembl chr 4:149,750,101...149,754,458
G
Or6e1
olfactory receptor family 6 subfamily E member 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OR6E1 mRNA
CTD
PMID:22129741
NCBI chr15:27,733,881...27,734,825
Ensembl chr15:27,729,827...27,736,945
G
Or8g2c
olfactory receptor family 8 subfamily G member 2C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OR8G2C mRNA
CTD
PMID:22129741
NCBI chr 8:40,226,318...40,227,241
Ensembl chr 8:40,223,812...40,227,610
G
Or8h10c
olfactory receptor family 8 subfamily H member 10C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OR8H10C mRNA
CTD
PMID:22129741
NCBI chr 3:72,046,706...72,047,671
Ensembl chr 3:72,046,706...72,047,671 Ensembl chr 3:72,046,706...72,047,671
G
Or9i13
olfactory receptor family 9 subfamily I member 13
affects expression
EXP
indole-3-carbinol affects the expression of OR9I13 mRNA
CTD
PMID:21396975
NCBI chr 1:210,949,465...210,950,427
Ensembl chr 1:210,949,465...210,950,427
G
Or9r3c
olfactory receptor family 9 subfamily R member 3C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OR9R3C mRNA
CTD
PMID:22129741
NCBI chr 7:6,846,678...6,847,622
Ensembl chr 7:6,846,678...6,847,622
G
Orc3
origin recognition complex, subunit 3
affects expression
EXP
indole-3-carbinol affects the expression of ORC3 mRNA
CTD
PMID:21396975
NCBI chr 5:49,123,758...49,181,552
Ensembl chr 5:49,126,955...49,181,633
G
Oscp1
organic solute carrier partner 1
affects expression
EXP
indole-3-carbinol affects the expression of OSCP1 mRNA
CTD
PMID:21396975
NCBI chr 5:138,334,552...138,365,220
Ensembl chr 5:138,333,893...138,366,822
G
Osgep
O-sialoglycoprotein endopeptidase
affects expression
EXP
indole-3-carbinol affects the expression of OSGEP mRNA
CTD
PMID:21396975
NCBI chr15:24,137,149...24,144,568
Ensembl chr15:24,137,153...24,144,568
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
affects expression
EXP
indole-3-carbinol affects the expression of OSGEPL1 mRNA
CTD
PMID:21396975
NCBI chr 9:48,214,995...48,229,440
Ensembl chr 9:48,215,402...48,229,388
G
Otoa
otoancorin
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of OTOA mRNA
CTD
PMID:22129741
NCBI chr 1:175,642,978...175,710,528
Ensembl chr 1:175,642,975...175,710,435
G
Otud1
OTU deubiquitinase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of OTUD1 mRNA
CTD
PMID:22129741
NCBI chr17:82,259,920...82,262,770
Ensembl chr17:82,259,840...82,262,995
G
P2rx5
purinergic receptor P2X 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of P2RX5 mRNA
CTD
PMID:22129741
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
G
Pabpc6
poly(A) binding protein, cytoplasmic 6
affects expression
EXP
indole-3-carbinol affects the expression of PABPC3 mRNA
CTD
PMID:21396975
NCBI chr 1:51,045,264...51,048,340
Ensembl chr 1:51,045,233...51,048,340
G
Pafah2
platelet-activating factor acetylhydrolase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PAFAH2 mRNA
CTD
PMID:22129741
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
G
Pak6
p21 (RAC1) activated kinase 6
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA
CTD
PMID:22129741
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
G
Palm
paralemmin
affects expression
EXP
indole-3-carbinol affects the expression of PALM mRNA
CTD
PMID:21396975
NCBI chr 7:9,886,634...9,912,389
Ensembl chr 7:9,886,643...9,912,555
G
Pals1
protein associated with LIN7 1, MAGUK p55 family member
affects expression
EXP
indole-3-carbinol affects the expression of PALS1 mRNA
CTD
PMID:21396975
NCBI chr 6:97,548,133...97,654,163
Ensembl chr 6:97,548,630...97,653,305
G
Pals2
protein associated with LIN7 2, MAGUK p55 family member
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PALS2 mRNA
CTD
PMID:22129741
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
affects expression
EXP
indole-3-carbinol affects the expression of PAMR1 mRNA
CTD
PMID:21396975
NCBI chr 3:88,889,061...88,988,615
Ensembl chr 3:88,889,046...88,988,606
G
Pank3
pantothenate kinase 3
affects expression
EXP
indole-3-carbinol affects the expression of PANK3 mRNA
CTD
PMID:21396975
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
G
Panx2
pannexin 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PANX2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PANX2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:120,139,259...120,153,056
Ensembl chr 7:120,139,294...120,152,361
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
affects expression
EXP
indole-3-carbinol affects the expression of PAPSS2 mRNA
CTD
PMID:21396975
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Paqr7
progestin and adipoQ receptor family member 7
affects expression
EXP
indole-3-carbinol affects the expression of PAQR7 mRNA
CTD
PMID:21396975
NCBI chr 5:146,709,159...146,720,577
Ensembl chr 5:146,708,900...146,720,673
G
Paqr9
progestin and adipoQ receptor family member 9
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PAQR9 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAQR9 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:96,114,249...96,116,546
G
Pard6b
par-6 family cell polarity regulator beta
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PARD6B mRNA
CTD
PMID:22129741
NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:156,790,540...156,811,622
G
Park7-ps2
Parkinsonism associated deglycase, pseudogene 2
affects expression
EXP
indole-3-carbinol affects the expression of PARK7-PS2 mRNA
CTD
PMID:21396975
NCBI chr16:39,728,910...39,729,268
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
Acetylcysteine inhibits the reaction [indole-3-carbinol results in increased cleavage of PARP1 protein]; indole-3-carbinol promotes the reaction [TNF protein results in increased cleavage of PARP1 protein]; indole-3-carbinol results in decreased expression of and results in increased cleavage of PARP1 protein
CTD
PMID:15811958 PMID:29775573 PMID:29992829 PMID:33118390 PMID:34085558
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pbdc1
polysaccharide biosynthesis domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of PBDC1 mRNA
CTD
PMID:21396975
NCBI chr X:70,154,106...70,197,827
Ensembl chr X:70,154,106...70,184,552
G
Pbxip1
PBX homeobox interacting protein 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PBXIP1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PBXIP1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:174,856,339...174,868,922
Ensembl chr 2:174,856,397...174,868,919
G
Pcp4l1
Purkinje cell protein 4-like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PCP4L1 mRNA
CTD
PMID:22129741
NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966
G
Pcsk5
proprotein convertase subtilisin/kexin type 5
affects expression
EXP
indole-3-carbinol affects the expression of PCSK5 mRNA
CTD
PMID:21396975
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600
G
Pdcd5l1
programmed cell death 5 like 1
affects expression
EXP
indole-3-carbinol affects the expression of PDCD5L1 mRNA
CTD
PMID:21396975
NCBI chr 3:63,644,615...63,646,013
Ensembl chr 3:63,644,581...63,664,425
G
Pde3b
phosphodiesterase 3B
affects expression
EXP
indole-3-carbinol affects the expression of PDE3B mRNA
CTD
PMID:21396975
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334
G
Pde6b
phosphodiesterase 6B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDE6B mRNA
CTD
PMID:22129741
NCBI chr14:1,323,310...1,366,450
Ensembl chr14:1,323,310...1,366,450
G
Pdgfa
platelet derived growth factor subunit A
affects expression
EXP
indole-3-carbinol affects the expression of PDGFA mRNA
CTD
PMID:21396975
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdha2
pyruvate dehydrogenase E1 subunit alpha 2
affects expression
EXP
indole-3-carbinol affects the expression of PDHA2 mRNA
CTD
PMID:21396975
NCBI chr 2:229,872,300...229,873,848
G
Pdk3
pyruvate dehydrogenase kinase 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PDK3 mRNA
CTD
PMID:22129741
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:58,486,554...58,553,557
G
Pdk4
pyruvate dehydrogenase kinase 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PDK4 mRNA
CTD
PMID:22129741
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pex11a
peroxisomal biogenesis factor 11 alpha
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PEX11A mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PEX11A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PEX11A mRNA]
CTD
PMID:22129741
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
G
Pex11g
peroxisomal biogenesis factor 11 gamma
affects expression
EXP
indole-3-carbinol affects the expression of PEX11G mRNA
CTD
PMID:21396975
NCBI chr12:1,502,606...1,532,347
Ensembl chr12:1,503,646...1,512,585
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
affects expression
EXP
indole-3-carbinol affects the expression of PFKFB1 mRNA
CTD
PMID:21396975
NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182
G
Pfkm
phosphofructokinase, muscle
affects expression
EXP
indole-3-carbinol affects the expression of PFKM mRNA
CTD
PMID:21396975
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
G
Pfkp
phosphofructokinase, platelet
affects expression
EXP
indole-3-carbinol affects the expression of PFKP mRNA
CTD
PMID:21396975
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Phgdh
phosphoglycerate dehydrogenase
affects expression
EXP
indole-3-carbinol affects the expression of PHGDH mRNA
CTD
PMID:21396975
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Pibf1
progesterone immunomodulatory binding factor 1
affects expression
EXP
indole-3-carbinol affects the expression of PIBF1 mRNA
CTD
PMID:21396975
NCBI chr15:75,850,389...76,019,711
Ensembl chr15:75,850,624...76,019,712
G
Pigv
phosphatidylinositol glycan anchor biosynthesis, class V
affects expression
EXP
indole-3-carbinol affects the expression of PIGV mRNA
CTD
PMID:21396975
NCBI chr 5:145,889,642...145,901,533
Ensembl chr 5:145,889,646...145,901,533
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
affects expression
EXP
indole-3-carbinol affects the expression of PIK3AP1 mRNA
CTD
PMID:21396975
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
affects expression
EXP
indole-3-carbinol affects the expression of PIK3R1 mRNA
CTD
PMID:21396975
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIM1 mRNA
CTD
PMID:22129741
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Pip
prolactin induced protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIP mRNA
CTD
PMID:22129741
NCBI chr 4:70,787,627...70,791,921
Ensembl chr 4:70,787,627...70,791,921
G
Pir
pirin
affects expression
EXP
indole-3-carbinol affects the expression of PIR mRNA
CTD
PMID:21396975
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pirb
paired Ig-like receptor B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LILRB3 mRNA
CTD
PMID:22129741
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
G
Piwil4
piwi-like RNA-mediated gene silencing 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PIWIL4 mRNA
CTD
PMID:22129741
NCBI chr 8:11,536,520...11,579,883
Ensembl chr 8:11,536,520...11,579,761
G
Pkib
cAMP-dependent protein kinase inhibitor beta
affects expression
EXP
indole-3-carbinol affects the expression of PKIB mRNA
CTD
PMID:21396975
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
G
Pla2g12a
phospholipase A2, group XIIA
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA
CTD
PMID:22129741
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:218,436,513...218,452,740
G
Pla2g7
phospholipase A2 group VII
affects expression
EXP
indole-3-carbinol affects the expression of PLA2G7 mRNA
CTD
PMID:21396975
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Plaat3
phospholipase A and acyltransferase 3
affects expression
EXP
indole-3-carbinol affects the expression of PLAAT3 mRNA
CTD
PMID:21396975
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
G
Plau
plasminogen activator, urokinase
increases expression
ISO
indole-3-carbinol results in increased expression of PLAU mRNA
CTD
PMID:18025290
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plbd1
phospholipase B domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of PLBD1 mRNA
CTD
PMID:21396975
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plgrkt
plasminogen receptor with a C-terminal lysine
affects expression
EXP
indole-3-carbinol affects the expression of PLGRKT mRNA
CTD
PMID:21396975
NCBI chr 1:227,099,005...227,111,277
Ensembl chr 1:227,099,015...227,111,194
G
Plin2
perilipin 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLIN2 mRNA
CTD
PMID:22129741
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin3
perilipin 3
affects expression
EXP
indole-3-carbinol affects the expression of PLIN3 mRNA
CTD
PMID:21396975
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLK1 mRNA
CTD
PMID:22129741
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk3
polo-like kinase 3
affects expression
EXP
indole-3-carbinol affects the expression of PLK3 mRNA
CTD
PMID:21396975
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plp2
proteolipid protein 2
affects expression
EXP
indole-3-carbinol affects the expression of PLP2 mRNA
CTD
PMID:21396975
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Plppr1
phospholipid phosphatase related 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PLPPR1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PLPPR1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 5:63,437,457...63,725,286
Ensembl chr 5:63,437,816...63,763,835
G
Plscr1
phospholipid scramblase 1
affects expression
EXP
indole-3-carbinol affects the expression of PLSCR1 mRNA
CTD
PMID:21396975
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
G
Plxdc2
plexin domain containing 2
affects expression
EXP
indole-3-carbinol affects the expression of PLXDC2 mRNA
CTD
PMID:21396975
NCBI chr17:79,169,238...79,594,279
Ensembl chr17:79,196,369...79,585,282
G
Pmm1
phosphomannomutase 1
affects expression
EXP
indole-3-carbinol affects the expression of PMM1 mRNA
CTD
PMID:21396975
NCBI chr 7:113,466,632...113,477,004
Ensembl chr 7:113,466,632...113,477,022
G
Pmp22
peripheral myelin protein 22
affects expression
EXP
indole-3-carbinol affects the expression of PMP22 mRNA
CTD
PMID:21396975
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
G
Pms1
PMS1 homolog 1, mismatch repair system component
affects expression
EXP
indole-3-carbinol affects the expression of PMS1 mRNA
CTD
PMID:21396975
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pmvk
phosphomevalonate kinase
affects expression
EXP
indole-3-carbinol affects the expression of PMVK mRNA
CTD
PMID:21396975
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
G
Pnoc
prepronociceptin
affects expression
EXP
indole-3-carbinol affects the expression of PNOC mRNA
CTD
PMID:21396975
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Pnpla5
patatin-like phospholipase domain containing 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNPLA5 mRNA
CTD
PMID:22129741
NCBI chr 7:115,246,050...115,257,039
Ensembl chr 7:115,246,050...115,257,039
G
Pnrc1
proline-rich nuclear receptor coactivator 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PNRC1 mRNA
CTD
PMID:22129741
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
G
Polg
DNA polymerase gamma, catalytic subunit
affects expression
EXP
indole-3-carbinol affects the expression of POLG mRNA
CTD
PMID:21396975
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
Polr1f
RNA polymerase I subunit F
affects expression
EXP
indole-3-carbinol affects the expression of POLR1F mRNA
CTD
PMID:21396975
NCBI chr 6:50,053,289...50,070,514
Ensembl chr 6:50,053,289...50,070,514
G
Pop4
POP4 homolog, ribonuclease P/MRP subunit
affects expression
EXP
indole-3-carbinol affects the expression of POP4 mRNA
CTD
PMID:21396975
NCBI chr 1:90,960,026...90,968,360
Ensembl chr 1:90,960,022...90,968,443
G
Pop5
POP5 homolog, ribonuclease P/MRP subunit
affects expression
EXP
indole-3-carbinol affects the expression of POP5 mRNA
CTD
PMID:21396975
NCBI chr12:41,376,755...41,384,882
Ensembl chr12:41,376,755...41,381,336
G
Pparg
peroxisome proliferator-activated receptor gamma
affects expression
EXP
indole-3-carbinol affects the expression of PPARG mRNA
CTD
PMID:21396975
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
affects expression
EXP
indole-3-carbinol affects the expression of PPARGC1A mRNA
CTD
PMID:21396975
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppic
peptidylprolyl isomerase C
affects expression
EXP
indole-3-carbinol affects the expression of PPIC mRNA
CTD
PMID:21396975
NCBI chr18:46,842,410...46,855,016
Ensembl chr18:46,842,409...46,855,017
G
Ppip5k1
diphosphoinositol pentakisphosphate kinase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PPIP5K1 mRNA
CTD
PMID:22129741
NCBI chr 3:108,284,120...108,327,683
Ensembl chr 3:108,284,120...108,323,428
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
affects expression
EXP
indole-3-carbinol affects the expression of PPP1R1B mRNA
CTD
PMID:21396975
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Pramef8l3
PRAME family member 8 like 3
affects expression
EXP
indole-3-carbinol affects the expression of PRAMEF8L3 mRNA
CTD
PMID:21396975
NCBI chr14:14,458,467...14,461,102
Ensembl chr14:14,458,467...14,461,102
G
Pramel38
PRAME like 38
affects expression
EXP
indole-3-carbinol affects the expression of PRAMEL38 mRNA
CTD
PMID:21396975
NCBI chr14:14,165,928...14,168,560
Ensembl chr14:14,165,928...14,168,560
G
Prdx1
peroxiredoxin 1
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of PRDX1 protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of PRDX1 protein]
CTD
PMID:29992829 PMID:33118390
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prh1
proline rich protein HaeIII subfamily 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRH1 mRNA
CTD
PMID:22129741
NCBI chr 4:166,543,755...166,547,614
G
Prkn
parkin RBR E3 ubiquitin protein ligase
affects expression
EXP
indole-3-carbinol affects the expression of PRKN mRNA
CTD
PMID:21396975
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Prlr
prolactin receptor
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PRLR mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PRLR mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRLR mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRLR mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prodh2
proline dehydrogenase 2
affects expression
EXP
indole-3-carbinol affects the expression of PRODH2 mRNA
CTD
PMID:21396975
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prp25l1
acidic proline-rich protein 25-like 1
affects expression
EXP
indole-3-carbinol affects the expression of PRP25L1 mRNA
CTD
PMID:21396975
NCBI chr 4:165,737,710...165,740,324
Ensembl chr 4:165,737,710...165,740,304
G
Prp2l1
proline rich protein 2-like 1
affects expression
EXP
indole-3-carbinol affects the expression of PRP2L1 mRNA
CTD
PMID:21396975
NCBI chr10:88,462,262...88,540,642
Ensembl chr10:88,462,289...88,523,061
G
Prr11
proline rich 11
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRR11 mRNA
CTD
PMID:22129741
NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
G
Prrg4
proline rich and Gla domain 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PRRG4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PRRG4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Prtfdc1
phosphoribosyl transferase domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of PRTFDC1 mRNA
CTD
PMID:21396975
NCBI chr17:83,549,608...83,654,517
Ensembl chr17:83,548,803...83,655,179
G
Psat1
phosphoserine aminotransferase 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PSAT1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psd3
pleckstrin and Sec7 domain containing 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSD3 mRNA
CTD
PMID:22129741
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psmc3ip
PSMC3 interacting protein
affects expression
EXP
indole-3-carbinol affects the expression of PSMC3IP mRNA
CTD
PMID:21396975
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
G
Psmg3
proteasome assembly chaperone 3
affects expression
EXP
indole-3-carbinol affects the expression of PSMG3 mRNA
CTD
PMID:21396975
NCBI chr12:14,809,440...14,812,357
Ensembl chr12:14,809,450...14,812,342
G
Pspc1
paraspeckle component 1
affects expression
EXP
indole-3-carbinol affects the expression of PSPC1 mRNA
CTD
PMID:21396975
NCBI chr15:30,828,617...30,911,315
Ensembl chr15:30,828,626...30,911,202
G
Psx1
placenta specific homeobox 1
affects expression
EXP
indole-3-carbinol affects the expression of PSX1 mRNA
CTD
PMID:21396975
NCBI chr 3:6,251,362...6,252,207
Ensembl chr 3:6,251,495...6,252,166
G
Ptar1
protein prenyltransferase alpha subunit repeat containing 1
affects expression
EXP
indole-3-carbinol affects the expression of PTAR1 mRNA
CTD
PMID:21396975
NCBI chr 1:221,283,306...221,326,861
Ensembl chr 1:221,283,415...221,327,073
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO
[phenethyl isothiocyanate co-treated with indole-3-carbinol] results in decreased expression of PTGS2 mRNA; [Resveratrol co-treated with indole-3-carbinol] results in decreased expression of PTGS2 mRNA; [xanthohumol co-treated with indole-3-carbinol] results in decreased expression of PTGS2 mRNA; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] indole-3-carbinol results in decreased expression of PTGS2 mRNA
CTD
PMID:15811958 PMID:29775573 PMID:32070777
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk6
protein tyrosine kinase 6
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PTK6 mRNA
CTD
PMID:22129741
NCBI chr 3:168,307,073...168,315,664
Ensembl chr 3:168,307,073...168,315,664
G
Ptp4a3
protein tyrosine phosphatase 4A3
affects expression
EXP
indole-3-carbinol affects the expression of PTP4A3 mRNA
CTD
PMID:21396975
NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919
G
Ptprs
protein tyrosine phosphatase, receptor type, S
affects expression
EXP
indole-3-carbinol affects the expression of PTPRS mRNA
CTD
PMID:21396975
NCBI chr 9:1,245,408...1,307,015
Ensembl chr 9:1,245,410...1,306,947
G
Ptprt
protein tyrosine phosphatase, receptor type, T
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of PTPRT mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PTPRT mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 3:150,189,343...151,288,145
Ensembl chr 3:150,194,859...151,288,124
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
affects expression
EXP
indole-3-carbinol affects the expression of PTTG1 mRNA
CTD
PMID:21396975
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
G
Pvr
PVR cell adhesion molecule
affects expression
EXP
indole-3-carbinol affects the expression of PVR mRNA
CTD
PMID:21396975
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Pyroxd1
pyridine nucleotide-disulphide oxidoreductase domain 1
affects expression
EXP
indole-3-carbinol affects the expression of PYROXD1 mRNA
CTD
PMID:21396975
NCBI chr 4:175,292,124...175,311,143
Ensembl chr 4:175,292,177...175,308,689
G
Qrich1
glutamine-rich 1
affects expression
EXP
indole-3-carbinol affects the expression of QRICH1 mRNA
CTD
PMID:21396975
NCBI chr 8:109,216,900...109,256,472
Ensembl chr 8:109,217,376...109,261,359
G
Rab13
RAB13, member RAS oncogene family
affects expression
EXP
indole-3-carbinol affects the expression of RAB13 mRNA
CTD
PMID:21396975
NCBI chr 2:175,674,894...175,680,043
Ensembl chr 2:175,675,005...175,680,036
G
Rab30
RAB30, member RAS oncogene family
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RAB30 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAB30 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAB30 mRNA]
CTD
PMID:22129741
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
G
Rad1
RAD1 checkpoint DNA exonuclease
affects expression
EXP
indole-3-carbinol affects the expression of RAD1 mRNA
CTD
PMID:21396975
NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
G
Rad18
RAD18 E3 ubiquitin protein ligase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAD18 mRNA
CTD
PMID:22129741
NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069
G
Rad50
RAD50 double strand break repair protein
affects expression
EXP
indole-3-carbinol affects the expression of RAD50 mRNA
CTD
PMID:21396975
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of RAF1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RAF1 mRNA
CTD
PMID:22129741
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Ralgds
ral guanine nucleotide dissociation stimulator
affects expression
EXP
indole-3-carbinol affects the expression of RGL4 mRNA
CTD
PMID:21396975
NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059
G
Ralgdsl5
ral guanine nucleotide dissociation stimulator like 5
affects expression
EXP
indole-3-carbinol affects the expression of RALGDSL5 mRNA
CTD
PMID:21396975
NCBI chr18:40,683,330...40,686,500
Ensembl chr18:40,683,424...40,685,381
G
Ramp2
receptor activity modifying protein 2
affects expression
EXP
indole-3-carbinol affects the expression of RAMP2 mRNA
CTD
PMID:21396975
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
G
Ramp3
receptor activity modifying protein 3
affects expression
EXP
indole-3-carbinol affects the expression of RAMP3 mRNA
CTD
PMID:21396975
NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
G
Rassf1
Ras association domain family member 1
affects expression
EXP
indole-3-carbinol affects the expression of RASSF1 mRNA
CTD
PMID:21396975
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
affects expression
EXP
indole-3-carbinol affects the expression of RBBP4 mRNA
CTD
PMID:21396975
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284 Ensembl chr 2:141,638,421...141,675,284
G
Rbbp4l1
RB binding protein 4, chromatin remodeling factor like 1
affects expression
EXP
indole-3-carbinol affects the expression of RBBP4L1 mRNA
CTD
PMID:21396975
NCBI chr 2:153,958,955...153,961,336
Ensembl chr 2:153,958,955...153,960,757
G
Rbm12
RNA binding motif protein 12
affects expression
EXP
indole-3-carbinol affects the expression of RBM12 mRNA
CTD
PMID:21396975
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915
G
Rbm43
RNA binding motif protein 43
affects expression
EXP
indole-3-carbinol affects the expression of RBM43 mRNA
CTD
PMID:21396975
NCBI chr 3:36,394,431...36,404,757
Ensembl chr 3:36,395,346...36,404,816
G
Rbms2
RNA binding motif, single stranded interacting protein 2
affects expression
EXP
indole-3-carbinol affects the expression of RBMS2 mRNA
CTD
PMID:21396975
NCBI chr 7:560,787...603,881
Ensembl chr 7:560,648...600,232
G
Reep5
receptor accessory protein 5
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of REEP5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of REEP5 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Reep6
receptor accessory protein 6
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of REEP6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of REEP6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Reg4
regenerating family member 4
affects expression
EXP
indole-3-carbinol affects the expression of REG4 mRNA
CTD
PMID:21396975
NCBI chr 2:185,818,946...185,833,252
Ensembl chr 2:185,821,210...185,833,353
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases activity increases expression decreases expression
ISO EXP
[indole-3-carbinol co-treated with phenethyl isothiocyanate] results in decreased activity of RELA protein; [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in decreased expression of RELA mRNA; [indole-3-carbinol co-treated with Resveratrol] results in decreased expression of RELA mRNA; [indole-3-carbinol co-treated with xanthohumol] results in decreased activity of RELA protein; [indole-3-carbinol co-treated with xanthohumol] results in decreased expression of RELA mRNA; indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of RELA protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein]; indole-3-carbinol inhibits the reaction [TNF protein affects the localization of RELA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of RELA protein] indole-3-carbinol results in decreased activity of RELA protein [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased activity of RELA protein; indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of RELA protein]; RELA protein affects the reaction [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL22 mRNA] indole-3-carbinol inhibits the reaction [letrozole affects the localization of RELA protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole affects the localization of RELA protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole affects the localization of RELA protein]] indole-3-carbinol results in increased expression of RELA protein indole-3-carbinol results in decreased expression of RELA mRNA
CTD
PMID:15811958 PMID:16082211 PMID:21948866 PMID:28619389 PMID:29775573 PMID:32070777 PMID:35295139 More...
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
multiple interactions
ISO
RELB protein affects the reaction [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL22 mRNA]
CTD
PMID:35295139
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rell1
RELT-like 1
affects expression
EXP
indole-3-carbinol affects the expression of RELL1 mRNA
CTD
PMID:21396975
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Renbp
renin binding protein
affects expression
EXP
indole-3-carbinol affects the expression of RENBP mRNA
CTD
PMID:21396975
NCBI chr X:151,661,463...151,670,538
Ensembl chr X:151,661,458...151,670,516
G
Retreg3
reticulophagy regulator family member 3
affects expression
EXP
indole-3-carbinol affects the expression of RETREG3 mRNA
CTD
PMID:21396975
NCBI chr10:86,028,767...86,052,575
Ensembl chr10:86,028,774...86,052,692
G
Rex1bd
required for excision 1-B domain containing
affects expression
EXP
indole-3-carbinol affects the expression of REX1BD mRNA
CTD
PMID:21396975
NCBI chr16:18,922,050...18,924,521
Ensembl chr16:18,922,037...18,924,526
G
Rfc4
replication factor C subunit 4
affects expression
EXP
indole-3-carbinol affects the expression of RFC4 mRNA
CTD
PMID:21396975
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
RGD1306474
similar to RIKEN cDNA 9530003J23
affects expression
EXP
indole-3-carbinol affects the expression of RGD1306474 mRNA
CTD
PMID:21396975
NCBI chr 7:52,875,842...52,880,716
Ensembl chr 7:52,875,842...52,880,716
G
RGD1309362
similar to interferon-inducible GTPase
affects expression
EXP
indole-3-carbinol affects the expression of RGD1309362 mRNA
CTD
PMID:21396975
G
RGD1559545
similar to ATPase inhibitory factor 1
affects expression
EXP
indole-3-carbinol affects the expression of RGD1559545 mRNA
CTD
PMID:21396975
NCBI chr 6:89,821,916...89,842,882
G
RGD1559600
RGD1559600
affects expression
EXP
indole-3-carbinol affects the expression of RGD1559600 mRNA
CTD
PMID:21396975
NCBI chr 1:173,973,318...173,988,758
Ensembl chr 1:173,973,856...173,985,592
G
Rgs16
regulator of G-protein signaling 16
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of RGS16 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs2
regulator of G-protein signaling 2
affects expression
EXP
indole-3-carbinol affects the expression of RGS2 mRNA
CTD
PMID:21396975
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs5
regulator of G-protein signaling 5
affects expression
EXP
indole-3-carbinol affects the expression of RGS5 mRNA
CTD
PMID:21396975
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
G
Rgsl2h
regulator of G-protein signaling like 2 homolog (mouse)
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGSL2H mRNA
CTD
PMID:22129741
NCBI chr13:65,973,695...65,974,702
Ensembl chr13:65,972,938...65,978,052
G
Rhbdd2
rhomboid domain containing 2
affects expression
EXP
indole-3-carbinol affects the expression of RHBDD2 mRNA
CTD
PMID:21396975
NCBI chr12:21,043,605...21,054,305
Ensembl chr12:21,043,608...21,054,289
G
Rhbdf2
rhomboid 5 homolog 2
affects expression
EXP
indole-3-carbinol affects the expression of RHBDF2 mRNA
CTD
PMID:21396975
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
G
Rhbdl2
rhomboid like 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RHBDL2 mRNA
CTD
PMID:22129741
NCBI chr 5:136,037,560...136,081,970
Ensembl chr 5:136,037,305...136,081,969
G
Rhbg
Rh family B glycoprotein
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of RHBG mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RHBG mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:173,704,852...173,717,380
Ensembl chr 2:173,704,562...173,717,321
G
Rhob
ras homolog family member B
affects expression
EXP
indole-3-carbinol affects the expression of RHOB mRNA
CTD
PMID:21396975
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:31,363,548...31,366,108
G
Ric3
RIC3 acetylcholine receptor chaperone
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RIC3 mRNA
CTD
PMID:22129741
NCBI chr 1:163,030,621...163,086,583
Ensembl chr 1:163,032,158...163,086,519
G
Rilpl1
Rab interacting lysosomal protein-like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RILPL1 mRNA
CTD
PMID:22129741
NCBI chr12:32,071,870...32,109,687
Ensembl chr12:32,071,693...32,109,938
G
Riok2
RIO kinase 2
affects expression
EXP
indole-3-carbinol affects the expression of RIOK2 mRNA
CTD
PMID:21396975
NCBI chr 1:58,103,132...58,119,397
Ensembl chr 1:58,103,084...58,120,512
G
Rlim
ring finger protein, LIM domain interacting
affects expression
EXP
indole-3-carbinol affects the expression of RLIM mRNA
CTD
PMID:21396975
NCBI chr X:68,983,259...69,004,368
Ensembl chr X:68,988,375...69,004,271
G
Rnase2
ribonuclease A family member 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of RNASE2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNASE2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479
G
Rnf125
ring finger protein 125
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RNF125 mRNA
CTD
PMID:22129741
NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983
G
Rnf138
ring finger protein 138
affects expression
EXP
indole-3-carbinol affects the expression of RNF138 mRNA
CTD
PMID:21396975
NCBI chr18:12,291,557...12,315,931
Ensembl chr18:12,291,590...12,315,930
G
Rnf146
ring finger protein 146
affects expression
EXP
indole-3-carbinol affects the expression of RNF146 mRNA
CTD
PMID:21396975
NCBI chr 1:28,458,864...28,475,758
Ensembl chr 1:28,458,887...28,475,923
G
Rnf170
ring finger protein 170
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RNF170 mRNA
CTD
PMID:22129741
NCBI chr16:65,928,886...65,954,092
Ensembl chr16:65,928,895...65,954,083
G
Rnf41
ring finger protein 41
affects expression
EXP
indole-3-carbinol affects the expression of RNF41 mRNA
CTD
PMID:21396975
NCBI chr 7:838,160...876,869
Ensembl chr 7:838,203...865,511
G
Rngtt
RNA guanylyltransferase and 5'-phosphatase
affects expression
EXP
indole-3-carbinol affects the expression of RNGTT mRNA
CTD
PMID:21396975
NCBI chr 5:47,706,929...47,913,297
Ensembl chr 5:47,706,799...47,913,295
G
Rogdi
rogdi atypical leucine zipper
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ROGDI mRNA
CTD
PMID:22129741
NCBI chr10:10,567,834...10,572,453
Ensembl chr10:10,567,834...10,572,452
G
Ror2
receptor tyrosine kinase-like orphan receptor 2
affects expression
EXP
indole-3-carbinol affects the expression of ROR2 mRNA
CTD
PMID:21396975
NCBI chr17:11,972,830...12,148,152
Ensembl chr17:11,972,830...12,148,152
G
Rora
RAR-related orphan receptor A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA
CTD
PMID:22129741
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpl17
ribosomal protein L17
affects expression
EXP
indole-3-carbinol affects the expression of RPL17 mRNA
CTD
PMID:21396975
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253 Ensembl chr 3:68,581,098...68,584,253
G
Rpl22l1
ribosomal protein L22 like 1
affects expression
EXP
indole-3-carbinol affects the expression of RPL22L1 mRNA
CTD
PMID:21396975
NCBI chr 2:111,754,687...111,756,623
Ensembl chr 2:111,754,687...111,756,625
G
Rpl22l2
ribosomal protein L22-like 2
affects expression
EXP
indole-3-carbinol affects the expression of RPL22L2 mRNA
CTD
PMID:21396975
NCBI chr 3:116,994,156...116,994,620
Ensembl chr 3:116,994,164...116,994,532
G
Rpl29-ps23
ribosomal protein L29, pseudogene 23
affects expression
EXP
indole-3-carbinol affects the expression of RPL29-PS23 mRNA
CTD
PMID:21396975
NCBI chr 2:39,720,319...39,720,958
G
Rpl29-ps3
ribosomal protein L29, pseudogene 3
affects expression
EXP
indole-3-carbinol affects the expression of RPL29-PS3 mRNA
CTD
PMID:21396975
NCBI chr17:66,552,468...66,553,027
G
Rpl31
ribosomal protein L31
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RPL31 mRNA
CTD
PMID:22129741
NCBI chr 9:41,647,397...41,651,441
Ensembl chr 9:41,647,426...41,662,129 Ensembl chr 8:41,647,426...41,662,129
G
Rpl31l7
ribosomal protein L31 like 7
affects expression
EXP
indole-3-carbinol affects the expression of RPL31L7 mRNA
CTD
PMID:21396975
NCBI chr18:57,532,608...57,533,012
Ensembl chr18:57,532,644...57,533,657
G
Rplp0l1
ribosomal protein lateral stalk subunit P0 like 1
affects expression
EXP
indole-3-carbinol affects the expression of RPLP0L1 mRNA
CTD
PMID:21396975
NCBI chr 2:191,921,503...191,922,661
Ensembl chr 2:191,921,574...191,922,646
G
Rpp30
ribonuclease P/MRP subunit p30
affects expression
EXP
indole-3-carbinol affects the expression of RPP30 mRNA
CTD
PMID:21396975
NCBI chr 1:233,786,048...233,808,958
Ensembl chr 1:233,786,099...233,808,952
G
Rpp38
ribonuclease P/MRP subunit p38
affects expression
EXP
indole-3-carbinol affects the expression of RPP38 mRNA
CTD
PMID:21396975
NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431
G
Rps17-ps8
ribosomal protein S17, pseudogene 8
affects expression
EXP
indole-3-carbinol affects the expression of RPS17-PS8 mRNA
CTD
PMID:21396975
NCBI chr15:28,868,265...28,868,692
G
Rps18l2
ribosomal protein S18 like 2
affects expression
EXP
indole-3-carbinol affects the expression of RPS18L2 mRNA
CTD
PMID:21396975
NCBI chr19:13,107,145...13,107,646
Ensembl chr19:13,107,145...13,107,603
G
Rps24-ps17
ribosomal protein S24, pseudogene 17
affects expression
EXP
indole-3-carbinol affects the expression of RPS24-PS17 mRNA
CTD
PMID:21396975
NCBI chr 7:67,167,622...67,168,537
Ensembl chr 7:67,167,806...67,168,141
G
Rps25l2
ribosomal protein S25 like 2
affects expression
EXP
indole-3-carbinol affects the expression of RPS25L2 mRNA
CTD
PMID:21396975
NCBI chr 6:54,521,335...54,521,746
G
Rps26-ps12
ribosomal protein S26, pseudogene 12
affects expression
EXP
indole-3-carbinol affects the expression of RPS26-PS12 mRNA
CTD
PMID:21396975
NCBI chr 9:6,019,031...6,020,447
Ensembl chr 6:52,996,214...52,996,878
G
Rps26l1
ribosomal protein S26 like 1
affects expression
EXP
indole-3-carbinol affects the expression of RPS26L1 mRNA
CTD
PMID:21396975
NCBI chr 7:62,981,687...62,982,757
Ensembl chr 7:62,981,946...62,982,326
G
Rps4x-ps13
ribosomal protein S4, X-linked, pseudogene 13
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RPS4Y2 mRNA
CTD
PMID:22129741
NCBI chr 4:181,269,507...181,270,440
Ensembl chr 4:181,269,081...181,270,349
G
Rps7
ribosomal protein S7
affects expression
EXP
indole-3-carbinol affects the expression of RPS7 mRNA
CTD
PMID:21396975
NCBI chr 6:45,266,200...45,271,064
Ensembl chr 6:45,223,980...45,271,145 Ensembl chr 5:45,223,980...45,271,145
G
Rrm2
ribonucleotide reductase regulatory subunit M2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RRM2 mRNA
CTD
PMID:22129741
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rsph3
radial spoke head 3
affects expression
EXP
indole-3-carbinol affects the expression of RSPH3 mRNA
CTD
PMID:21396975
NCBI chr 1:47,101,961...47,155,201
Ensembl chr 1:47,101,961...47,154,232
G
RT1-Cl
RT1 class Ib, locus Cl
affects expression
EXP
indole-3-carbinol affects the expression of RT1-CL mRNA
CTD
PMID:21396975
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
affects expression
EXP
indole-3-carbinol affects the expression of RT1-M3-1 mRNA
CTD
PMID:21396975
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
G
RT1-S2
RT1 class Ib, locus S2
affects expression
EXP
indole-3-carbinol affects the expression of RT1-S2 mRNA
CTD
PMID:21396975
NCBI chr20:2,650,233...2,651,654
Ensembl chr20:2,649,964...2,652,027
G
Rtp1
receptor (chemosensory) transporter protein 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RTP1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RTP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RTP1 mRNA]
CTD
PMID:22129741
NCBI chr11:77,422,982...77,425,498
Ensembl chr11:77,422,982...77,425,498
G
Runx2
RUNX family transcription factor 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of RUNX2 mRNA
CTD
PMID:22129741
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
G
S100a11
S100 calcium binding protein A11
affects expression
EXP
indole-3-carbinol affects the expression of S100A11 mRNA
CTD
PMID:21396975
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a11l1
S100 calcium binding protein A11 like 1
affects expression
EXP
indole-3-carbinol affects the expression of S100A11L1 mRNA
CTD
PMID:21396975
NCBI chr17:488,657...489,098
Ensembl chr17:488,817...489,089
G
S100a13
S100 calcium binding protein A13
affects expression
EXP
indole-3-carbinol affects the expression of S100A13 mRNA
CTD
PMID:21396975
NCBI chr 2:175,999,439...176,005,933
G
S100a4
S100 calcium-binding protein A4
affects expression
EXP
indole-3-carbinol affects the expression of S100A4 mRNA
CTD
PMID:21396975
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254
G
S100a6
S100 calcium binding protein A6
affects expression
EXP
indole-3-carbinol affects the expression of S100A6 mRNA
CTD
PMID:21396975
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S100pbp
S100P binding protein
affects expression
EXP
indole-3-carbinol affects the expression of S100PBP mRNA
CTD
PMID:21396975
NCBI chr 5:141,494,352...141,535,752
Ensembl chr 5:141,494,353...141,535,525
G
Sacs
sacsin molecular chaperone
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SACS mRNA
CTD
PMID:22129741
NCBI chr15:35,285,783...35,370,335
Ensembl chr15:35,285,782...35,370,335
G
Samd4a
sterile alpha motif domain containing 4A
affects expression
EXP
indole-3-carbinol affects the expression of SAMD4A mRNA
CTD
PMID:21396975
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
G
Sbspon
somatomedin B and thrombospondin, type 1 domain containing
affects expression
EXP
indole-3-carbinol affects the expression of SBSPON mRNA
CTD
PMID:21396975
NCBI chr 5:3,402,763...3,433,338
Ensembl chr 5:3,402,648...3,435,420
G
Scd
stearoyl-CoA desaturase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SCD1 mRNA
CTD
PMID:22129741
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scml4
Scm polycomb group protein like 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SCML4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SCML4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr20:46,347,350...46,441,246
Ensembl chr20:46,347,413...46,440,103
G
Scn4b
sodium voltage-gated channel beta subunit 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SCN4B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SCN4B mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292
G
Scnn1a
sodium channel epithelial 1 subunit alpha
affects expression
EXP
indole-3-carbinol affects the expression of SCNN1A mRNA
CTD
PMID:21396975
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
G
Scoc
short coiled-coil protein
affects expression
EXP
indole-3-carbinol affects the expression of SCOC mRNA
CTD
PMID:21396975
NCBI chr19:24,659,651...24,689,237
Ensembl chr19:24,659,651...24,693,217
G
Scpep1
serine carboxypeptidase 1
affects expression
EXP
indole-3-carbinol affects the expression of SCPEP1 mRNA
CTD
PMID:21396975
NCBI chr10:73,703,275...73,732,892
Ensembl chr10:73,703,278...73,732,850
G
Scrn1
secernin 1
affects expression
EXP
indole-3-carbinol affects the expression of SCRN1 mRNA
CTD
PMID:21396975
NCBI chr 4:84,962,450...85,024,577
Ensembl chr 4:83,632,131...83,693,852
G
Sctr
secretin receptor
affects expression
EXP
indole-3-carbinol affects the expression of SCTR mRNA
CTD
PMID:21396975
NCBI chr13:31,127,781...31,190,162
Ensembl chr13:31,127,858...31,180,189
G
Selenoi
selenoprotein I
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SELENOI mRNA
CTD
PMID:22129741
NCBI chr 6:26,073,127...26,111,326
Ensembl chr 6:26,072,648...26,111,314
G
Senp17
Sumo1/sentrin/SMT3 specific peptidase 17
affects expression
EXP
indole-3-carbinol affects the expression of SENP17 mRNA
CTD
PMID:21396975
NCBI chr 4:161,126,901...161,128,328
Ensembl chr 4:161,126,901...161,128,328 Ensembl chr 4:161,126,901...161,128,328
G
Septin4
septin 4
affects expression
EXP
indole-3-carbinol affects the expression of SEPTIN4 mRNA
CTD
PMID:21396975
NCBI chr10:72,366,729...72,390,764
Ensembl chr10:72,366,873...72,390,768
G
Serpinb1a
serpin family B member 1A
affects expression
EXP
indole-3-carbinol affects the expression of SERPINB1A mRNA
CTD
PMID:21396975
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Sesn2
sestrin 2
affects expression
EXP
indole-3-carbinol affects the expression of SESN2 mRNA
CTD
PMID:21396975
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sesn3
sestrin 3
affects expression
EXP
indole-3-carbinol affects the expression of SESN3 mRNA
CTD
PMID:21396975
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Sez6
seizure related 6 homolog
affects expression
EXP
indole-3-carbinol affects the expression of SEZ6 mRNA
CTD
PMID:21396975
NCBI chr10:62,818,931...62,868,686
Ensembl chr10:62,819,069...62,868,671
G
Sfrp2
secreted frizzled-related protein 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SFRP2 mRNA
CTD
PMID:22129741
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
G
Sfxn1
sideroflexin 1
affects expression
EXP
indole-3-carbinol affects the expression of SFXN1 mRNA
CTD
PMID:21396975
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Sh3bgrl2
SH3 domain binding glutamate-rich protein like 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SH3BGRL2 mRNA
CTD
PMID:22129741
NCBI chr 8:93,341,104...93,433,143
Ensembl chr 8:84,461,121...84,551,564
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
affects expression
EXP
indole-3-carbinol affects the expression of SH3BGRL3 mRNA
CTD
PMID:21396975
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
G
Shisa2
shisa family member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SHISA2 mRNA
CTD
PMID:22129741
NCBI chr15:33,806,715...33,811,013
Ensembl chr15:33,805,958...33,811,013
G
Sik1
salt-inducible kinase 1
affects expression
EXP
indole-3-carbinol affects the expression of SIK1 mRNA
CTD
PMID:21396975
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,396...9,958,991
G
Sik2
salt-inducible kinase 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SIK2 mRNA
CTD
PMID:22129741
NCBI chr 8:51,225,543...51,325,343
Ensembl chr 8:51,225,543...51,325,415
G
Sla2
Src-like-adaptor 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLA2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLA2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 3:145,367,070...145,383,586
Ensembl chr 3:145,368,598...145,382,480
G
Slc12a3
solute carrier family 12 member 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC12A3 mRNA
CTD
PMID:22129741
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc13a3
solute carrier family 13 member 3
affects expression
EXP
indole-3-carbinol affects the expression of SLC13A3 mRNA
CTD
PMID:21396975
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc14a2
solute carrier family 14 member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC14A2 mRNA
CTD
PMID:22129741
NCBI chr18:71,612,460...72,039,462
Ensembl chr18:71,612,460...71,792,968
G
Slc15a3
solute carrier family 15 member 3
affects expression
EXP
indole-3-carbinol affects the expression of SLC15A3 mRNA
CTD
PMID:21396975
NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157
G
Slc16a1
solute carrier family 16 member 1
affects expression
EXP
indole-3-carbinol affects the expression of SLC16A1 mRNA
CTD
PMID:21396975
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
G
Slc16a2
solute carrier family 16 member 2
affects expression
EXP
indole-3-carbinol affects the expression of SLC16A2 mRNA
CTD
PMID:21396975
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
G
Slc1a2
solute carrier family 1 member 2
affects expression
EXP
indole-3-carbinol affects the expression of SLC1A2 mRNA
CTD
PMID:21396975
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc1a4
solute carrier family 1 member 4
affects expression
EXP
indole-3-carbinol affects the expression of SLC1A4 mRNA
CTD
PMID:21396975
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc20a1
solute carrier family 20 member 1
affects expression
EXP
indole-3-carbinol affects the expression of SLC20A1 mRNA
CTD
PMID:21396975
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc24a2
solute carrier family 24 member 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC24A2 mRNA
CTD
PMID:22129741
NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337
G
Slc25a25
solute carrier family 25 member 25
affects expression
EXP
indole-3-carbinol affects the expression of SLC25A25 mRNA
CTD
PMID:21396975
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
G
Slc25a29
solute carrier family 25 member 29
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLC25A29 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A29 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 6:127,742,027...127,752,915
Ensembl chr 6:127,742,033...127,752,940
G
Slc25a30
solute carrier family 25, member 30
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A30 mRNA
CTD
PMID:22129741
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
G
Slc25a35
solute carrier family 25, member 35
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLC25A35 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A35 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:53,672,851...53,677,501
Ensembl chr10:53,673,340...53,698,160
G
Slc25a47
solute carrier family 25, member 47
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLC25A47 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC25A47 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 6:127,767,365...127,773,000
Ensembl chr 6:127,767,305...127,773,005
G
Slc28a2
solute carrier family 28 member 2
affects expression
EXP
indole-3-carbinol affects the expression of SLC28A2 mRNA
CTD
PMID:21396975
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc34a2
solute carrier family 34 member 2
affects expression
EXP
indole-3-carbinol affects the expression of SLC34A2 mRNA
CTD
PMID:21396975
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc35b3
solute carrier family 35 member B3
affects expression
EXP
indole-3-carbinol affects the expression of SLC35B3 mRNA
CTD
PMID:21396975
NCBI chr17:25,846,590...25,873,115
Ensembl chr17:25,846,748...25,872,557
G
Slc35e3
solute carrier family 35, member E3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC35E3 mRNA
CTD
PMID:22129741
NCBI chr 7:53,337,091...53,350,152
Ensembl chr 7:53,337,095...53,350,165
G
Slc35g1
solute carrier family 35, member G1
affects expression
EXP
indole-3-carbinol affects the expression of SLC35G1 mRNA
CTD
PMID:21396975
NCBI chr 1:236,163,593...236,172,115
Ensembl chr 1:236,163,175...236,170,262
G
Slc39a11
solute carrier family 39, member 11
affects expression
EXP
indole-3-carbinol affects the expression of SLC39A11 mRNA
CTD
PMID:21396975
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
G
Slc39a4
solute carrier family 39 member 4
affects expression
EXP
indole-3-carbinol affects the expression of SLC39A4 mRNA
CTD
PMID:21396975
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc44a4
solute carrier family 44, member 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLC44A4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC44A4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc45a3
solute carrier family 45, member 3
affects expression
EXP
indole-3-carbinol affects the expression of SLC45A3 mRNA
CTD
PMID:21396975
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
G
Slc51b
SLC51 subunit beta
affects expression
EXP
indole-3-carbinol affects the expression of SLC51B mRNA
CTD
PMID:21396975
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slc5a9
solute carrier family 5 member 9
affects expression
EXP
indole-3-carbinol affects the expression of SLC5A9 mRNA
CTD
PMID:21396975
NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:126,709,769...126,733,468
G
Slc66a1
solute carrier family 66 member 1
affects expression
EXP
indole-3-carbinol affects the expression of SLC66A1 mRNA
CTD
PMID:21396975
NCBI chr 5:151,537,870...151,552,259
Ensembl chr 5:151,542,376...151,552,259
G
Slc6a6
solute carrier family 6 member 6
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SLC6A6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
G
Slc7a14
solute carrier family 7, member 14
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC7A14 mRNA
CTD
PMID:22129741
NCBI chr 2:112,065,286...112,171,319
Ensembl chr 2:112,065,286...112,171,313
G
Slc9a5
solute carrier family 9 member A5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC9A5 mRNA
CTD
PMID:22129741
NCBI chr19:33,225,481...33,246,913
Ensembl chr19:33,226,816...33,246,903
G
Slco1a5
solute carrier organic anion transporter family, member 1A5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLCO1A5 mRNA
CTD
PMID:22129741
NCBI chr 4:175,172,390...175,254,598
Ensembl chr 4:174,710,004...175,254,573
G
Sln
sarcolipin
affects expression
EXP
indole-3-carbinol affects the expression of SLN mRNA
CTD
PMID:21396975
NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791
G
Slx4ip
SLX4 interacting protein
affects expression
EXP
indole-3-carbinol affects the expression of SLX4IP mRNA
CTD
PMID:21396975
NCBI chr 3:124,220,215...124,396,797
Ensembl chr 3:124,221,198...124,396,797
G
Smim1
small integral membrane protein 1 (Vel blood group)
affects expression
EXP
indole-3-carbinol affects the expression of SMIM1 mRNA
CTD
PMID:21396975
NCBI chr 5:164,579,327...164,584,650
G
Smok
sperm motility kinase
affects expression
EXP
indole-3-carbinol affects the expression of SMOK mRNA
CTD
PMID:21396975
NCBI chr16:64,457,344...64,469,296
Ensembl chr16:64,458,376...64,469,295
G
Smok2al1
sperm motility kinase 2A like 1
affects expression
EXP
indole-3-carbinol affects the expression of SMOK2AL1 mRNA
CTD
PMID:21396975
NCBI chr 1:53,705,042...53,713,934
Ensembl chr 1:53,705,263...53,713,952
G
Smokwl2
sperm motility kinase W like 2
affects expression
EXP
indole-3-carbinol affects the expression of SMOKWL2 mRNA
CTD
PMID:21396975
NCBI chr 7:17,311,785...17,330,229
Ensembl chr 7:17,311,697...17,330,495
G
Smokxl2
sperm motility kinase x like 2
affects expression
EXP
indole-3-carbinol affects the expression of SMOKXL2 mRNA
CTD
PMID:21396975
NCBI chr17:85,789,242...85,807,842
G
Smyd5
SMYD family member 5
affects expression
EXP
indole-3-carbinol affects the expression of SMYD5 mRNA
CTD
PMID:21396975
NCBI chr 4:117,969,615...117,984,082
Ensembl chr 4:117,969,626...117,984,347
G
Snrnp27
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
affects expression
EXP
indole-3-carbinol affects the expression of SNRNP27 mRNA
CTD
PMID:21396975
NCBI chr 4:119,123,676...119,133,234
Ensembl chr 4:119,121,877...119,133,234
G
Snrpc
small nuclear ribonucleoprotein polypeptide C
affects expression
EXP
indole-3-carbinol affects the expression of SNRPC mRNA
CTD
PMID:21396975
NCBI chr20:5,888,453...5,906,638
Ensembl chr20:5,888,453...5,906,638 Ensembl chr10:5,888,453...5,906,638
G
Snrpn
small nuclear ribonucleoprotein polypeptide N
affects expression
EXP
indole-3-carbinol affects the expression of SNRPN mRNA
CTD
PMID:21396975
NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:111,101,329...111,123,634
G
Sntb1
syntrophin, beta 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNTB1 mRNA
CTD
PMID:22129741
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
G
Sntg1
syntrophin, gamma 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SNTG1 mRNA
CTD
PMID:22129741
NCBI chr 5:9,980,550...10,794,666
Ensembl chr 5:9,981,115...10,791,181
G
Snw1
SNW domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of SNW1 mRNA
CTD
PMID:21396975
NCBI chr 6:107,095,450...107,119,536
Ensembl chr 6:107,095,457...107,119,536
G
Snx10
sorting nexin 10
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of SNX10 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNX10 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
G
Sod1
superoxide dismutase 1
multiple interactions
EXP
indole-3-carbinol inhibits the reaction [Thioacetamide results in decreased expression of SOD1 protein]
CTD
PMID:37150287
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sorl1
sortilin related receptor 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SORL1 mRNA
CTD
PMID:22129741
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sort1
sortilin 1
affects expression
EXP
indole-3-carbinol affects the expression of SORT1 mRNA
CTD
PMID:21396975
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:195,924,099...196,002,354
G
Sox9
SRY-box transcription factor 9
affects expression
EXP
indole-3-carbinol affects the expression of SOX9 mRNA
CTD
PMID:21396975
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp1
Sp1 transcription factor
multiple interactions decreases activity
ISO
indole-3-carbinol analog inhibits the reaction [SP1 protein binds to CDK6 promoter] indole-3-carbinol results in decreased activity of SP1 protein
CTD
PMID:16082211 PMID:20570586
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sparcl1
SPARC like 1
affects expression
EXP
indole-3-carbinol affects the expression of SPARCL1 mRNA
CTD
PMID:21396975
NCBI chr14:5,632,816...5,663,866
Ensembl chr14:5,632,569...5,663,865
G
Spata24
spermatogenesis associated 24
affects expression
EXP
indole-3-carbinol affects the expression of SPATA24 mRNA
CTD
PMID:21396975
NCBI chr18:27,249,047...27,257,129
Ensembl chr18:27,248,609...27,257,124
G
Spata7
spermatogenesis associated 7
affects expression
EXP
indole-3-carbinol affects the expression of SPATA7 mRNA
CTD
PMID:21396975
NCBI chr 6:117,879,828...117,925,284
Ensembl chr 6:117,879,823...117,925,284
G
Spc25
SPC25 component of NDC80 kinetochore complex
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SPC25 mRNA
CTD
PMID:22129741
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spetex2a
Spetex-2A protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2A mRNA
CTD
PMID:21396975
G
Spetex2b
Spetex-2B protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2B mRNA
CTD
PMID:21396975
G
Spetex2c
Spetex-2C protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2C mRNA
CTD
PMID:21396975
NCBI chr15:4,779,251...4,781,549
Ensembl chr15:4,779,229...4,781,731
G
Spetex2d
Spetex-2D protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2D mRNA
CTD
PMID:21396975
G
Spetex2e
Spetex-2E protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2E mRNA
CTD
PMID:21396975
NCBI chr15:4,813,644...4,816,793
Ensembl chr15:4,739,331...4,816,815
G
Spetex2f
Spetex-2F protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2F mRNA
CTD
PMID:21396975
NCBI chr15:17,716,315...17,720,203
Ensembl chr15:17,716,358...17,733,744
G
Spetex2g
Spetex-2G protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2G mRNA
CTD
PMID:21396975
NCBI chr15:4,615,554...4,619,166
Ensembl chr15:4,615,466...4,662,812
G
Spetex2h
Spetex-2H protein
affects expression
EXP
indole-3-carbinol affects the expression of SPETEX2H mRNA
CTD
PMID:21396975
G
Spink1
serine peptidase inhibitor, Kazal type 1
affects expression
EXP
indole-3-carbinol affects the expression of SPINK1 mRNA
CTD
PMID:21396975
NCBI chr18:36,121,626...36,133,596
Ensembl chr18:35,824,550...35,882,642
G
Spmip11
sperm microtubule inner protein 11
affects expression
EXP
indole-3-carbinol affects the expression of SPMIP11 mRNA
CTD
PMID:21396975
NCBI chr 7:129,720,950...129,742,485
Ensembl chr 7:129,720,950...129,742,485
G
Spock2
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SPOCK2 mRNA
CTD
PMID:22129741
NCBI chr20:28,037,334...28,064,272
Ensembl chr20:28,033,475...28,064,272
G
Spp1
secreted phosphoprotein 1
affects expression
EXP
indole-3-carbinol affects the expression of SPP1 mRNA
CTD
PMID:21396975
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Sprr1a
small proline-rich protein 1A
affects expression
EXP
indole-3-carbinol affects the expression of SPRR1A mRNA
CTD
PMID:21396975
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Srcap
Snf2-related CREBBP activator protein
affects expression
EXP
indole-3-carbinol affects the expression of SRCAP mRNA
CTD
PMID:21396975
NCBI chr 1:182,123,562...182,172,643
Ensembl chr 1:182,118,416...182,176,610
G
Srd5a1
steroid 5 alpha-reductase 1
affects expression
EXP
indole-3-carbinol affects the expression of SRD5A1 mRNA
CTD
PMID:21396975
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srebf1
sterol regulatory element binding transcription factor 1
affects expression
EXP
indole-3-carbinol affects the expression of SREBF1 mRNA
CTD
PMID:21396975
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srfbp1
serum response factor binding protein 1
affects expression
EXP
indole-3-carbinol affects the expression of SRFBP1 mRNA
CTD
PMID:21396975
NCBI chr18:45,920,389...45,945,385
Ensembl chr18:45,920,446...45,942,515
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SRMS mRNA
CTD
PMID:22129741
NCBI chr 3:168,318,511...168,324,915
Ensembl chr 3:168,318,512...168,324,915
G
Sry
sex determining region Y
affects expression
EXP
indole-3-carbinol affects the expression of SRY mRNA
CTD
PMID:21396975
NCBI chr Y:441,525...442,037
G
Ssc5d
scavenger receptor cysteine rich family member with 5 domains
affects expression
EXP
indole-3-carbinol affects the expression of SSC5D mRNA
CTD
PMID:21396975
NCBI chr 1:68,891,942...68,910,462
Ensembl chr 1:68,891,949...68,909,743
G
St14
ST14 transmembrane serine protease matriptase
affects expression
EXP
indole-3-carbinol affects the expression of ST14 mRNA
CTD
PMID:21396975
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:29,540,811...29,581,517
G
St6galnac2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
affects expression
EXP
indole-3-carbinol affects the expression of ST6GALNAC2 mRNA
CTD
PMID:21396975
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
G
Stac3
SH3 and cysteine rich domain 3
affects expression
EXP
indole-3-carbinol affects the expression of STAC3 mRNA
CTD
PMID:21396975
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
G
Stard3nl
STARD3 N-terminal like
affects expression
EXP
indole-3-carbinol affects the expression of STARD3NL mRNA
CTD
PMID:21396975
NCBI chr17:45,583,278...45,617,226
Ensembl chr17:45,583,266...45,617,226
G
Stmn1
stathmin 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of STMN1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of STMN1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stra8
stimulated by retinoic acid 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of STRA8 mRNA
CTD
PMID:22129741
NCBI chr 4:63,601,443...63,624,777
Ensembl chr 4:63,601,604...63,624,771
G
Stx6
syntaxin 6
affects expression
EXP
indole-3-carbinol affects the expression of STX6 mRNA
CTD
PMID:21396975
NCBI chr13:67,332,329...67,378,580
Ensembl chr13:67,332,314...67,378,576
G
Stx7
syntaxin 7
affects expression
EXP
indole-3-carbinol affects the expression of STX7 mRNA
CTD
PMID:21396975
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Sugct
succinylCoA:glutarate-CoA transferase
affects expression
EXP
indole-3-carbinol affects the expression of SUGCT mRNA
CTD
PMID:21396975
NCBI chr17:47,376,392...48,234,362
Ensembl chr17:47,376,521...48,234,376
G
Sult1e1
sulfotransferase family 1E member 1
affects expression
EXP
indole-3-carbinol affects the expression of SULT1E1 mRNA
CTD
PMID:21396975
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SULT2A1 mRNA
CTD
PMID:22129741
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Sult2b1
sulfotransferase family 2B member 1
affects expression
EXP
indole-3-carbinol affects the expression of SULT2B1 mRNA
CTD
PMID:21396975
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Supt3h
SPT3 homolog, SAGA and STAGA complex component
affects expression
EXP
indole-3-carbinol affects the expression of SUPT3H mRNA
CTD
PMID:21396975
NCBI chr 9:15,878,296...16,206,768
Ensembl chr 9:15,868,287...16,206,706
G
Susd1
sushi domain containing 1
affects expression
EXP
indole-3-carbinol affects the expression of SUSD1 mRNA
CTD
PMID:21396975
NCBI chr 5:74,157,653...74,281,171
Ensembl chr 5:74,157,773...74,276,291
G
Sycp3
synaptonemal complex protein 3
affects expression
EXP
indole-3-carbinol affects the expression of SYCP3 mRNA
CTD
PMID:21396975
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Syngr1
synaptogyrin 1
affects expression
EXP
indole-3-carbinol affects the expression of SYNGR1 mRNA
CTD
PMID:21396975
NCBI chr 7:111,635,911...111,659,341
Ensembl chr 7:111,635,918...111,659,341
G
Syt16
synaptotagmin 16
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SYT16 mRNA
CTD
PMID:22129741
NCBI chr 6:92,721,415...92,972,140
Ensembl chr 6:92,721,101...92,971,748
G
Syt3
synaptotagmin 3
affects expression
EXP
indole-3-carbinol affects the expression of SYT3 mRNA
CTD
PMID:21396975
NCBI chr 1:94,880,835...94,895,518
Ensembl chr 1:94,881,247...94,895,246
G
Taar5
trace amine-associated receptor 5
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TAAR5 mRNA
CTD
PMID:22129741
NCBI chr 1:21,469,923...21,470,936
Ensembl chr 1:21,469,923...21,470,936
G
Tada3lb
transcriptional adaptor 3 (NGG1 homolog, yeast)-like B
affects expression
EXP
indole-3-carbinol affects the expression of TADA3LB mRNA
CTD
PMID:21396975
NCBI chr17:42,510,228...42,511,974
G
Tafa1
TAFA chemokine like family member 1
affects expression
EXP
indole-3-carbinol affects the expression of TAFA1 mRNA
CTD
PMID:21396975
NCBI chr 4:128,738,028...129,244,223
Ensembl chr 4:128,739,313...129,243,777
G
Tango2
transport and golgi organization 2 homolog
affects expression
EXP
indole-3-carbinol affects the expression of TANGO2 mRNA
CTD
PMID:21396975
NCBI chr11:82,645,978...82,692,574
Ensembl chr11:82,645,974...82,692,574
G
Tars1
threonyl-tRNA synthetase 1
affects expression
EXP
indole-3-carbinol affects the expression of TARS1 mRNA
CTD
PMID:21396975
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tas2r108
taste receptor, type 2, member 108
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TAS2R108 mRNA
CTD
PMID:22129741
NCBI chr 4:69,287,667...69,288,581
Ensembl chr 4:69,287,667...69,288,581
G
Tbc1d30
TBC1 domain family, member 30
affects expression
EXP
indole-3-carbinol affects the expression of TBC1D30 mRNA
CTD
PMID:21396975
NCBI chr 7:56,779,570...56,869,092
Ensembl chr 7:56,782,165...56,870,515
G
Tbc1d31
TBC1 domain family, member 31
affects expression
EXP
indole-3-carbinol affects the expression of TBC1D31 mRNA
CTD
PMID:21396975
NCBI chr 7:89,427,354...89,506,894
Ensembl chr 7:89,426,780...89,506,894
G
Tbc1d8
TBC1 domain family, member 8
affects expression
EXP
indole-3-carbinol affects the expression of TBC1D8 mRNA
CTD
PMID:21396975
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
G
Tbl1xr1
TBL1X/Y related 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TBL1XR1 mRNA
CTD
PMID:22129741
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tc2n
tandem C2 domains, nuclear
affects expression
EXP
indole-3-carbinol affects the expression of TC2N mRNA
CTD
PMID:21396975
NCBI chr 6:120,761,112...120,856,835
Ensembl chr 6:120,761,119...120,849,326
G
Tceal9
transcription elongation factor A like 9
affects expression
EXP
indole-3-carbinol affects the expression of TCEAL9 mRNA
CTD
PMID:21396975
NCBI chr X:99,245,645...99,247,720
Ensembl chr X:99,228,458...99,247,763
G
Tcp11l1
t-complex 11 like 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TCP11L1 mRNA
CTD
PMID:22129741
NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006
G
Tdpoz2l1
TD and POZ domain containing 2 like 1
affects expression
EXP
indole-3-carbinol affects the expression of TDPOZ2L1 mRNA
CTD
PMID:21396975
NCBI chr 2:179,601,807...179,602,949
Ensembl chr 2:179,601,834...179,602,964
G
Tekt3
tektin 3
affects expression
EXP
indole-3-carbinol affects the expression of TEKT3 mRNA
CTD
PMID:21396975
NCBI chr10:47,729,635...47,763,589
Ensembl chr10:47,729,635...47,763,588
G
Tenm2
teneurin transmembrane protein 2
affects expression
EXP
indole-3-carbinol affects the expression of TENM2 mRNA
CTD
PMID:21396975
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
G
Tes
testin LIM domain protein
affects expression
EXP
indole-3-carbinol affects the expression of TES mRNA
CTD
PMID:21396975
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
G
Tex13b
testis expressed 13B
affects expression
EXP
indole-3-carbinol affects the expression of TEX13B mRNA
CTD
PMID:21396975
NCBI chr X:104,490,937...104,511,224
Ensembl chr X:104,490,091...104,494,201
G
Tex9
testis expressed 9
affects expression
EXP
indole-3-carbinol affects the expression of TEX9 mRNA
CTD
PMID:21396975
NCBI chr 8:73,168,519...73,213,935
Ensembl chr 8:73,177,810...73,214,261
G
Tff1
trefoil factor 1
decreases expression
ISO
indole-3-carbinol results in decreased expression of TFF1 protein
CTD
PMID:11110848
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tfpi
tissue factor pathway inhibitor
affects expression
EXP
indole-3-carbinol affects the expression of TFPI mRNA
CTD
PMID:21396975
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO EXP
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of TGFB1 mRNA indole-3-carbinol inhibits the reaction [letrozole results in increased expression of TGFB1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in increased expression of TGFB1 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in increased expression of TGFB1 protein]]
CTD
PMID:21948866 PMID:28619389
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
multiple interactions increases expression
ISO
Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of TGFB2 mRNA]
CTD
PMID:21948866
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
increases expression multiple interactions
ISO
indole-3-carbinol results in increased expression of TGFB3 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of TGFB3 mRNA]
CTD
PMID:21948866
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgm1
transglutaminase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TGM1 mRNA
CTD
PMID:22129741
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tgm4
transglutaminase 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TGM4 mRNA
CTD
PMID:22129741
NCBI chr 8:122,689,429...122,726,463
Ensembl chr 8:122,689,429...122,726,463
G
Them6
thioesterase superfamily member 6
affects expression
EXP
indole-3-carbinol affects the expression of THEM6 mRNA
CTD
PMID:21396975
NCBI chr 7:106,606,570...106,609,747
Ensembl chr 7:106,606,570...106,609,746
G
Thop1
thimet oligopeptidase 1
affects expression
EXP
indole-3-carbinol affects the expression of THOP1 mRNA
CTD
PMID:21396975
NCBI chr 7:8,632,911...8,645,339
Ensembl chr 7:8,632,916...8,645,275
G
Timm21
translocase of inner mitochondrial membrane 21
affects expression
EXP
indole-3-carbinol affects the expression of TIMM21 mRNA
CTD
PMID:21396975
NCBI chr18:78,314,900...78,319,362
Ensembl chr18:78,314,909...78,319,454
G
Timm50
translocase of inner mitochondrial membrane 50
affects expression
EXP
indole-3-carbinol affects the expression of TIMM50 mRNA
CTD
PMID:21396975
NCBI chr 1:83,574,872...83,582,748
Ensembl chr 1:83,556,757...83,582,793
G
Timm9
translocase of inner mitochondrial membrane 9
affects expression
EXP
indole-3-carbinol affects the expression of TIMM9 mRNA
CTD
PMID:21396975
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Tlr3
toll-like receptor 3
affects expression
EXP
indole-3-carbinol affects the expression of TLR3 mRNA
CTD
PMID:21396975
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tma16
translation machinery associated 16 homolog
affects expression
EXP
indole-3-carbinol affects the expression of TMA16 mRNA
CTD
PMID:21396975
NCBI chr16:23,236,686...23,252,706
Ensembl chr16:23,236,710...23,252,701
G
Tmbim7
transmembrane BAX inhibitor motif containing 7
affects expression
EXP
indole-3-carbinol affects the expression of TMBIM7 mRNA
CTD
PMID:21396975
NCBI chr 4:30,466,651...30,499,565
Ensembl chr 4:30,466,653...30,499,256
G
Tmcc1
transmembrane and coiled-coil domain family 1
affects expression
EXP
indole-3-carbinol affects the expression of TMCC1 mRNA
CTD
PMID:21396975
NCBI chr 4:149,069,252...149,239,585
Ensembl chr 4:149,069,260...149,239,620
G
Tmem102
transmembrane protein 102
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of TMEM102 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMEM102 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:54,523,901...54,525,997
Ensembl chr10:54,523,585...54,525,990
G
Tmem130
transmembrane protein 130
affects expression
EXP
indole-3-carbinol affects the expression of TMEM130 mRNA
CTD
PMID:21396975
NCBI chr12:9,837,055...9,862,843
Ensembl chr12:9,837,055...9,862,840
G
Tmem140
transmembrane protein 140
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TMEM140 mRNA
CTD
PMID:22129741
NCBI chr 4:63,536,477...63,547,478
Ensembl chr 4:63,536,168...63,548,455
G
Tmem150c
transmembrane protein 150C
affects expression
EXP
indole-3-carbinol affects the expression of TMEM150C mRNA
CTD
PMID:21396975
NCBI chr14:9,454,999...9,525,300
Ensembl chr14:9,508,515...9,525,298
G
Tmem163
transmembrane protein 163
affects expression
EXP
indole-3-carbinol affects the expression of TMEM163 mRNA
CTD
PMID:21396975
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
G
Tmem164
transmembrane protein 164
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMEM164 mRNA
CTD
PMID:22129741
NCBI chr X:106,288,019...106,448,642
Ensembl chr X:106,289,371...106,448,640
G
Tmem171
transmembrane protein 171
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of TMEM171 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMEM171 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049
G
Tmem184c
transmembrane protein 184C
affects expression
EXP
indole-3-carbinol affects the expression of TMEM184C mRNA
CTD
PMID:21396975
NCBI chr19:30,345,183...30,361,275
Ensembl chr19:30,345,290...30,361,269
G
Tmem220
transmembrane protein 220
affects expression
EXP
indole-3-carbinol affects the expression of TMEM220 mRNA
CTD
PMID:21396975
NCBI chr10:51,719,777...51,728,792
Ensembl chr10:51,719,777...51,728,776
G
Tmem231
transmembrane protein 231
affects expression
EXP
indole-3-carbinol affects the expression of TMEM231 mRNA
CTD
PMID:21396975
NCBI chr19:39,883,077...39,904,296
Ensembl chr19:39,883,077...39,904,269
G
Tmem67
transmembrane protein 67
affects expression
EXP
indole-3-carbinol affects the expression of TMEM67 mRNA
CTD
PMID:21396975
NCBI chr 5:25,536,458...25,589,378
Ensembl chr 5:25,536,458...25,589,334
G
Tmem97
transmembrane protein 97
affects expression
EXP
indole-3-carbinol affects the expression of TMEM97 mRNA
CTD
PMID:21396975
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmprss7
transmembrane serine protease 7
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMPRSS7 mRNA
CTD
PMID:22129741
NCBI chr11:55,127,992...55,166,597
Ensembl chr11:55,128,998...55,164,882
G
Tmsb10
thymosin, beta 10
affects expression
EXP
indole-3-carbinol affects the expression of TMSB10 mRNA
CTD
PMID:21396975
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmtc4
transmembrane O-mannosyltransferase targeting cadherins 4
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMTC4 mRNA
CTD
PMID:22129741
NCBI chr15:100,000,157...100,056,573
Ensembl chr15:100,000,152...100,056,543
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
indole-3-carbinol inhibits the reaction [TNF protein affects the localization of RELA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of CHUK protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of IKBKB protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of RELA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC2 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC3 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC5 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of TRAF1 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of XIAP protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased ubiquitination of NFKBIA protein]; indole-3-carbinol promotes the reaction [TNF protein results in increased cleavage of PARP1 protein] [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of TNF protein; indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of TNF protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] [Hemin co-treated with indole-3-carbinol co-treated with 1,2-Dimethylhydrazine] affects the expression of TNF mRNA; indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TNF protein]; indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of TNF protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of TNF protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TNF protein]]
CTD
PMID:15811958 PMID:21948866 PMID:24200994 PMID:28619389 PMID:29269057 PMID:29775573 PMID:37150287 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip8
TNF alpha induced protein 8
affects expression
EXP
indole-3-carbinol affects the expression of TNFAIP8 mRNA
CTD
PMID:21396975
NCBI chr18:45,370,334...45,486,036
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf11a
TNF receptor superfamily member 11A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TNFRSF11A mRNA
CTD
PMID:22129741
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf12a
TNF receptor superfamily member 12A
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of TNFRSF12A mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TNFRSF12A mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf13c
TNF receptor superfamily member 13C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF13C mRNA
CTD
PMID:22129741
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
G
Tnfrsf19
TNF receptor superfamily member 19
affects expression
EXP
indole-3-carbinol affects the expression of TNFRSF19 mRNA
CTD
PMID:21396975
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA
CTD
PMID:22129741
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
G
Tnnc1
troponin C1, slow skeletal and cardiac type
affects expression
EXP
indole-3-carbinol affects the expression of TNNC1 mRNA
CTD
PMID:21396975
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
G
Tns3
tensin 3
affects expression
EXP
indole-3-carbinol affects the expression of TNS3 mRNA
CTD
PMID:21396975
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
G
Togaram1
TOG array regulator of axonemal microtubules 1
affects expression
EXP
indole-3-carbinol affects the expression of TOGARAM1 mRNA
CTD
PMID:21396975
NCBI chr 6:83,019,025...83,083,343
Ensembl chr 6:83,018,859...83,082,807
G
Tomm5
translocase of outer mitochondrial membrane 5
affects expression
EXP
indole-3-carbinol affects the expression of TOMM5 mRNA
CTD
PMID:21396975
NCBI chr 5:59,362,360...59,365,191
Ensembl chr 5:59,362,240...59,365,269
G
Top2a
DNA topoisomerase II alpha
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TOP2A mRNA
CTD
PMID:22129741
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tor3a
torsin family 3, member A
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of TOR3A mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TOR3A mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TOR3A mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TOR3A mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
G
Tp53
tumor protein p53
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of TP53 protein indole-3-carbinol results in increased expression of and results in increased phosphorylation of TP53 protein
CTD
PMID:29992829 PMID:34085558
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tpm1
tropomyosin 1
affects expression
EXP
indole-3-carbinol affects the expression of TPM1 mRNA
CTD
PMID:21396975
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
G
Traf1
TNF receptor-associated factor 1
multiple interactions
ISO
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of TRAF1 protein]
CTD
PMID:15811958
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:18,222,054...18,241,807
G
Traf3ip2
Traf3 interacting protein 2
affects expression
EXP
indole-3-carbinol affects the expression of TRAF3IP2 mRNA
CTD
PMID:21396975
NCBI chr20:44,565,992...44,609,240
Ensembl chr20:43,011,450...43,054,667
G
Trappc2
trafficking protein particle complex subunit 2
affects expression
EXP
indole-3-carbinol affects the expression of TRAPPC2 mRNA
CTD
PMID:21396975
NCBI chr X:28,004,051...28,015,336
Ensembl chr X:27,994,054...28,015,346
G
Trib1
tribbles pseudokinase 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRIB1 mRNA
CTD
PMID:22129741
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trib3
tribbles pseudokinase 3
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of TRIB3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TRIB3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim37
tripartite motif-containing 37
affects expression
EXP
indole-3-carbinol affects the expression of TRIM37 mRNA
CTD
PMID:21396975
NCBI chr10:71,943,384...72,075,563
Ensembl chr10:71,943,375...72,075,558
G
Trmo
tRNA methyltransferase O
affects expression
EXP
indole-3-carbinol affects the expression of TRMO mRNA
CTD
PMID:21396975
NCBI chr 5:60,663,106...60,676,423
Ensembl chr 5:60,667,864...60,676,423
G
Trmt6
tRNA methyltransferase 6 non-catalytic subunit
affects expression
EXP
indole-3-carbinol affects the expression of TRMT6 mRNA
CTD
PMID:21396975
NCBI chr 3:120,074,899...120,086,639
Ensembl chr 3:120,074,911...120,086,559
G
Troap
trophinin associated protein
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TROAP mRNA
CTD
PMID:22129741
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
G
Trpc7
transient receptor potential cation channel, subfamily C, member 7
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TRPC7 mRNA
CTD
PMID:22129741
NCBI chr17:7,708,911...7,833,435
Ensembl chr17:7,709,583...7,833,435
G
Trpm4
transient receptor potential cation channel, subfamily M, member 4
affects expression
EXP
indole-3-carbinol affects the expression of TRPM4 mRNA
CTD
PMID:21396975
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
G
Tsen2
tRNA splicing endonuclease subunit 2
affects expression
EXP
indole-3-carbinol affects the expression of TSEN2 mRNA
CTD
PMID:21396975
NCBI chr 4:148,602,805...148,638,219
Ensembl chr 4:148,602,863...148,638,215
G
Tsku
tsukushi, small leucine rich proteoglycan
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TSKU mRNA
CTD
PMID:22129741
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Tspan8
tetraspanin 8
affects expression
EXP
indole-3-carbinol affects the expression of TSPAN8 mRNA
CTD
PMID:21396975
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
G
Tssk1b
testis-specific serine kinase 1B
multiple interactions
EXP
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of TSSK1 mRNA]
CTD
PMID:27178563
NCBI chr11:83,090,930...83,092,353
Ensembl chr11:83,086,578...83,093,011
G
Ttc23
tetratricopeptide repeat domain 23
affects expression
EXP
indole-3-carbinol affects the expression of TTC23 mRNA
CTD
PMID:21396975
NCBI chr 1:121,245,996...121,329,500
Ensembl chr 1:121,248,084...121,329,494
G
Ttc39a
tetratricopeptide repeat domain 39A
affects expression
EXP
indole-3-carbinol affects the expression of TTC39A mRNA
CTD
PMID:21396975
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttc39b
tetratricopeptide repeat domain 39B
affects expression
EXP
indole-3-carbinol affects the expression of TTC39B mRNA
CTD
PMID:21396975
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270
G
Ttc7b
tetratricopeptide repeat domain 7B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA
CTD
PMID:22129741
NCBI chr 6:119,587,389...119,799,167
Ensembl chr 6:119,587,390...119,799,330
G
Ttc9b
tetratricopeptide repeat domain 9B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC9B mRNA
CTD
PMID:22129741
NCBI chr 1:82,953,434...82,955,659
Ensembl chr 1:82,953,434...82,955,616
G
Ttl
tubulin tyrosine ligase
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TTL mRNA
CTD
PMID:22129741
NCBI chr 3:116,298,813...116,328,538
Ensembl chr 3:116,298,797...116,328,538
G
Tuba3b
tubulin, alpha 3B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TUBA3B mRNA
CTD
PMID:22129741
NCBI chr 4:178,588,779...178,594,328
Ensembl chr 4:178,588,779...178,594,326
G
Tubb6
tubulin, beta 6 class V
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TUBB6 mRNA
CTD
PMID:22129741
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tube1
tubulin, epsilon 1
affects expression
EXP
indole-3-carbinol affects the expression of TUBE1 mRNA
CTD
PMID:21396975
NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314
G
Tusc3
tumor suppressor candidate 3
affects expression
EXP
indole-3-carbinol affects the expression of TUSC3 mRNA
CTD
PMID:21396975
NCBI chr16:53,196,195...53,345,241
Ensembl chr16:53,196,195...53,344,781
G
Txn1
thioredoxin 1
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of TXN protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of TXN protein]
CTD
PMID:29992829 PMID:33118390
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txndc8
thioredoxin domain containing 8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TXNDC8 mRNA
CTD
PMID:22129741
NCBI chr 5:72,749,708...72,785,858
Ensembl chr 5:72,749,725...72,785,931
G
Ubd
ubiquitin D
affects expression
EXP
indole-3-carbinol affects the expression of UBD mRNA
CTD
PMID:21396975
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ube2c
ubiquitin-conjugating enzyme E2C
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UBE2C mRNA
CTD
PMID:22129741
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ufm1
ubiquitin-fold modifier 1
affects expression
EXP
indole-3-carbinol affects the expression of UFM1 mRNA
CTD
PMID:21396975
NCBI chr 2:137,969,476...137,977,620
Ensembl chr 2:137,966,678...137,978,089 Ensembl chr 2:137,966,678...137,978,089
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of UGT1A2 mRNA; indole-3-carbinol affects the expression of UGT1A3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A3 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of UGT1A6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A6 mRNA]
CTD
PMID:21396975 PMID:22129741
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a8
UDP glucuronosyltransferase family 1 member A8
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT1A8 mRNA
CTD
PMID:22129741
NCBI chr 9:88,727,094...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2a3
UDP glucuronosyltransferase family 2 member A3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2A3 mRNA
CTD
PMID:22129741
NCBI chr14:20,572,793...20,590,795
Ensembl chr14:20,572,808...20,590,729
G
Ugt2b
UDP glycosyltransferase 2 family, polypeptide B
affects expression
EXP
indole-3-carbinol affects the expression of UGT2B mRNA
CTD
PMID:21396975
NCBI chr14:20,630,572...20,665,062
Ensembl chr14:20,630,250...20,651,776
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
multiple interactions affects expression
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B17 mRNA indole-3-carbinol affects the expression of UGT2B1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b34l1
UDP glucuronosyltransferase 2 family, polypeptide B34 like 1
affects expression
EXP
indole-3-carbinol affects the expression of UGT2B34L1 mRNA
CTD
PMID:21396975
NCBI chr14:21,146,140...21,167,706
Ensembl chr14:21,145,827...21,167,704
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B34 mRNA
CTD
PMID:22129741
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of UHRF1 mRNA
CTD
PMID:22129741
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Unc13d
unc-13 homolog D
affects expression
EXP
indole-3-carbinol affects the expression of UNC13D mRNA
CTD
PMID:21396975
NCBI chr10:101,296,755...101,311,513
Ensembl chr10:101,296,776...101,311,687
G
Unc45b
unc-45 myosin chaperone B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UNC45B mRNA
CTD
PMID:22129741
NCBI chr10:67,845,464...67,873,143
Ensembl chr10:67,845,462...67,873,389
G
Unc5b
unc-5 netrin receptor B
affects expression
EXP
indole-3-carbinol affects the expression of UNC5B mRNA
CTD
PMID:21396975
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Upp2
uridine phosphorylase 2
affects expression
EXP
indole-3-carbinol affects the expression of UPP2 mRNA
CTD
PMID:21396975
NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417
G
Uprt
uracil phosphoribosyltransferase homolog
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UPRT mRNA
CTD
PMID:22129741
NCBI chr X:69,516,573...69,546,811
Ensembl chr X:69,516,738...69,546,797
G
Ush1c
USH1 protein network component harmonin
affects expression
EXP
indole-3-carbinol affects the expression of USH1C mRNA
CTD
PMID:21396975
NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671
G
Ush1g
USH1 protein network component sans
affects expression
EXP
indole-3-carbinol affects the expression of USH1G mRNA
CTD
PMID:21396975
NCBI chr10:100,559,721...100,563,590
Ensembl chr10:100,557,629...100,563,590
G
Usp11
ubiquitin specific peptidase 11
affects expression
EXP
indole-3-carbinol affects the expression of USP11 mRNA
CTD
PMID:21396975
NCBI chr X:1,473,349...1,489,520
Ensembl chr X:1,473,350...1,489,520
G
Ust4r
integral membrane transport protein UST4r
affects expression
EXP
indole-3-carbinol affects the expression of UST4R mRNA
CTD
PMID:21396975
NCBI chr 1:205,072,204...205,142,718
Ensembl chr 1:205,072,296...205,142,691
G
Ust5r
integral membrane transport protein UST5r
affects expression
EXP
indole-3-carbinol affects the expression of SLC22A25 mRNA
CTD
PMID:21396975
NCBI chr 1:205,210,558...205,286,868
Ensembl chr 1:205,211,034...205,286,718
G
Vav2
vav guanine nucleotide exchange factor 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VAV2 mRNA
CTD
PMID:22129741
NCBI chr 3:10,584,688...10,754,128
Ensembl chr 3:10,584,688...10,754,052
G
Vcpkmt
valosin containing protein lysine methyltransferase
affects expression
EXP
indole-3-carbinol affects the expression of VCPKMT mRNA
CTD
PMID:21396975
NCBI chr 6:88,036,485...88,042,151
Ensembl chr 6:88,036,494...88,042,000
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
indole-3-carbinol results in decreased expression of VEGFA protein
CTD
PMID:29775573
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VEGFB mRNA
CTD
PMID:22129741
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944
G
Vim
vimentin
decreases expression
ISO
indole-3-carbinol results in decreased expression of VIM protein
CTD
PMID:18025290
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Vkorc1l1
vitamin K epoxide reductase complex, subunit 1-like 1
affects expression
EXP
indole-3-carbinol affects the expression of VKORC1L1 mRNA
CTD
PMID:21396975
NCBI chr12:26,717,959...26,768,193
Ensembl chr12:26,623,976...26,768,225
G
Vmo1
vitelline membrane outer layer 1 homolog
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of VMO1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VMO1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VMO1 mRNA]
CTD
PMID:22129741
NCBI chr10:55,227,944...55,234,794
Ensembl chr10:55,227,944...55,229,289
G
Vnn1
vanin 1
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of VNN1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of VNN1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VNN1 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Vom2r1
vomeronasal 2 receptor, 1
affects expression
EXP
indole-3-carbinol affects the expression of VOM2R1 mRNA
CTD
PMID:21396975
NCBI chr 1:775,164...785,885
Ensembl chr 1:689,460...785,885
G
Vom2r2
vomeronasal 2 receptor, 2
affects expression
EXP
indole-3-carbinol affects the expression of VOM2R2 mRNA
CTD
PMID:21396975
Ensembl chr 1:689,460...785,885
G
Vom2r6
vomeronasal 2 receptor, 6
affects expression
EXP
indole-3-carbinol affects the expression of VOM2R6 mRNA
CTD
PMID:21396975
NCBI chr 1:1,214,035...1,222,755
Ensembl chr 1:1,161,832...1,224,262
G
Vom2r63
vomeronasal 2 receptor, 63
affects expression
EXP
indole-3-carbinol affects the expression of VOM2R63 mRNA
CTD
PMID:21396975
NCBI chr12:17,625,141...17,652,806
Ensembl chr12:17,625,091...17,652,806 Ensembl chr12:17,625,091...17,652,806
G
Vom2r65
vomeronasal 2 receptor, 65
affects expression
EXP
indole-3-carbinol affects the expression of VOM2R65 mRNA
CTD
PMID:21396975
G
Vpreb1b
V-set pre-B cell surrogate light chain 1B
affects expression
EXP
indole-3-carbinol affects the expression of VPREB1B mRNA
CTD
PMID:21396975
NCBI chr11:83,009,396...83,010,106
Ensembl chr11:83,009,396...83,010,106
G
Vps37a
VPS37A subunit of ESCRT-I
affects expression
EXP
indole-3-carbinol affects the expression of VPS37A mRNA
CTD
PMID:21396975
NCBI chr16:51,736,170...51,775,384
Ensembl chr16:51,737,481...51,775,390
G
Vrk2
VRK serine/threonine kinase 2
affects expression
EXP
indole-3-carbinol affects the expression of VRK2 mRNA
CTD
PMID:21396975
NCBI chr14:100,313,771...100,434,520
Ensembl chr14:100,313,601...100,434,527
G
Vwde
von Willebrand factor D and EGF domains
affects expression
EXP
indole-3-carbinol affects the expression of VWDE mRNA
CTD
PMID:21396975
NCBI chr 4:41,453,573...41,525,421
Ensembl chr 4:41,455,281...41,533,374
G
Vwf
von Willebrand factor
affects expression
EXP
indole-3-carbinol affects the expression of VWF mRNA
CTD
PMID:21396975
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Wdr35
WD repeat domain 35
affects expression
EXP
indole-3-carbinol affects the expression of WDR35 mRNA
CTD
PMID:21396975
NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
G
Wdr73
WD repeat domain 73
affects expression
EXP
indole-3-carbinol affects the expression of WDR73 mRNA
CTD
PMID:21396975
NCBI chr 1:134,860,329...134,868,475
Ensembl chr 1:134,860,180...134,868,479
G
Wfdc6a
WAP four-disulfide core domain 6A
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of WFDC6A mRNA
CTD
PMID:22129741
NCBI chr 3:153,305,336...153,309,144
Ensembl chr 3:153,305,336...153,309,144
G
Wnt3a
Wnt family member 3A
affects expression
EXP
indole-3-carbinol affects the expression of WNT3A mRNA
CTD
PMID:21396975
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Wnt4
Wnt family member 4
affects expression
EXP
indole-3-carbinol affects the expression of WNT4 mRNA
CTD
PMID:21396975
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Wwc2
WW and C2 domain containing 2
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of WWC2 mRNA
CTD
PMID:22129741
NCBI chr16:44,258,372...44,421,815
Ensembl chr16:44,258,372...44,421,812
G
Wwox
WW domain-containing oxidoreductase
affects expression
EXP
indole-3-carbinol affects the expression of WWOX mRNA
CTD
PMID:21396975
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:42,432,152...43,359,391
G
Xiap
X-linked inhibitor of apoptosis
decreases expression multiple interactions
ISO
indole-3-carbinol results in decreased expression of XIAP indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of XIAP protein]
CTD
PMID:15811958 PMID:16082211
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xpa
XPA, DNA damage recognition and repair factor
affects expression
EXP
indole-3-carbinol affects the expression of XPA mRNA
CTD
PMID:21396975
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:60,431,673...60,475,726
G
Xpr1
xenotropic and polytropic retrovirus receptor 1
affects expression
EXP
indole-3-carbinol affects the expression of XPR1 mRNA
CTD
PMID:21396975
NCBI chr13:67,441,205...67,585,950
Ensembl chr13:67,446,380...67,585,946
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
decreases phosphorylation
ISO
indole-3-carbinol results in decreased phosphorylation of YWHAQ protein
CTD
PMID:29992829
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:40,935,949...40,966,273
G
Zan
zonadhesin
affects expression
EXP
indole-3-carbinol affects the expression of ZAN mRNA
CTD
PMID:21396975
NCBI chr12:19,215,018...19,322,789
Ensembl chr12:19,215,102...19,271,240
G
Zbtb16
zinc finger and BTB domain containing 16
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZBTB16 mRNA
CTD
PMID:22129741
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
Zbtb21
zinc finger and BTB domain containing 21
affects expression
EXP
indole-3-carbinol affects the expression of ZBTB21 mRNA
CTD
PMID:21396975
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
G
Zbtb40
zinc finger and BTB domain containing 40
affects expression
EXP
indole-3-carbinol affects the expression of ZBTB40 mRNA
CTD
PMID:21396975
NCBI chr 5:149,216,496...149,283,746
Ensembl chr 5:149,219,677...149,254,415
G
Zbtb41
zinc finger and BTB domain containing 41
affects expression
EXP
indole-3-carbinol affects the expression of ZBTB41 mRNA
CTD
PMID:21396975
NCBI chr13:51,042,948...51,065,768
Ensembl chr13:51,042,948...51,065,768
G
Zbtb8os
zinc finger and BTB domain containing 8 opposite strand
affects expression
EXP
indole-3-carbinol affects the expression of ZBTB8OS mRNA
CTD
PMID:21396975
NCBI chr 5:141,675,595...141,687,148
Ensembl chr 5:141,675,857...141,688,660
G
Zc3h15l1
zinc finger CCCH-type containing 15 like 1
affects expression
EXP
indole-3-carbinol affects the expression of ZC3H15L1 mRNA
CTD
PMID:21396975
NCBI chr17:43,670,444...43,671,788
Ensembl chr17:43,670,508...43,671,788
G
Zc3h3
zinc finger CCCH type containing 3
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZC3H3 mRNA
CTD
PMID:22129741
NCBI chr 7:107,440,694...107,525,451
Ensembl chr 7:107,440,694...107,525,451
G
Zdhhc19
zinc finger DHHC-type palmitoyltransferase 19
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZDHHC19 mRNA
CTD
PMID:22129741
NCBI chr11:68,277,847...68,289,110
Ensembl chr11:68,277,848...68,288,954
G
Zdhhc2
zinc finger DHHC-type palmitoyltransferase 2
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ZDHHC2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZDHHC2 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr16:51,808,465...51,878,060
Ensembl chr16:51,808,468...51,878,060
G
Zeb2
zinc finger E-box binding homeobox 2
affects expression
EXP
indole-3-carbinol affects the expression of ZEB2 mRNA
CTD
PMID:21396975
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:29,218,301...29,345,157
G
Zfand2a
zinc finger AN1-type containing 2A
affects expression
EXP
indole-3-carbinol affects the expression of ZFAND2A mRNA
CTD
PMID:21396975
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfhx4
zinc finger homeobox 4
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ZFHX4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFHX4 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 2:96,224,763...96,408,245
Ensembl chr 2:96,224,767...96,408,228
G
Zfp24
zinc finger protein 24
affects expression
EXP
indole-3-carbinol affects the expression of ZFP24 mRNA
CTD
PMID:21396975
NCBI chr18:15,295,687...15,307,319
Ensembl chr18:15,298,290...15,306,799
G
Zfp362
zinc finger protein 362
affects expression
EXP
indole-3-carbinol affects the expression of ZFP362 mRNA
CTD
PMID:21396975
NCBI chr 5:141,119,073...141,153,304
Ensembl chr 5:141,119,898...141,156,716
G
Zfp386
zinc finger protein 386 (Kruppel-like)
affects expression
EXP
indole-3-carbinol affects the expression of ZFP386 mRNA
CTD
PMID:21396975
NCBI chr 6:136,966,547...136,984,013
Ensembl chr 6:136,966,586...136,983,441
G
Zfp395
zinc finger protein 395
multiple interactions
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA
CTD
PMID:22129741
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp639
zinc finger protein 639
affects expression
EXP
indole-3-carbinol affects the expression of ZFP639 mRNA
CTD
PMID:21396975
NCBI chr 2:115,292,431...115,305,798
Ensembl chr 2:115,292,516...115,303,628
G
Zftraf1
zinc finger TRAF type containing 1
affects expression
EXP
indole-3-carbinol affects the expression of ZFTRAF1 mRNA
CTD
PMID:21396975
NCBI chr 7:108,363,989...108,377,428
Ensembl chr 7:108,364,381...108,380,021
G
Zfyve9
zinc finger FYVE-type containing 9
affects expression
EXP
indole-3-carbinol affects the expression of ZFYVE9 mRNA
CTD
PMID:21396975
NCBI chr 5:123,370,677...123,529,699
Ensembl chr 5:123,370,677...123,529,699
G
Zmynd12
zinc finger, MYND-type containing 12
affects expression multiple interactions
EXP
indole-3-carbinol affects the expression of ZMYND12 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZMYND12 mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr 5:133,026,917...133,059,985
Ensembl chr 5:133,027,009...133,059,995
G
Zswim6
zinc finger, SWIM-type containing 6
affects expression
EXP
indole-3-carbinol affects the expression of ZSWIM6 mRNA
CTD
PMID:21396975
NCBI chr 2:39,211,131...39,378,877
Ensembl chr 2:39,212,949...39,378,924
G
Zwint
ZW10 interacting kinetochore protein
multiple interactions affects expression
EXP
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZWINT mRNA indole-3-carbinol affects the expression of ZWINT mRNA
CTD
PMID:21396975 PMID:22129741
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all